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Footprinting of Oligonucleotides on Double Helical 
DNA using MPEoFe(II), DNase I, and Dimethyl Sulfate 
Pyrimidine oligonucleotides can, when equipped with the thymidine-
EDT A - Fe(II) analogue (T*), recognize and subsequently cleave double helical 
DNA at binding sites> 15 base pairs in size. If binding affinities of unmodified 
oligonucleotides are to be determined under conditions relevant to those in 
vivo, alternate methods of detecting oligonucleotide-directed triple helix 
formation are required. The footprinting of short (up to 15 base pairs) triple 
helical regions on restriction fragment size DNA has been undertaken. 
Techniques for the determination of o ligonucleo tide binding to double 
helical DNA using MPE-Fe(II), DNase I, and dimethyl sulfate have been 
developed. MPE· Fe(II) allows for the determination of binding site size, and 
has shown that oligonucleo tide binding to DNA is cation concentration, 
solvent, and oligonucleotide length dependent. DNase I footprinting was 
conducted under conditions optimal fo r DNase I activity (10 mM in each 
Mg+2 and Ca+2), demonstrating tha t oligonucleotide-directed triplexes are 
capable of interfering with protein activity at the oligonucleotide binding site 
under physiological conditions, and that divalent cations can stabilize triple 
helix formation. Footprinting using dimethyl sulfate reveals that a single 
guanine 3' to the binding site becomes hyperreac tive to m ethylation upon 
triplex formation. This sugges ts that the triplex-duplex junction involves a 
change in DNA conformation which is largely limited to a single base pair. 
v 
DMS footprinting revea ls that the oligonucleotide CT-IS (Ts(CT)s) does not 
bind the terminal 2 base pairs of the binding site in plasmid pDMAGIO. DMS 
footprinting can be used to analyze the binding of oligonucleotides to DNA 
under conditions not amenable to MPEoFe(II) or DNase I activity, and to assay 
the kinetics of oligonucleotide binding. DMS and DNase I footprinting 
techniques were used to assay for the effect of oligonucleotide concentration 
and base composition on binding affinity. 
vi 
Chapter III 
Oligonucleotide-Directed Triple Helix Formation using 
Oligonucleotides with Increased Binding Affinities 
The specificity offered by the triple helix motif might provide a method for 
the artificial repression of gene expression and viral diseases. Changes in 
oligonucleotide s tructure could be used to control oligonucleotide affinity 
under in vivo conditions, where temporal and spatial intracellular pH (7.0 -
7.4) and ionic strength are strictly regulated and cannot be altered. Substitution 
at position 5 of pyrimidines alters the hydrophobic driving force, base stacking, 
and the electronic complementarity of the Hoogsteen base pairing for triple 
helix formation. Incorporation of 5-substituted pyrimidines offers a method of 
modulating binding affinity without changing the hydrogen bonding pattern 
and sequence specificities of pyrimidine oligonucleotides. Replacement of 2'-
d eoxycytidine with 5-methyl-2'-deoxycytidine increases the oligonucleotide 
affinity and extends the pH range for binding. Substitution of 5-bromo-2'-
d eoxyuridine for thymidine increases binding affini ty . Oligonucleotides 
constructed with 2'-deoxyuridine show lower binding affinities. Pyrimidine 
oligonucleotides constructed from 5-iodo-2'-deoxyuridines and 5-ethynyl-2'-
deoxyuridines display increased binding affinities relative to thymidine, but 
decreased relative to 5-bromouridine containing Oligonucleotides. Substitution 
by ethyl, pentyl, pentynyl, 2-phenyl-ethynyl, or fluoro at the 5 position of 2'-
deoxyuridine or bromo at the 5 position of 2'-deoxycytidine residues results in 
oligonucleotides with decreased binding affinities for double helical DNA. 
vii 
Chapter IV 
Efficient, Base-Specific Alkylation of DNA 
using N-Bromoacetyloligonucleotides 
The attachment of a non-specific diffusible cleaving functionality to a 
DNA binding molecule allows for the elucidation of the s tructural principles 
for DNA recognition, a technique termed affinity cleaving. Once these 
principles have been determined, it becomes p ossible to design and attach 
structural domains d esigned to carry out a desired DNA modification. The 
development of a thymidine derivative capable of efficient and base specific 
DNA modification is reported. N-bromoacetyloligonucleotides are capable of 
near quantitative double strand modification of double helical DNA at a single 
guanine position in a manner which produces ends which are ligatable with 
compatible ends produced by conventional restriction enzyme digestion. The 
products thus produced are capable of transforming bacterial cell lines. N-
bromoacety loligonucleo tides modify double he lical DNA with specificities 
great enough to produce efficient (>90 %) chemical cleavage at a single site 
within a yeast chromosome 340 kbp in size. 
The acceleration obtained by tethering a reactive moiety to a DNA binding 
unit has been estimated. The rate of alkylation of DNA by N-
bromoacetyloligonucleotides and bromoacetamide has been measured. 
Comparison of these ra tes indicates that an effective molarity of 2-3 M is 
obtained upon tethering the bromoacetyl moiety to an oligonucleotide to effect 
triple helix mediated DNA alkylation. 
vii i 
The utility of the bromoacetyl moiety as a reporter group is shown in 
studies concerning the effect of oligonucleotide length on binding affinity and 
the cooperative interaction between oligonucleotides binding abutting sites is 
reported. 
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Chapter I 
Introduction to Oligonucleotide-Directed Recognition 
of Double Helical DNA and Triple Helical DNA Complexes 
The recognition of specific DNA sequences, the folding of proteins into 
functional domains, signal transduction via the recognition of messenger 
molecules follwed by induced allosteric changes in protein structure, the 
discrimination between antigens and "self" epitopes by the immune system: 
these are a few of the fundamental biological processes controlled and 
directed by the formation of ensembles of individually weak interactions. 
The organic chemist has just begun to turn his attention in earnest to the 
study of how weak non-covalent interactions impart to biological systems the 
specificities and affinities which enable them to be sensitive to small changes 
in environment and to avidly bind minute quantities of the molecule of 
interest in the presence of myriads of other, often similar, structures. 
The problem of DNA recognition can only be solved once the rules for 
"non-covalent" chemistry are understood. The tools of molecular biology can 
be used to analyze large numbers of potential binding sites, allowing the rapid 
analysis of specificity and affinity. As is often the case, the scientist takes as an 
example the exquisite molecules constructed by nature. The living organism 
depends on the ability of molecules to recognize and bind sequences of DNA 
with high specificity and with binding constants which enable their actions to 
be felt under physiological conditions. The modern era of molecular biology 
2 
was ushered in with the discovery and isolation of molecules which can 
modify DNA quantitatively at specific sequences.1,2 Without reagents such as 
kinases, polymerases, and restriction endonucleases, common procedures 
such as gene isolation, DNA sequence determination, and DNA 
recombination and cloning would remain intractable tasks. 
The use of restriction enzymes to quantitatively cut DNA with almost 
absolute specificity at the recognition sequence is the foundation for 
laboratory DNA manipulation, enabling the study of not only the DNA, but 
the gene product of interest l ,2 The effectiveness of restriction enzymes, both 
as natural defense mechanisms and as tools in the laboratory, lies largely in 
their selectivity for the correct binding site and ability to effect quantitative 
reaction at that site. For instance, upon introduction of any incorrect base pair 
into the EcoR I binding site, the rate of cleavage decreases by five orders of 
magnitude.3 
Recent interest in the manipulation and sequencing of genomic DNA, 
however, has made the sequence specificities of commonly available 
restriction enzymes (4-8 base pairs) inadequate (Table 1)4,5 Molecules which 
recognize 8 base pair sequences cleave statistically once every 32,000 base pairs. 
Cleavage of human chromosomal DNA (average size = 130,000,000 base pairs) 
would result in the production of over 4,000 pieces. If manipulation of 
chromosomal DNA (up to 108 base pairs) is to become a reality, the 
recognition of unique sites> 14 base pairs in size will be necessary (Table 1.1).4 
The need for "rare cleaving" molecules capable of such specific 
recognition is reflected in the number of strategies which have been 
developed to extend the specificity of restriction enzymes to the 8-12 base pair 
level. 6-14 Molecules with >16 base pair specificities would allow the 
recognition of single sequences within human genomic size DNA, and might 
3 
additionally posses s therapeu tic significance as agents for specific gene 
repression or activa tio n. The challenge to build molecules possessing 
arbitrary DNA sequence specifici t ies and which can effect d esired 
modifications has been answered by chemists, not only because a solution 
might usher in a new era of rational drug d esign, but to obtain a conceptual 
understanding of how n on-covalent forces dictate the function of biologically 
relevant macromolecules . 
base pairs unique sites base pairs unique si tes 
4 136 13 33,554,432 
5 512 14 134,225,920 
6 2,080 15 536,870,912 
7 8,192 16 2,147,516,416 
8 32,896 17 8,589,934,592 
9 131,072 18 68,719,607,808 
10 524,800 19 137,438,953,472 
11 2,097,152 20 549,756,338,176 
12 8,390,656 21 2,199,023,300,000 
Table 1.1: Re lation be tween binding-site size and number of unique 
sequences 4 A binding site size of 16 base p airs is sufficient to define unique 
sequences with DNA the size of human chromosomal DNA. 
During the past 15 years, work in this laboratory has centered on 
elucidation of the s tructural principles responsible for the sequence specific 
recognition of DNA b y s mall minor g roove binding m olecules, as well as 
major groove binding proteins and oligonucleotides. It is hoped that an 
understanding of these principles might allow for the design of novel DNA 
binding m o lecules with specifici ties fo r arbitrary sequences :) base p airs or 
more in length. 
4 
DNA recognition by minor groove binding molecules. Studies of small 
minor groove binding molecules have centered on analogues of netropsin 
and distamycin, natural products which recognize A-T base pairs in the 
minor groove of DNA4,S,15-22 These studies have exemplified the power of 
synthesis as a means of structural analysis and of creating novel structures 
with pre-designed functions. For example, an understanding of the structural 
requirements for DNA recognition by this class of molecules has allowed the 
design of stereospecific15 and metallo-regulated16 derivatives of these natural 
products. Despite extensive success in the recognition of stretches of dA edT 
DNA up to 16 base pairs in length,23 extension to the recognition of G-C base 
pairs from the minor groove has been slow24 
Protein DNA binding motifs. Our understanding of DNA recognition by 
proteins has been greatly enhanced by solution NMR,2S,26 and X-ray 
crystallography data27-31 A number of structural motifs used by DNA binding 
proteins have been identified 2S,26 Searches of protein data banks indicate that 
each of these motifs (leucine zipper, zinc finger, helix-tum-helix and helix-
loop-helix) is used by a family of proteins to recognize different target DNA 
sequences. The affinity cleaving technique developed in this group has 
provided a means by which models of protein-DNA structures can be tested 
in solution32-36 Despite these advances, no generalized binding scheme for 
the recognition of base pairs by "complementary" amino acids has or is likely 
to emergeY The de novo synthesis of DNA binding proteins with arbitrary 
DNA binding specificities is therefore limited by the complexity inherent in 
the design and prediction of protein super-secondary structure.38-40 
Three stranded DNA complexes. The concept of oligonucleotide-
directed triple helix formation as a motif for the recognition of double helical 
DNA was inspired by the observation that polynucleotides form not only 
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double, but triple helical complexes under proper stoichiometric ratios and 
sait conditions. The first such complex, poly(U):poly(A):poly(U), was reported 
over 30 years ago based on UV mixing studies41 Rich et al. suggested that the 
third uridine strand could be accomodated in the major groove of DNA with 
the formation of Hoogsteen base pairing42,43 Triple helical complexes 
between a varie ty of DNA and RNAs have subsequently been found. The 
most common such triple helical complexes are composed of 2 pyrimidine 
strands and a single purine strand (including U·A_U,43-45 dT.dA-dT,46 dT'A-
U,47 dT.A-T,47 C+G_C,48-51 dT'A-dT,47,52 U'dA_U,48-51 and U'dA-dT,53) 
although purine · purine' pyrimidine complexes (I-A-dT,47 G_G_C,48,SO and dI-
dC-dIs4) and purine'purine'purine triplexes (I-A-I,43 and 1-1-155) have also 
been reported. 
It was recognized that within the pyrimidineopurineopyrimidine family 
of triple helices, isomorphous base triplets ToAT and C+GC could be formed 
between any purine-pyrimidine duplex and a sequence specific (in a 
Hoogsteen sense) third pyrimidine strand (Fig. 1.1). The DNA duplex poly 
(dT-dC)'poly (dG-dA) was subsequently shown to associate with poly (U_C)53 
or poly (dT-dC)56 to afford triple helical complexes. 
Fiber diffraction studies obtained in the 1970's indicated that triplexes of 
this type most closely resemble an A' form helix as is commonly formed by 
double helical RNA under high salt conditions (Fig. 1.2)57-61 These studies 
indicated that:6o (i) the bases are predominantly flat with respect to each other 
(base tilt -8.5°) (ii) Hoogsteen base pairing is involved; (iii) that all three 
strands are composed of sugars in a C-3' endo sugar conformation, with anti-
glycosidic bonds; (iv) a 30° rotation per residue around the helical axis; (v) an 
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Figure 1.1. (Top) Watson-Crick base pairs in double helical DNA. Major and 
minor grooves offer different hydrogen bonding patterns for recognition by 
DNA binding molecules. (Bottom) Isomorphous base triple ts formed by 
incorporation of a third pyrimidine strand in the major groove of double 
helical DNA parallel to the Watson-Crick purine strand via Hoogsteen base 
pairing. 
Recently, solution NMR structures of intramolecular triplexes62 at low 
pH indicate that these parameters are predominantly correct.63-67 An A-form 
helix with 3'-endo sugar puckers is suggested; however, Feigon has proposed 
that the purine strand exists in a different conformation (C-2' endo sugar 
pucker)63-66 Triple helical stru ctures have also been studied by a variety of 
other techniques, induding electron microscopy,68 circular dichroism,69,70 and 
Raman spectroscopy71,n 
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Oligonucleotide-directed recognition of double helical DNA: 
pyrimidine-pyrimidine-purine motif. The use of oligonucleotides to form a 
local triple helical complex (oligonucleotide-directed triple helix formation) 
offers a motif for the recognition of duplex DNA at the > 15 base pair level. 
This makes the potential specificity of this motif for the recognition of double 
helical DNA in principle 104-105 times greater than that attainable by 
restriction enzymes (6-8 base pair specificity). The recognition of a large 
numbers of sequences is made possible by the existence of a "triple helical 
code", much like the genetic code, whereby thymi dines recognize A-T base 
pairs (T-A-T base triplets) and protonated cytosines recognize G-C base pairs 
(C+G-C base triplets) via Hoogsteen hydrogen bonding43,53,73 Furthermore, 
issues of folding and secondary structure, which complicate the modeling and 
design of protein domains, are largely avoided, making the modeling and 
design of new molecules with altered specificities easier and more accurate. 
Moser and Dervan were the first to demonstrate that pyrimidine 
oligonucleotides complementary to a purine sequence could bind double 
helical DNA in a sequence specific manner73 The double helical cleavage of 
plasmid DNA (4.06 kbp) at a single site using oligonucleotides containing a 
modified thymidine-EDTA - Fe(1I) (T*)74 (Fig. 1.3) was achieved,?3 Using 
affinity cleaving, Moser and Dervan were able to positively discern the 
orientation of the third strand as parallel to the purine strand, eliminating D-
looping as a mode of binding?3 The asymmetry in the cleavage pattern 
confirmed the location of the third s trand in the major groove of the 
duplex,?3 The importance of high salt and neutral to acidic pH as conditions 
conducive to oligonucleotide-directed triple helix formation was stressed. 
Oligonucleotide binding was restricted to solutions containing the polycations 
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Fig. 1.2. Oligonucleotide-directed triple helix formation allows the 
recognition and cleavage of a 15 base pair site within plasmid DNA 
as described by Moser and Dervan. A simplified model of the triple 
helical complex between the Hoogsteen-bound DNA-EDTA-Fe(I1) 
at a single site within 4.06 kbp of plasmid DNA is shown. Specificity 
is impaned by Hoogsreen hydrogen bonded base triplets T-AT 
and C+Gc. 
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accumulation of negative charge upon accomodation of a third polyanion in 
the major groove and the requirement for protonation at N-3 of cytosine for 
the formation of Hoogsteen hydrogen bonds. Binding of a pyrimidine 
oligonucleotide to a purine-pyrimidine tract in plasmid DNA was also 
reported to occur at low pH, as assayed by gel mobility changes.75 Improving 
the stability of oligonucleotide-directed triplexes may be required before 
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Fig~e 1.3. DMT-protected T*-phosphoramidite-triethylester74 compatible 
with automated synthesis techniques for the construction of oligonucleotide-
EDTA for cleavage of double helical DNA via triple helix formation. 
Strobel, Moser and Dervan extended this study to the cleavage of large 
DNA. Cleavage at a single site within the genome of the phage lambda 
(48,500 base pairs) using thymidine-EDTAoFe(II) containing oligonucleotides 
was achieved in 25% yield/6 however, cleavage of an engineered site within 
chromosome III (340 kbp) of the Saccharomyces cerevisiae genome could 
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only be accomplished in low yield (5%), and cleavage at secondary sites was 
observed?? The presence of secondary cleavage sites is thought to arise due to 
the known over-representation of purine sequences in genomic DNA.78,79 
This study indicates that there are limits to the specificity and cleavage 
efficiency obtainable on large DNA using oligonucleotides equipped with 
non-specific DNA modification moiety. Use of a specific cleavage moiety may 
result in the production of DNA cleaving molecules with increased 
specificities. 
Work by Maher, Wold and Dervan has shown the ability of local 
triplexes to disrupt protein function 80 These studies indicate that pre-formed 
triple helices can inhibit methylases, restriction endonucleases, and 
transcription factors when the triplex and the protein binding sites overlap.so 
Inhibition of restriction endonuclease activity (i. e. restriction endonuclease 
footprinting) can be used as a method of assaying for triple helix 
formation. SO,S! This work demonstrated the feasibility of using triple helix 
formation to direct restriction endonuclease cleavage of DNA via an 
"Achilles heel" strategy13,!4 In this strategy, triple helix formation is used to 
inhibit methylation at a methylase/triplex site. Complete methylation of 
intact DNA renders all methylase/ restriction enzyme sites not protected by 
the oligonucleotide resistant to cleavage by the endonuclease. Disruption of 
the triplex exposes the purine / methylase site for cleavage by a 
complementary restriction endonuclease. 
Strobel and Dervan have shown the utility of the triple helix mediated 
"Achilles heel" strate gy by using oligonucleotides and EcoR I 
methylase/restriction enzymes to effect the enzymatic cleavage of a yeast 
chromosome at a single engineered purine/methylase/restriction site82 In 
this study, near quantita tive cleavage of a 340 kbp yeast chromosome (94%) 
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was achieved at a single site. No cleavage of any other chromosome was 
detected. This work demonstrates the feasibility of using triple helix strategies 
to impart >16 base pair specificity to restriction enzymes to realize the 
cleavage of single sites within chromosomal DNA. Although a 
triplex/ meth ylase / restri c tion s i te was specifically engineered into 
chromosomal DNA for the purpose of this study, the generalizability of the 
triple helix motif allows the recognition and cleavage of sequences present in 
genetic markers of interest. 
A method for the screening of large sequences of DNA for triple helix 
methylation-restriction sites using oligonucleotides degenerate in the 
nucleosides 5-bromouridine and 5-methyicytidine has made the 
determination of endogenous sites cleavable by the Achilles heel strategy 
possible.83 This technique has been used by Strobel and Dervan to determine 
the sequence of a purine/restriction enzyme site within an unsequenced 
genetic marker near the Huntington's disease gene. Specific cleavage of a 
human chromosomal DNA at this site has been achieved.83 
.. 
The specificity of triple helix formation offers the tantalizing possibility 
of using these molecules as specific gene repressors or activators in vivo. 
Recent work indicates that triplexes can lower the efficiency of transcription 
in vitro when formed near the site of initiation, both when the triplex does or 
does not block specific transcription factors.84 This suggests that triple helix 
formation can effect transcription both through structural changes imparted 
to the DNA, and by inhibiting the binding of required transcrio tional 
promoters. 84 
Characterization of the thermodynamics underlying triple helix 
formation has been und ertaken using UV melting,8S NMR,86 CD,87,88 and 
differential scanning calorimetry methods 89 Estimates for the enthalpic 
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contributions for triplex fo rmation indicate that, at pH 6.5 in 200 mM NaCI, 
the ilHo for triplex formation is approximately 2.0 kcal/mol base triplet (the 
ilHO for duplex formation was determined at 6.1 kcal/mol bp),89 but that 
triplex formation is entropically much less unfavorable than is duplex 
formation. Melting of the triple helix is en tropically disfavored by 
approximately 6.5 cal/mol· oK (the duplex transition is approximately 18.5 
cal/mol °K) 89 Triplex formation at 25 °C, close to neutral p H (6.5), and 200 
mM NaCI is favored by 1.3 kcal / mol for a 15 base pair 0ligonucleotide.89 
These studies are conducted using Oligonucleotide Watson-Crick duplexes. 
Binding of oligonucleotides to large DN A m ay differ in several aspects, not 
least of which is the production of a triplex to duplex transition within the 
target DNA. These values are expected to be sequence dependent. The study 
of a large number of sequences will be required before general parameters for 
the a priori prediction of triple helix stability will be possible. 
Oligonucl eot ide-di rec ted recogn ition of doubl e helical DNA: 
purineopurin e-pyrimidin e m otif. A less well understood motif 
(purine 0 purine-pyrimidine) allows for recognition of G-C base pairs with 
guanines, and A-T base pairs with either thymine or adenine bases (Fig. 
1.4) 90-95 Binding of the third purine strand is anti-parallel to the Watson-
Crick purine strand, again elimina ted D-looping as a mode of recognition90 
Pre liminary data indicate that triplexes of this type are driven by the 
formation of stable GoG-C triplets 90,92,95 In the study of Cooney et aI., a 27 
base long oligonucleotide parallel to the purine strand (incorrect orientation) 
was able to bind a target sequence due to the high G content (20 out of 28 
positions were G)95 
Since protonation IS not required for formation of GoG-C or AoA-T 
triplets, these triplexes are much less pH dependent than are 
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pyrimidineopurine-pyrimidine triplexes 90 An intramolecular triple helix of 
this family has been reported91 Studies of this motif are in their infancy, and 
little has been accomplished to extend the recognition alphabet of this motif 
to all four possible base pairs (A-T, T-A, G-C, C-G) of the double helix. The 
two triplex families are complementary: pyrimidine o ligonucleotides bind 
with higher affinities to A-T rich sequences; purine G-rich oligonucleotides 
can be used to recognize predominantly G-C containing sequences. 
A.AT-basetriplet T·AT-basetriplet 
Fig. 1.4. Models proposed by Beal and Dervan90 for GoGC, AoAT, and ToAT 
base triple ts within a purineopurine-pyrimidine triple helix motif where the 
third strand is antiparallel to the purine Watson-Crick s trand and the bases 
are in the anti conformation. 
General triple helical solut ions to DNA recognition. The above studies 
clearly d e monstrate the power of o ligonucleotide directed triple h elix 
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formation as a motif for the recognition of specific sequences of double helical 
DNA; however, these studies have been limited to the use of purine-
pyrimidine sites. Extension of triple helix formation as a motif for the 
recognition of arbitrary sequences containing all four base pairs has focussed 
on five strategies: (i) the search for novel natural base triplets, such as 
GoTA;96 (ij) the design and synthesis of oligonucleotides which can cross-over 
the major groove, making the recognition of purine-pyrimidine type 
sequences possible;97 (iii) the use of "null" bases to skip over the "unreadable" 
base pairs C-G and T _A;98 (iv) the study of novel triple helical motifs which 
are99,lOO or are not90 protein mediated; and (v) the design of new heterocycles 
which might allow the recognition of all four base pairs within a triple helical 
motif.101 
Natural roles for triple helices. Since the discovery of triple helices, roles 
for these structures in vivo have been postulatedl02-104 Anti-bodies raised 
against triple helical DN A are reported to bind eucaryotic chromosomes in 
VivolOS 
Purine runs have been located at the 5' ends of many genes94,9S,106-l28 
Long purine runs are found to be statistically over-represented in 
mammalian DNAs?8,79, 11 7,129 Many of these runs display differential 
reactivity to DNA modification agents and nucleases. Several structures were 
proposed to account for the changes in reactivity observed. A triple helical 
structure was first proposed by Christophe, Vassart and co-workers to explain 
the sensitivity of these sequences under superhelical stress to Sl nuclease. lo8 
Kamenetskii and co-workers studied purine runs more extensively, and 
named the intramolecular triple helical complex formed by extended purine 
sequences H-form DNA130-136 These workers postulated that half of the 
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pyrimidine strand folds back to Hoogs teen hydrogen bond with one half of 
the purine sequence, leaving half of the purine run in a single stranded form. 
The reactivity of such sequences to chemical DNA modification reagents 
has been extensively studied, and models concerning the exact nature of the 
loops of the DNA have been proposed1 37-139 Modelling indicates that H-
form DNA preferentially forms asymmetrically such that the 3' half of the 
polypyrimidine strand loops back to become Hoogsteen hydrogen 
bonded.137,1 38 This conformer results in the release of maximal super helical 
tension.137 Chemical reactivity data as a function of superhelical stress 
support this idea1 37 This structure generally best explains the reactivity of 
these sequences in vivo to nucleases and in v itro to chemical modification 
reagents. I06,I08,114-1 28,139-142 
Alternate "H-form" DNAs which result in the formation of purine-
purine-pyrimidine triplexes and a "free" pyrimidine strand have also been 
postulated.92 Some sequences are reported to form either of these types of "H-
form" DNAs, the s tructure formed being d ependent on the concentration of 
Mg+2.92 The homo pyrimidine-homo purine sequence d(CT /GA)22 was 
recently shown to undergo transition to a *H-form DNA, different from 
either of the triplexes above143 This transition is promoted by zinc ions, and 
a structure has not yet been assigned143 
These motifs have been suggested to play roles in the regulation of 
downstream genes in ViV0 94 ,95, I 08,109,144 Oligonucleotides complementary in 
a Hoogsteen sense to the purine site prevent formation of H-form DNA,75 
offering a possible mechani sm for oligonucleotide control of gene 
expression.94,95 Hogan et al . have shown that the sensitivity of the sequence 
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5' to the c-myc gene to 51 nuclease increases in the presence of a RNA factor. 
In vitro, a G-rich purine oligonucleotide forms a triplex at this site.95 The site 
is rich in G-C base pairs, and only a purine rich (i. e. G rich) oligonucleotide is 
capable of altering gene activi ty 95 Triple helical regions have also been 
implicated in a variety of other biological functions, including viral 
integration llO differential methylation of sequences,127 and DNA 
inversions.107 
Other triplex work. Not surprisingly, the number of workers in the triple 
helix field has grown substantially w ithin the last few years. A strategy for the 
high yield site-specific cleavage of double helical DNA via a triple helix 
strategy, as demonstrated by Pei and Schultz, is the use of semi-synthetic 
nuclease-oligonucleotide conjugates.145 Although this strategy offers higher 
yields than those obtained with oligonucleo tide-EDT A 0 Fe(II), no additional 
specificity is obtained using a non-specific nuclease as a cleaving functionality. 
Helene and co-workers have equipped triple helix forming 
oligonucleotides with intercalators,146,147 DNA cross-linking reagents,148,149 
and DNA cleaving reagents (1,10 phenanthroline oCu(II)).150 Triplex 
formation between several types of modified oligonucleotides and native 
DNA has also been investiga tedl51-155 Triplex formation with 
phosphorothioates, phosphorodithioates, methyl phosphonates has been 
reported. 154,155 Haner has shown that pyrimidine oligonucleotides made with 
2'-OMe nucleosides bind with higher affinity than their DNA analogues.156 
Helene and co-workers have cons tructed nuclease resistant oligonucleotides 
from [a)-deoxynucleotides1 51,152 One of the interesting properties of these 
molecules is their binding orientation, which is the opposite of that normally 
observed in oligonucleotide oduplex DNA complexes. Modified 
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oligonucleotides have properties such as nuclease resistance and increased 
permeability through phospholipid membranes which may make them 
attractive for use in vivo and as possible therapeutic agents. 
Description of work. This thesis descr ibes experiments designed to 
improve our understanding of oligonucleotide-directed triple helix 
formation, to improve the stability of pyrimidineopyrimidine-purine 
triplexes, and to equip triple helix forming oligonucleotides with reactive 
moieties capable of efficient and base specific DNA modification. 
Chapter II describes the development of footprinting techniques which 
can be used to detect triple helix formation. Affinity cleaving requires the 
synthesis and incorporation of modified nucleosides into the oligonucleotide. 
Incorporation of su ch nucleosides may change oligonucleotide binding 
characteristics, and limits binding assays to those conditions compatible with 
EDT A chemistry. The development of conditions for footprinting using 
several different reagents (MPEoFe(II), DNase I, dimethyl sulfate) allows for 
the analYSis of triple helix formation under a variety of salt conditions, over a 
large range of pH values and a varie ty of time intervals. 
Chapter III focuses on the incorporation of modified nucleosides to 
afford oligonucleotides with increased binding affinities. Oligonucleotides 
which are resistant to denaturation at slightly alkaline pH might be important 
if they are to be used in environments, such as those within living systems, 
where cation concentration and pH are strictly regulated and cannot be 
altered.157-160 Substitution at the 5-position of pyrimidines affects the 
hydrophobic driving force, base stacking, and electronic complementarity of 
these nucleosides in triple helix formation161,162 Oligonucleotides containing 
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5-methylcytosine and 5-bromouracil bases display increased binding affinities 
over an extended pH range. Modified oligonucleotides have been repeatedly 
used in applications where high binding affinities are required. Preliminary 
communication of these results has appeared 1 63 
Chapter IV describes the development of a nucleoside derivative capable 
of highly efficient and base specific DNA modification.164 Incorporation and 
derivatization of this nucleoside affords N -bromoacetyloligonucleotides 
capable of efficient chemical modification and cleavage of chromosomal DNA 
at a single nucleotide position. Due to the high cleavage efficiency possible 
with this moiety, it is an ideal reporter group to assay for small changes in 
binding affinity. Studi es concerning the ability of N-
bromoace tyloligonucleotides to bind to abutting sites in a cooperative manner 
and to inhibit transcription downstream from the initiation site will be 
reported. 
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Chapter II 
Footprinting of Oligonucleotides on Double Helical DNA 
Using MPE· Fe(II), DNase I, and Dimethyl Sulfate 
Introduction 
The work of Moser and Dervan indicated that pyrimidine 
oligonucleotide-directed triple helix formation offers a promising method for 
the recognition of extended (> 15 bp) sequences of DNAI Pyrimidine 
oligonucleotides can, when equipped with a thymidine analogue tethered to 
EDTAoFe(II) (T*)2 (Figure 1.1), bind and cleave a single 15 base pair site within 
4 kilobases of double helical DNA1 The power of affinity cleaving to 
elucidate the structural principles for DNA recognition has been exemplified 
in the discovery of novel base triplets,3 the synthesis of novel Oligonucleotide 
binding heterocycles,4 the study of abasic sites within triple helices,S and the 
analysis of novel triple helical motifs 6 The determination of binding 
affinities using this technique requires the incorporation of the modified 
nucleoside thymidine-EDTA into the oligonucleotide, a modification which 
can result in changes in oligonucleotide binding affinity.2,7 Analysis 
additionally requires the addition of reductants and is subject to interference 
by metals ubiquitous in biology8 If binding affinities of unmodified 
oligonucleotides are to be determined under conditions relevant to those in 
vivo, alternate methods of analysis are required. 
29 
In light of this, the footprinting of short (up to 15 base pairs) triple helical 
regions on restriction fragment size DNA has been undertaken. Footprinting 
can be accomplished using any reagent capable of non-specific DNA cleavage 
(Figure 2.1) .9-14 Analysis requires inhibition of cleavage at the binding site by 
the DNA binding molecule. Since the completion of this study, the 
footprinting of oligonucleotides by several reagents has been reportedl5,16 
5' 3' 







Fig. 2.1. Binding of a sequence specific DNA binding molecule interferes with 
cleavage by a non-specific DNA cleaving agent (MPE o Fe(II) , DNase I, 
dime thyl sulfate) a t the bound site. 
M P E oFe(II) jootprinting. Procedures for the footprinting of 
oligonucleotides on DNA have been developed involving several reagents. 
MPEoFe(II) footprinting is advantageous due to the highly non-sequence 
specific nature of this reagent, allowing high resolution definition of binding 
site sizel1 ,!3 The ability of ethidium based molecules to bind to triple helical 
DNAs has been investigated by several groups. Ethidium has been shown to 
lower the melting temperature of the third strand in the triplex 
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poly(rA) 02 poly(rU), indicating a stabilization of the duplex poly(rA) opoly(rU) 
relative to the triplex upon ethidium intercalationY Consistent with this, Le 
Pecq observed that ethidium preferentia lly binds to the dupl ex 
poly(rA)opoly(rU )18,19 Lehrman and Crothers reported that RNA oDNA 
hybrids previously observed only as A-form conformations are induced into a 
B-form double helix by the presence of ethidium bromide,20 suggesting the 
preferential binding of ethidium to B-form DNA. Triplexes, which are 
thought to exist in an A'-form conformation,21-23 are therefore destabilized by 
ethidium bromide1 7 Ethidium is not thought to bind to triple helices 
containing alternating C+G-C base triplets, due to charge repulsion between 
the positive charges in the triplex structure and the ethidium cation24 In 
contrast to these s tudies, it has been reported that ethidium preferentially 
binds the duplex fo rm of poly(dA) opoly(dT)25 It remained to be determined 
if a local triplex could significantly inhibit intercalation by an ethidium-based 
reagent (MPE oPe(II» (binding affinity = - 1.5 x 105 M-l)26 at the triplex site. 
DNase I fo otprinting. Binding of oligonucleotides in the major groove 
might be expected to result in a change in DNA geometry and groove width at 
the triplex s ite, facto r s w hich lead to changes in DNase I activitylO 
Polynucleotide triplexes have previously been shown to be resistant to DNase 
I and RNase deg radation 27 The data here were the first evidence that triple 
helices can inhibit enzym e activity a t the binding site under physiological 
conditions. Since these studies w ere undertaken, oligonucleotides have been 
shown to interfere with DNA binding by a variety of proteins and to prevent 
subsequent protein activity at the triplex binding site.16,28-30 Inhibition of 
enzyme activity (Ava 128,29 or EcoR 116 footprinting) can also be used as a 
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Fig. 2.2. Triple helix formation results in hydrogen bonding at N-7 of guanine 
bases and inhibition of DMS reactivity. No such decrease in methylation of 
N-3 of adenine results. 
Dimethyl su lfa te footprinting. Dimethyl s ulfate alkylates DNA 
primarily at the N-7 position of guanine and N-3 position of adenine (Figure 
2.2) 3 1-33 Base work-up results in cleavage at guanine residues, while acidic 
work-up results in preferential cleavage at adenine residues.32•33 Within the 
pyrimidine motif, guanine bases involved in triple helix formation are 
hydrogen bonded in both Watson-Crick and Hoogsteen base pairing schemes 
32 
(Figure 2.2).1 ,34 Hoogsteen hydrogen bonding of the third strand in the major 
groove is expected to hinder reactivity of guanine bases with alkylating agents 
such as dimethyl sulfate (DMS) in the major groove (i. e. reaction at N-7 of 
guanine). Methylation at N-3 of adenine, which occurs from the minor 
groove, is not expected to be affected. The footprinting of triplexes using 
dimethyl sulfate has been recently reported16 
Results and Discussion 
Footprinting of oligonucleotides on double helical DNA is possible using 
a variety of DNA cleaving reagents, including MPEoFe(II) , DNase I, and 
dimethyl sulfate. Use of these reagents allows analysis of triple helix 
formation under conditions not amenable to affinity cleaving, enzyme 
inhibition, or transcriptional inhibition assays. The various footprinting 
reagents are complementary to each o ther, as well as to other techniques, for 
the determination of oligonucleotide affinity for double helical DNA. 
MPE 0 Fe(I!) footprinting 
A review of the literature indicates that intercalation by ethidium was 
disfavored in A-form DNA and in triple helical complexes (see discussion 
above),17-2o,24 although at leas t one conflicting report has been published.25 It 
remained to be determined if local triple helices, formed by binding of an 
oligonucleotide to a lo ng piece of double helical DNA, are stable to 
intercalation by MPEoFe(II), w hich has a binding constant for DNA of 
approximately 1.5 x 105 M-126 
33 
5'- TTTTTCTCTCTCTCT-3' Cf-15 
5' .... TAT AT A TA T A ATAG ... .3' 
3· .... A TAT A TAT AT T ATC .... 5' 
,---,-~,-,.·· I = triplex site II.1N@H¥tl = dam I methylase site 
Fig. 2,3. Oligonucleotide CT-15 used in footprinting studies of triple helix 
formation. Oligonucleotide CT-15 binds a 15 base pair site within plasmid 
pDMAGI0.1,35 The final two base pairs are part of a darn I methylase site. The 
3' terminal A in the triplex site is N-6 methylated in these studies36 
Effect of cations and organic co-solvents. Formation of polynucleotide 
complexes, including triplexes, is supported by the presence of cations.1,37-40 
Polycations such as spermine and Co(NH3)6+3 support such structures at 
much lower concentrations than monovalent or divalent cations40,41 The 
effect of various polycations on triplex stability was studied using MPE ° Fe(II) 
footprinting. 
Binding of the oligonucleotide CT-15 (Figure 2.3) to its duplex DNA 
target site can be detected using MPE ° Pe(II) footprinting under conditions in 
which triplexes are known to form (Figures 2.4 and 2.5).1,42 In accordance 
with the work of Moser, who found efficient cleavage of DNA by EDTAoFe(II) 
functionalized oligonucleotides in the presence of 1-10 mM Co(NH3)6+342 or 1 
mM spermine1, clear protection against cleavage by MPE ° Fe(II) is observed at 
the target sequence under these conditions. High concentrations of cations 
result in shielding of the DNA and a decrease in DNA cleavage by MPEope(II) 
(Figure 2.4). Optimal footprints are observed at a Co(NH3)6+3 concentration of 
1 mM. 
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Figure 2.4. Autoradiogram of 8% polyacrylamide high resolution denaturing 
gel electrophoresis of 32P-endlabeled 628 bp restriction fragment from 
pDMAG10 (EcoR II Bgi 1) indicating M P E • Fe (I 1) footprinting of 
oligonucleotide CT-15. Oligonucleotide CT-15 was equilibrated with duplex 
DNA under conditions stated at 0 °C for at least 60 minutes. MPE was 
equilibrated with 2 equivalents of Fe(II), and added as a lOx solution. After 15 
minutes, reactions were activated with the addition of orr to a final 
concentration of 2 mM. Reactions were allowed to run for 14 hours at 0 oc, 
and were stopped by precipitation with NaOAc and ethanol. All lanes: 20% 
ethylene glycol, 100 mM NaCl, 100 11M calf thymus DNA, 100 mM Tris pH 7.0 
buffer unless noted. Lane 1: Intact DNA. Lane 2: Maxam-Gilbert G sequencing 
lane. Lane 3: Maxam-Gilbert A + G sequencing lane. Even lanes: no 
oligonucleotide. Odd lanes: 211M oligonucleotide CT-15. Lanes 4 and 5: 10 11M 
spermine; Lanes 6 and 7: 100 11M spermine; Lanes 8 and 9: 400 11M spermine; 
Lanes 10 and 11: 1 mM spermine; Lanes 12 and 13: 4 mM spermine; Lanes 14 -
19: 1 mM Co(NH3)6+3; Lanes 14 and 15: no ethylene glycol; Lanes 16 and 17: 
20% ethylene glycol; Lanes 18 and 19: 40% ethylene glycol; Lanes 20 and 21: 10 
11M CUCl2; Lanes 22 and 23: 100 11M CUCI2; Lanes 24 and 25: 1 mM CUCI2. 
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Among the divalent cations, Cu+ 2 is known to bind most tightly to 
DNA.43 For this reason, oligonucleotide binding in the presence of Cu+2 was 
studied by MPE -Fe (lI) and DMS footprinting techniques (vide infra). 
Micromolar concentrations of Cu+ 2 can be used to stabilize triple helix 
formation, and MPE - Fe(lI) can be used under these conditions to footprint 
triple helical regions (Fig. 2.4). DMS footprinting indicates that binding of 
shorter oligonucleotides can be promoted by Cu+2 (vide infra). It has been 
postulated that Cu+ 2 binds tightly to N-3 of cytosine bases.44-46 At this 
position, Cu+2 might replace the proton required for Hoogsteen hydrogen 
bonding. No studies on the effect of pH on oligonucleotide binding in the 
presence of Cu+2 have been undertaken. 
The addition of organic solvents increases the cleavage efficiency of 
oligonucleotides-EDTA-Fe(lI)1 The addition of co-solvents may result in 
dehydration of the DNA 47 and stabilization of the B t~ A' transition which is 
thought to accompany oligonucleotide binding.21 -23 Ethylene glycol is 
necessary for footprinting of the triple helix by MPE - Fe (II) (Figure 2.4). High 
concentrations of ethylene glycol result in a noticeable decrease in the 
MP E - Fe(lI) activity; under otherwise identical conditions, M P E - Fe (II) 
digestion is reduced in the presence of 40% ethylene glycol, due to the radical 
scavenging properties of this solvent. Approximately 20% ethylene glycol is 
optimal for MPE - Fe(lI) footprin ting of triple helical complexes. 
Since footprinting involves competition for a binding site on DNA 
between the DNA cleaving reagent and the oligonucleotide, it is not 
surprising that robust triple helix formation conditions are required for clear 
MPE - Fe(II) footprin ts to be observed. The binding affinity of MPE - Fe(II) is 
estimated to be in the range of 1.5 x 105 M-l,26 and several MPE-Fe(II) binding 
s ites are located within each oligonucleotide binding site. MPE - Fe(lI) 
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footprinting is the least sensitive of the three footprinting reagents used in 
this study. 
Analysis of footprint size and loca tion. A 3' shift in the cleavage pattern 
is observed, as is expected for cleavage originating from a minor groove DN A 
binder (Figure 2 .5)48 The footprint is transposed from the center of the 
binding site and extends to one side (the alternating G-A, or 3' end of the 
purine strand) of the binding site. This phenomenon may be due to the 
inherent stability associated with the B-form of poly(A) :poly(T) DN A or a 
higher stability of C+G-C base triplets. The difficulty with which poly(A) 0 (T) 
tracts form triplexes has recently been documented49 Gas phase calculations 
support the greater stability of C+G-C base triplets.5o The inherent lack of 
reactivity of MPEoFe(II) at p oly d(A):poly d(T) regions renders footprinting 
within this part of the binding si te difficult. The use of spermine oEDTA, 
which displays avid activity at such sites, as a footp rinting agent may help in 
elucidating this ambiguitySl 
It has recently been reported tha t ethidium preferentially intercalates 
into the triple helix poly(dA) 02 poly(dT) compared to the poly(dT) opoly(dA) 
duplex.2S No increase in MPEo Fe(II) ac tivity is observed at the TsoAs-Ts 
triplex. 
MPE 0 Fe(II) footprints are known to extend two base pairs to the 3' side of 
the binding sites of various antibiotics; however, reduction in MPE 0 Fe (II) 
activity is observed only one base pair beyond the target sequence to the 3' end 
of the oligonucleotide (Figure 2.5). This suggests that the oligonucleotide 3' 
end is not fully bound to the DNA, and that the triplex-duplex transition and 
any change in DNA form associated with oligonucleotide binding is sharp 
and limited to a very few base pairs . Further evidence for these assertions is 
obtained from DMS foo tprinting s tudies (vide infra) . 
A. MPE oFe(II) Footprinting 
32p 5'-TATATATA 
3'-ATATATAT ................ 
B. DNase I Footprinting 
I 
32p 5'- TAT A TAT A 





GAT A G GAT C C T C T A C G C C G-3' 
TCCTAGGAGATGCGGC-~ 
Figure 2.5. Histograms comparing the footprinting of oligonucleoitde CT-15 
by MPE.Fe(II) and DNase I using data in Figures 2.4 and 2.6. Box indicates the 
oligonucleotide binding site. Bars represent the extent of inhibition <11 
cleavage by (A) MPE·Fe(II) or (B) DNase 1. Inhibition of cleavage WJ' 
determined by densitometry of autoradiograms from Figures 2.4 and 2.6. 
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Figure 2.6. Autoradiogram of 8% polyacrylamide high resolution denaturing 
gel electrophoresis of 32P-endlabeled 628 bp res triction fragment from 
pDMAG10 (EcoR I/Bgl I) indicating DNase I footprinting of oligonucleotide 
CT-15. Oligonucleotide CT-15 was equilibrated with duplex DNA at 0 °C for at 
least 60 minutes. DNase I was added to a final concentration of 40 ng/ml, and 
the reaction allowed to proceed for 12 minutes at 4 0c. Reactions were 
stopped by precipitation with 0.25 volumes of a 10 M NRtOAc, 200 mM EDTA 
solution and 3 volumes of ethanol. Lane 1: Intact DNA. Lane 2: Maxam-
Gilbert G sequencing lane. Lane 3: Maxam-Gilbert G + A sequencing lane. 
Even lanes: no oligonucleotide. Odd lanes: 211M oligonucleotide CT-15 
oligonucleotide. All lanes 0% ethylene glycol, 100 11M calf thymus DNA, 100 
mM Tris pH 7.0 buffer, 10 mMMg+2, 10 mM Ca+2 and 5 mM K+. Lanes 4 and 
5: no additional cations; Lanes 6 and 7: 100 11M spermine; Lanes 8 and 9: 400 
11M spermine; Lanes 10 and 11: 1 mM spermine; Lanes 12 and 13: 4 mM 
spermine; Lanes 14 and 15: 100 11M Co(NH3)6+3; Lanes 20 and 21: 5 mM 
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DNase I Footprinting 
Polynucleotide triple helices are known to be resistant to both DNase I 
and RNase degradation.27 DNase I activity is optimal in the presence of both 
Mg+2 and Ca+2 ions; therefore, all DNase I reactions are run in 10 mM of each 
Mg+2 and Ca+2S2 Due to the high cationic content of the buffer, the addition 
of spermine, Co(NH3)6+3 or ethylene glycol to stabilize triple helix formation 
is not necessary (Figure 2.6). The addition of ethylene glycol results in 
reduced DNase I activity, as do high concentrations of spermine (> 1 mM) or 
Co(NH3)6+3 (> 1 mM). CUCI2, in 10 mM Mg+2 and 10 mM Ca+2, destroys 
DNase I activity even at low concentrations (lao JlM) (Fig. 2.6). 
DNase I footprint s ize and location. DNase I footprints extend five base 
pairs beyond each side of the target site (Figures 2.5 and 2.6). Presumably, the 
enzyme m akes contacts wi th the DNA several base pairs removed from the 
s ite of cleavageS3 Disruptions of these contacts results in reductions in 
cleavage intensi ty. It is in teresting that Hanvey and Wells report that 
protection of duplex DNA from endonu clease digestion requires that the 
oligonucleotide and restriction endonuclease recognition sites overlap.1 6 
Binding of the oligonucleotide to a site abutting the restriction enzyme 
recognition site res ults in marked d ecreases in the ability of the 
oligonucleotide to inhibit DNA cleavage16 This is in contrast to the results 
observed with DNase I, where binding of the oligonucleotide several base 
pairs away from the site of cleavage impairs DNase I activity. 
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Footprinting with Dimethyl Sulfate 
Reaction of ONA with dimethyl sulfate (OMS) results primarily in 
methylation at N-7 of guanine (reaction from the major groove) and N-3 of 
adenine (reaction from the minor g roove)31-33 Reaction with N-7 of guanine 
(major groove) is expected to be inhibited by binding of a third strand in the 
major groove (Fig. 2.2). No change in reactivity at N-3 of adenine is expected. 
The effect of oligonucleotide binding on the reactivity of OMS with both 
guanine and adenine bases within the triple helical complex was investiga ted. 
Footprinting of oligonucleotides using OMS and piperidine work-up (G 
reaction) h as been reported since the completion of this work.16 
The breadth of conditions assayable using OMS footprinting is displayed 
in Figure 2.7. While ONase I footprinting is possible only at pHs <: 5.7, OMS 
protection studies indicate that the triplexes are stable at low pH (to at least a 
pH of 2.7), but dissociate at slightly neutral pH (pH = 8). 
In OMS footprinting studies, CUCl2 was used to stabilize triple helix 
formation. CUCI2 was shown by OMS footprinting to be superior to 
Co(NH3)6+3 in promoting binding of oligonucleotides to duplex ONA. 
Upon formation of the triple s trand, a large enhancement in the 
reac tivity of the guanine base at the 3' end of the binding sequence and a 
decrease in the reactivity of the guanines involved in triple helix formation is 
observed (for histogram analysis, see Fig. 2.10). A similar increase in the 
reactivity a t the 3' triplex-duplex junction has also been observed with 
Cu(II) .phenanthroline l 5 No such enhancement in cleavage was observed 
on the p yrimidine s trand at the 5' end.1s 
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Figure 2.7. Autoradiogram of 8% polyacrylamide high resolution denaturing 
gel electrophoresis of 32P-endlabeled 628 bp restriction fragment from 
pDMAG10 (EcoR I/Bgl I) indicating DNase I and DMS footprinting of 
oligonucleotide CT -15 as a · function of pH. Oligon ucleotide CT -15 was 
incubated with duplex DNA under conditions stated for 60 minutes at 0 dc. 
DNase I footprinting was effected by addition of a lOx solution of DNase I to a 
final concentration of 40 ng/mL Reactions were conducted at 4 °C for 12 
minutes, and were quenched by addition of 0.25 volumes of a 10 M NI-40Ac, 
200 mM EDTA solution and 3 volumes of ethanoL DMS footprinting was 
effected by addition of 4 ill of a freshly prepared 2% aqueous solution of 
dimethyl sulfate. After 90 seconds at 0 °C, reactions were quenched with 5 ill 
of a DMS stop solution and 785 ill of ethanoJ.32.33 After washing with 70% 
ethanol, strand scission was obtained after incubation at 90 °C for 30 minutes 
in 10% aqueous piperidine. Lane 1: Intact DNA. Lane 2: Maxam-Gilbert G 
sequencing lane. Lane 3: Maxam-Gilbert A + G sequencing lane. Lanes 4-15: 
DNase I footprinting, 0% ethylene glycol, 100 ilM calf thymus DNA, 100 mM 
Tris, pH 7.0, 10 mM MgCl2, 10 mM CaCIz, and 5 mM KCL Even lanes: no 
oligonucleotide. Odd lanes: 2 ilM oligonucleotide CT-15. Lanes 4 and 5: pH 
2.7; Lanes 6 and 7: pH 3.7; Lanes 8 and 9: pH 4.7; Lanes 10 and 11: pH 5.7; Lanes 
12 and 13: pH 7.0; Lanes 14 and 15: pH 8.0. Lanes 16-27: DMS footprinting, 20% 
ethylene glycol, 100 ilM calf thymus DNA, 100 mM Tris, pH 7.0, 100 mM 
NaCl, 1 mM Co(NH3)+3 Lanes 16 and 17: pH 2.7; Lanes 18 and 19: pH 3.7; 
Lanes 20 and 21: pH 4.7; Lanes 22 and 23: pH 5.7; Lanes 24 and 25: pH 7.0; Lanes 
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Characterization of 3' triplex-duplex junction. Protection of the internal 
guanine residues is a direct result of formation of Hoogsteen hydrogen bonds 
at N-7 of guanine. One explanation for the hyperreactivity observed at the 3' 
end of the binding site is an alteration in the DNA structure at the triplex to 
duplex junction. The fact that the hyperreactivity is limited to a single 
guanine indicates that this transition is confined to the bases directly adjacent 
to the triple helix binding site. Such junctions have been modelled and 
structures proposed. Selsing and Wells have stated that a B to A transition 
could be accommodated within a single base pair in which the sugar ring on 
one strand is C2' endo puckered (as in B DNA) while the complementary 
sugar on the opposite strand exhibits C3' endo puckering (as is observed for A 
DNA)S4 The transition does not result in interruption in base stacking, 
introduce unpaired bases, or result in unwinding of the DNA. Experimental 
evidence for this model is limited to an NMR study of the oligonucleotide 
rCll· dC16-dGn,54 which indicates that the A to B transition does not occur 
over an extended stretch of basess4 
To characterize the nature of the triplex to duplex junction, the junction 
was treated with several DNA modification reagents. Sl nuclease efficiently 
cleaves single stranded DNA regions, as well as duplex DNA containing 
denatured or single stranded regions SS-57 To determine if single stranded or 
denatured regions are introduced upon triplex formation, the DNA 
restriction fragment containing the triplex binding site was treated with Sl 
nuclease after incubation with CT-15. Under conditions in which both 
formation of the triplex and Sl nuclease activity had been independently 
verified, no sites reactive to Sl nuclease were discovered, indicating that the 
hyperreactivity observed with dimethyl sulfate is not due to the presence of 
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single stranded or denatured regions. These experiments were conducted 
under conditions conducive to triple helix formation (pH 4.7); nonetheless, it 
cannot be ruled out that the nuclease primarily digests the excess 
oligonucleotide present in solution. Dissociation of the bound 
oligonucleotide and loss of the local triple helix structure may subsequently 
result. 
To determine the effect of triple helix formation on DNA reactivity from 
the minor groove, DNA with a local triplex (CT-15 complex) was methylated 
with DMS and treated with acid under conditions known to result in strand 
cleavage at methylated adenine residues32,33 Treatment of the triple helical 
complex in this manner results in strand scission at all adenines in the 
binding site, and at the guanine which displayed hyperreactivity with 
piperidine work-up. Methylation from the minor groove is not enhanced or 
reduced by the presence of the oligonucleotide and formation of the triple 
helical complex. Strand scission at the hyperreactive guanine occurs because 
this becomes the overwhelming site of DMS reaction once triple helix 
formation has occurred. 
Triplex formation similarly does not affect the reactivity of the DNA to 
diethyl pyrocarbonate, a minor groove modification reagent. Thus, the 
triplex to duplex junction is characterized by an increase in reactivity in the 
major groove at the 3' end of the triplex site, but little change in reactivity in 
the minor groove. 
Rate of Oligonucleotide Hybridization. The rapid rate of DNA 
methylation by DMS allows study of the kinetics of oligonucleotide binding. 
The oligonucleotide CT-15 (2 f.lM) confers hyperreactivity to the guanine base 
in less than one minute, indicating that when micromolar concentrations of 
oligonucleotide are used, binding is rapid (data not shown). A more 
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Figure 2.8. Autoradiogram of 8% polyacrylamide high resolution denaturing 
gel electrophoresis of 32P-endlabeled 628 bp restriction fragment from 
pDMAGlO (EcoR I / Bgl 1) indicati ng DN ase I and OMS footprinting of 
oligonucleotide CT-15 as a function of oligonucleotide concentration. 
Oligonucleotide CT-15 was equilibrated with duplex DNA under the 
conditions and concentration specified. DNase I footprinting was effected by 
addition of a lOx solution of DNase I to a final concentration of 40 ng/ml. 
Reactions were conducted at 4 °C for 12 minutes and were quenched by 
addition of 0.25 volumes of a 10 M N}-40Ac, 200 mM EDTA solution and 3 
volumes of ethanol. OMS footprinting was effected by addition of 4 ~l of a 
freshly prepared 2% aqueous solution of dimethyl sulfate. After 90 seconds at 
o °C, reactions were quenched with 5 ~l of a OMS stop solution and 785 ~l of 
ethanol.32,33 After washing with 70% ethanol, strand scission was obtained 
after incubation at 90 °C for 30 minutes in 10% aqueous piperidine. Lane 1: 
Intact DNA. Lane 2: Maxam-Gilbert G + A sequencing lane. Lanes 3-9: OMS 
footprinting, 20 % ethylene glycol, 100 ~M calf thymus DN A, 100 mM Tris, pH 
7.0, 100 mM NaCI, 1 mM Co(NH3)+3 Lane 3: no oligonucleotide; Lanes 2-9: 2 
~M, 660 nM, 200 nM, 66 nM, 20 11M, and 6 nM oligonucleotide CT-15. Lanes 
10-16:L DNase I footprinting, 0% ethylene glycol, 100 ~M calf thymus DNA, 
100 mM Tris pH 7.0, 10 mM Mg+2, 10 mM Ca+ 2, 5 mM K+. Lane 10: no 
oligonucleotide; Lanes 11-16: 2 ~M, 660 nM, 200 nM, 66 nM, 20 nM and 6 nM 
oligonucleotide CT-15. 
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Fig. 2.9. Histograms obtained by densitometry of autoradiogram from Fig. 2.8 
indicating the footprinting of oligonucleotide CT-15 using DNase I as a 
function of oligonucleotide concentration. Bars indicate extent of inhibition 
of cleavage at base indicated. Box ind ica tes oligonucleotide binding site. 
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DNase I Footprinting with 2000 nM CT-lS Probe 
.1 1.1. 
up~-TATATATATAAAAAGAGAGAGAGATCGATAGGATCCTCTACGCCG-~ 
3'- A TAT A TAT A TTTTTCTC TC TC TC A GC T A TCCT AGGAGA TGCGGC-S' 
DNase I Footprinting with 600 nM CT-lS Probe 
.1 III.. . 
32pS'- T AT A T A TA T~AAAA GAGAGAGm·TCGA T A GGA TCCTCTACGCCG-3' 
3'- A T A TA TAT A TTTTTCTCTCTC TC A GCT A TCCT AGGAGA TGCGGC-S' 
DNase I Footprinting with 200 nM CT-15 Probe 
.1 1.1. 
32pS'- TAT A TAT A T~AAAAGAGAGAGAGAIT CG AT AGGA TCCTC TACGC CG-3' 
3'- A TAT A T A TA T TITCTC TC TC TCTIA GC T A TCCT AGGAGA TGCGGC-5' 
DNase I Footprinting with 60 nM CT-15 Probe 
I ••••. 
32pS'- T AT A TAT A TlAAAAAGA GAGa-Ga-GAITCGA T AGGA TC CTCT AC GC CG-3' 
3'- A TAT A TAT A T T T T T C T C T C T C T C TAG C TAT C C TAG GAG A T G C G G C-S' 
DNase I Footprinting with 20 nM CT-15 Probe 
32p5'- TAT A TAT A T AA AAA GAGAGAGA GA TCG AT AGGA TC CTCT A C GC CG-3' 
3'- A TAT A TAT A TTTT TCTC TCTC TC T A GC T A TCC T AG GAGA TGCGGC-5' 
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Fig. 2.10. Relative reactivities of guanines to dimethyl sulfate as a function of 
oligon ucleotide concen tr a tion as determined by densitometry of 
autoradiogram in Fig. 2.8. Arrows indicate extent of cleavage at base 
indicated. Box indicates oligonucleotide binding site. 
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No Probe 
1 1 ! !! 1 11 
32p S'- TAT A TAT A T AAAA AGAGAGAGAGA TCGA T AGGA TCCTCTACGCCG-3' 
3'- A TA TAT A T A TT TTCTCTCTCTCT AGC TA TCCT AGGAGA TGCGGC-5' 
Probe CT-1S; 211M 
~ ~ ! 1 1 11 
32p S'- TAT A TAT AT AAAAAGA GAG AGAGA TCGA T AGGA TC CTCT ACGC CG-3' 
3~ATATATATATTTTTCTCTCTCTCTAGCTATCCTAGGAGATGCGGC~' 




Probe CT-1S; 200 nM 
! ! ! 1 1 11 
32p S:- TAT A TAT A T A AAAA GAGAGAGA GA TCGA T AGGA TCCTCT AC GC C G-3' 
3 - ATA TA T A TA TTTTTCTCTCTCTCTAGCTA TCCTAGGAGATGCCCC-5' 
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Probe CT-1S; 60 nM 
1 J J d J 11 
32p 5'- TAT A T A TA AAAAGAGAGAG A GA TCGA T AGGA TCCTCTACGCCG-3' 
3'-ATATATATAT TTTCTCT TC CTAGCTATCCTAGGAGATGCGGC-5' 
Probe CT-1S; 20 nM 
1 1 1 1 1 1 11 
.p5~TATATATATAAAAAGAGAGAGAGATCGATAGGATCCTCTACCCCG_~ 
3~ATATATATATTT CTCTCTCTCTAGCTATCCTAGGAGATGCGGC-~ 
Probe CT-1S; 6 nM 
1 ! 111 1 
32p 5'- TAT A TAT A T AAAAAGAGAGAG AGA TC GAT AGGA TC CTCTACCCC G-3' 
3'-ATATATATAT TTTCTCTCTC CTAGCTATCCTAGGAGATGCGGC-5' 
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comprehensive study of the kinetics of triple helix formation has recently 
been reported.29 The reported results are consistent with these observations. 
Binding affinities and oligonucleotide base composition characterized by 
footprin ting. 
Determination of binding affinities using DNase I and DMS footprinting. 
DNase I footprinting as a function of oligonucleotide concentration indicates 
that binding under conditions of 10 mM Mg+2, 10 mM Ca+2, 5 mM K+, 0% 
ethylene glycol, pH 7.0 is observed at an oligonucleotide (CT-15) concentration 
as low as 60 nM (Figures 2.8 and 2.9). Similar results are obtained using DMS 
footprinting under slightly different conditions (20% ethylene glycol, 25 mM 
pH 7.0 Tris, 100 mM NaCl, 1 mM Co(NH3)6+3) (Fig. 2.8 and 2.10). A binding 
constant of approximately 1 x 107 M-l is inferred. Since the completion of 
these studies, Maher has shown that the association rates of oligonucleotides 
for their binding sites are quite slow29 At low concentrations, equilibrium 
may not have been atta ined during the 60 minute incubation time used in 
these studies; therefore, the actual binding constant may be higher than that 
reported here. 29 
Studies of the effect of oligonucleotide composition using DNase I and 
DMS footprinting. To delineate the role of base composition and length on 
binding affinity oligonucleotides of various length and base compositions 
were synthesized and their relative binding affinities determined by DNase I 
and DMS footprinting (Figure 2.11). Oligonucleotides CT-13, CT-11, CT-09 and 
CT-07 are sequentially shortened by two bases from the 3' end of the 
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oligonucleotide CT-15, incrementally removing a C as well as a T residue. 
Oligonucleotides CT-12, CT-IO and CT-08 are analogous to CT-lS, CT-13, and 
CT-ll; however, 3 T bases from the 5' end of the oligonucleotide have been 
deleted. This results in a series of oligonucleotides with a slightly increased 
C:T content. Two oligonucleotides 15 bases in length which result in T-G and 
C-A mismatches upon triplex form a tion were also constructed. These 
oligonucleotides are analogous to those s tudied by Moser using affinity 
cleaving. 
5'- TTTTTCTCTCTCTCT-3' 
5'- T T TT T C TCT CT C T -3' 




5'- T T T T T C T -3' 
s~ TTCTCTCTCTCT-3' 








5'- T T C T C T C T -3' CT-08 
5'- TT TTTCTCT(]TCTCT-3' T-GMismatch 
5'- T T T T T C T C T c(gC T C T -3' C-A Mismatch 
5· .... TAT A TAT AT A ./ A TA G .... 3· 
3' .... A TAT A TAT T· ...... C TAT C .... 5· 
c...1--,----,1 = triplex site ImmWHMI = dam I methylase site 
Fig. 2.11. Oligonucleotides used in footprinting studies of triple helix 
formation. Oligonucleotides bind a site within plasmid pDMAGI0.35•58 The 
final two base pairs are part of a dam I methylase site. The mismatched base 
in the T-G and C-A mismatched p robes are indicated. The 3' terminal A 
within the triplex site is N -6 methylated in these s tudies. 
Footprinting using DNase I indica tes that the binding affinities of 
oligonucleotides less than 13 bases in length decrease sharply (Fig 2.12 and 
2.13) . Under the conditions studied (2 ~M oligonucleotide, 10 mM Mg+2 and 
Ca+ 2, 25 mM Tris , 5 mM K+, pH 7.0), the relative affinities of the 
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oligonucleotides studied is CT-15 > CT-13 > CT-ll = C-A mismatch> CT-12 > 
CT-09 = CT-10 > T-G mismatch > CT-08 > CT-07. Binding by the 
oligonucleotides CT-07 or CT-08 can barely be detected. As oligonucleotide 
length is decreased, a concomitant decrease in the size of the footprint is 
observed, the footprint consistently remaining approximately 5 base pairs 
larger than the oligonucleotide target site. 
The binding of these oligonucleotides was also studied by DMS 
footprinting. Based on the variable temperature data gathered in Figure 2.14, 
the melting temperature of the oligonucleotide CT-09 (2 mM CUCI2, 2 IJ,M 
oligonucleotide, 20 % ethylene glycol, 25 mM Tris pH 7.0) is approximately 
12°C. Oligonucleotide CT-ll forms a stable triplex at temperatures> 25 °C. 
Oligonucleotide CT- IO, w hich binds DN A via the formation 4 C+GoC 
base triplets and 6 ToA-T base trip lets, does not bind duplex DNA at 25 °C. 
Oligonucleotides CT-09, which forms 3 C+GoC triplets and 6 ToA-T triplets, 
melts at 12 °C. By comparison, oligonucleotide CT-ll, which forms 4 C+GoC 
triplets and 7 ToA-T triplets, melts at >25 0C. The series of oligonucleotides 
lacking the TS run at the 5' end appears to form triplexes of lower stability 
than do the oligonucleotides containing TS tails. The higher C content of 
these oligonucleotides may result in lower triplex stability at the pH used in 
this study. Frank-Kamenetskii and co-workers have suggested that at low 
pH, C+G-C base triplets are more stable than ToA-T triplets 59,60 The stability 
of the triplexes formed by these two se ts of oligonucleotides as a function of 
pH has not been determined. 
The oligonucleotides CT-13, CT-ll , CT-09, CT-07, CT-IO, and CT-08 each 
induce hyperreactivity to a single guanine base immediately adjacent to and 
outside of the oligonucleotide binding site (Figure 2.14-2.16). In contrast, 
oligonucleotides CT-15 and CT-12 confer increased reactivity to a guanine 
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Figure 2.12. Autoradiogram of 8% polyacrylamide high resolution denaturing 
gel electrophoresis of 32P-endlabeled 628 bp restriction fragment from 
pDMAG10 (EcoR I/Bgl I) indicating DNase I footprinting of various 
oligonucleotides. Oligonucleo tides (final concentration 2 ~M) were 
equilibrated with duplex DNA in 100 ~M calf thymus DNA, 100 mM Tris 
buffer, pH 7.0, 10 mM MgCI2, 10 mM CaCI2, 5 mM KCI. DNase I footprinting 
was effected by addi tion of a lOx solution of DNase I to a final concentration of 
40 ng/ml. Reactions were conducted at 4 °C for 12 minutes, and were 
quenched by addition of 0.25 volumes of a 10 M NH40Ac, 200 mM EDTA 
solution and 3 volumes of ethanol. Lane 1: Intact DNA. Lane 2: Maxam-
Gilbert G + A sequencing lane. Lane 3: Maxam-Gilbert G sequencing lane. 
Lane 4: no oligonucleotide; Lane 5: Oligonucleotide CT-15; Lane 6: 
Oligonucleotide CT -13; Lane 7: Oligonucleotide CT-ll; Lane 8: 
Oligonucleotide CT-09; Lane 9: Oligonucleotide CT-07; Lane 10: no 
oligonucleotide; Lane 11: Oligonucleotide CT-12; Lane 12: Oligonucleotide CT-
10; Lane 13: Oligonucleotide CT-08; Lane 14: TG mismatch oligonucleotide; 






10 r<l O>~ N 
roU"lU"l 
G - 00 90::2:~ , 
't9<l + f- f- f-f-f- f-f- f- , , 
A G u u UUU UU Uf-U 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 
•  ~ 
- ... 
- % ;-~ - - - --:: -~ - -. .- --- .- -... - .. - -
AT - --.- .- - -- .- - .- - ... 
GC \ 
- -..... .- .iii. .. --....... AT 41' =: . a ••• ... :.. GC .0-
AT - - - -GC -- - -AT - - - -GC - - -AT 
GC 
AT 
AT/ AT - -----.-AT -- - -' ------ -AT ----- ---- -.- --- - ---- - - - - --- - - ------------• -- - - - - .. - - .. • - - - ~ • -. ------.. -_A • • \ . 
• • ., 
59 
Fig. 2.13. Histograms obtained by densitometry of autoradiogram from Figure 
2.12, indicating the binding of oligonucleotides of various lengths and base 
composition as determined by DNase I footprinting. Bars indicate extent of 
inhibition of cleavage at base indicated. Boxes indicate oligonucleotide 
binding site. 
60 
DNase I Footprinting of CT-15 Probe 
32p5'- TAT A TAT A~r.""'''''''-';-;'''';-;;-''''''-;;-"i1~CGA T A GGA TC CTC TA CGC CG-3' 
3'- A TAT A TAT G C TAT C C TAG GAG A T G C G G C-5' 
I 




DNase I Footprinting of CT-ll Probe 
32p5'-TATATATA 
3'- A TAT A TAT II 











32p5'- TAT A TAT A T AAAAAGAGAGAGAGA TCGA T AGGA TC CTC T A CGCC G-3' 
3'- A TAT A TAT A TTTTTCTCTC TC T CT AGC T A TCC T A GGA GA TGC G GC-5' -- -
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DNase I Footprinting of CT-12 Probe 
32 P 5'- TAT A TAT A T A A ...... c-;;-c;-;;-..."..,...,....,,-n~ eGA TAG GAT C eTC T A C Gee G-3' 
~-ATATATATATT GCTATCCTAGGAGATGCGGC-~ .. r 
DNase I Footprinting of CT-IO Probe 
32p5'- TAT AT A TA TAA 
3'-ATATATATATT •• 
DNase I Footprinting of CT-08 Probe 
32p 5'- TAT A TAT A T A 
3'- A TAT A TAT A T -
CGATAGGATCCTCTACGCCG-~ 
GCTATCCTAGGAGATGCGGC-~ • 
A GAT eGA TAG GAT C eTC T A C Gee G-3' 
TCTAGCTATCCTAGGAGATGCGGC~' • 
DNase I Footprinting of T-G Mismatch Probe 
32p5'-TATATATA 
3'- A TAT A T A T.!!.~ ... -,-,--", 
II 
DNase I Footprinting of C-A Mismatch Probe 






Figure 2.14. Autoradiogram of 8% polyacrylamide high resolution 
denaturing gel electrophoresis of 32P-endlabeled 628 bp restriction fragment 
from pDMAGI0 (EcoR I/Bgl I) indicating OMS footprinting of 
oligonucleotides CT-15, CT-13, CT-11, CT-09 and CT-07. Oligonucleotides 
(final concentration 2 IlM) were incubated with the duplex DNA for 60 
minutes at 0 °C in 20 % ethylene glycol, 100 IlM calf thymus DNA, 100 mM 
Tris pH 7.0, 100 mM NaCl, and 2 mM CUCI2, than equilibrated for 15 minutes 
at the temperature specified. OMS footprinting was effected by addition of 4 
III of a freshly prepared 2% aqueous solution of dimethyl sulfate. After 90, 45 
or 30 seconds at the temperature specified, reactions were quenched with 5 III 
of a OMS stop solution and 785 III of ethanol32•33 After washing with 70% 
ethanol, strand scission was obtained after incubation at 90 °C for 30 minutes 
in 10% aqueous piperidine. Line 1: Intact DNA. Lane 2: Maxam-Gilbert G + A 
sequencing lane. Lanes 3-20: 20 % ethylene glycol, 100 IlM calf thymus DNA, 
100 mM Tris pH 7.0, 100 mM NaCI, 2 mM CUCI2, and 2 IlM oligonucleotide. 
Lanes 3-8: DoC, Lanes 9-1 4: 12.5 oC, Lanes 15-20: 25°C. Lanes 3, 9, 15: no 
oligonucleotide; Lanes 4, 10, 16: Oligonucleotide CT-15. Lanes 5, 11, 17: 
Oligonucleotide CT-13; Lanes 6,12,18: Oligonucleotide CT-ll; Lanes 7, 13, 19: 
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Figure 2.15. Autoradiogram of 8% polyacrylamide high resolution 
denaturing gel elec trophoresis of 32P-endlabeled 628 bp restriction fragment 
from pDMAG10 (EcoR I/Bg l I) indicating DMS footprinting of 
oligonucleotides CT-12, CT-10, CT-08, T-G mismatch, and C-A mismatch. 
Oligonucleotides (final concentration 2 fl.M) were incubated with the duplex 
DNA for 60 minutes at 0 °c in 20% ethylene glycol, 100 fl.M calf thymus 
DNA, 100 mM Tris pH 7.0, 100 mM NaCI, and 2 mM CUCI2, then equilibrated 
for 15 minutes at the temperature specified. DMS footprinting was effected 
by addition of 4 fl.l of a freshly prepared 2% aqueous solution of dimethyl 
sulfate. After 90 seconds at 0 °c, reactions were quenched with 5 fl.l of a DMS 
stop solution and 785 fl.l of eth anol32,33 After washing with 70% ethanol, 
strand scission was obtained by incubation at 90°C for 30 minutes in 10% 
aqueous piperidine. Lane 1: Intact DNA. Lane 2: Maxam-Gilbert G + A 
sequencing lane. Lanes 3-8: ooC, Lanes 9-14: 12.5 DC, Lanes 15-20: 250C. Lanes 
3, 9, 15: no oligonucleotide; Lanes 4, 10, 16: Oligonucleotide CT-12. Lanes 5, 11, 
17: Oligonucleotide CT-10; Lanes 6,12,18: Oligonucleotide CT-08; Lanes 7, 13, 


























































































































































































































































































































































Fig. 2.16. Histograms obtained from densitometric scanning of autoradiogram 
from Figures 2.14 and 2.15, indicating the binding of oligonucleotides as 
determined by OMS footprinting. Bars indicate extent of inhibition of 
cleavage at base indicated. Boxes indicate oligonucleotide binding site. 
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Probe CT-15 
32p 5'- TAT A TAT A T AA AAAGAGAG AG AGA TCGA T AGGA TCCTCTACGC CG-3' 
3'- A TA TAT A T A TTTTTCTCTC TC TCT AGC T A TCC T AGGAGA TGCGGC-5' 
Probe CT-13 
t • I 







32 5'- TAT A TAT A T AAAAAGAGAGAGAGA TCG AT AGGA TC CTC T ACGC CG-3, 






3'- A T A TA TAT A TTTTTCTCTCTCTCT AGCTA TCC T AGGAGA TGCGGC-5' 
Probe CT-1 0 
.. I 
Probe CT-08 
T-G Mismatch Probe 
32p 5'- TAT A TAT A T AAAAAGAGAGAGAGA TCGA T A GGA TCCTCTACGC CG-3' 
3'- A TAT A TAT A TTTTTCTCTC TCTCT AGC T A TCC T AGGAGATGCG GC-5' 
C-A Mismatch Probe 
• ! • 
32p 5'- TAT A TAT A T AAAAAGAGAGAGAGA TCGA T AGGA TC CTCT AC GC CG- 3: 3'- A TAT A TAT A TTTTTCTC TC TCTCT AGCTA TCC T AGGAGA TGCGGC-5 
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located within the binding site, indicating that the two 3' terminal bases of 
oligonucleotides CT-1 5 and CT-12 are not bound in the triple helical complex. 
Affinity cleaving results indicate that oligonucleotide CT-13-EDTAoFe(II) 
cleaves its target site as efficientl y as CT-15-EDTAoFe(II).1 These data 
corroborate conclusions drawn from OMS footprinting studies concerning the 
unbound state of the last two base p airs of the oligonucleotide CT-15. 
It is now known that the terminal adenine within the oligonucleotide 
binding site is a substrate for methylation by the methylase dam I. Under the 
conditions u sed to prepare the plasmid pDMAGlO, 100% m ethylation at N-6 
of this residue is expected. This fact has been confirmed by restriction enzyme 
inhibition studies 36 Methylation at this site interferes with H oogs teen 
hydrogen bond formation, preventing binding of the final (two) bases of the 
oligonucleotide to the targe t site (Fig. 2.18). 
DNase I footprinting indicates tha t the oligonucleotides C-A mismatch 
and CT-ll bind with approximately equal affinities, while the binding affinity 
of the T-G mismatch oligonucleotide is intermediate be tween those of the 
oligonucleotides CT-09 and CT-07. OMS footprinting indicates that both of 
these oligonucleotides bind only at 0 0c. The binding affinities of these 
oligonucleotides as assayed by OMS footprinting are thus lower than that 
observed for the oligonucleotide CT-09 . Binding of these oligonucleotides 
results in the appearance of two guanines h yperreactive to dime thyl 
sulfate(Figures 2.15, 2.16), indicating that these oligonucleotides can bind by 
accomodation of the misma tch via tautomerism of one of the bases, or by 
forming nine (T-G mismatch oli gonucleotide) or ten (C-A mismatched 
oligonucleotide) matched base triplets at the 5' end of the binding site. 
Affinity cleaving data indicate that these mismatched oligonucleotides 
are thought to bind to the target sequence approximately ten times less tightly 
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than their fully complementary counterpart, with the C-A mismatch 
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Fig. 2.17. Methylation at N -6 of terminal 3' adenine in triple helix target site 
interferes with formation of T- AT base triplets. 
One explanation for the difference in binding affinities between C-A and 
T-G mismatched oligonucleotides is that binding of the C-A mismatch allows 
accomodation of ten matched triplets, while the T-G mismatch 
oligonucleotide can only bind nine matched triplets. The relative intensities 
of the two hyperreactive guanines, however, indicates that accomodation of 
the mismatch is favored over binding of only the first nine or ten base pairs. 
The higher binding affinity of C-A mismatch may therefore indicate that the 
C-A mismatch is more easily accomodated than is the T-G mismatch. 
Two-dimensional models of the base triplets in these studies indicate 
that a T-G mismatch can be incorporated within a triplex with the formation 
of a hydrogen bond (Fig. 2.18). Incorporation of a C-A mismatch requires 
protonation of cytosine for the formation of a single hydrogen bond and 
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results in a potential steric clash between the exocyclic amino groups at C-6 of 
adenine and C-4 of cytosine. 
CH3 t==<. . ,H CH
3 
sug-N. r N ~>--N+ H , .. 0 , 
1/, H, _ H 
o H N N N ... JC .H' 'Y' 'Sug 
N "'..- II < I; 0 
~ N"" 
Sug 
CA T-basetriplet mismatch TGC-basetriplet mismatch 
Fig, 2,18, Base triplet mismatches formed by hybridization of the 
oligonucleotides C-A misma tch and T-G mismatch with triple helical target 
site. 
OMS footprinting of oligonucleotide binding to the sequence AsG 1 O. 
OMS footprinting was used to study triple helix formation between the 
oligonucleotides CC-1S, CC-13, CC-ll and the target sequence ASGlO (Fig. 2.19). 
5'- T T TT TC C C CCCC CC C-3' 
5'- TTTTTCCC CCCC C -3' 




5' .... TATAT A TA TA TAAAAAGGGGGG .GGGG TCGA TAG .... 3' 
3' .... ATATATAT AT A TT TTTCCCCCC'CCCCAG CT ATC .... 5' 
,---,_ ..... 1 = triplex site 
Fig, 2.19. Oligonucleotides used to study binding to the sequence AsGlO via 
OMS footprinting. No dam I methylase site exists in this sequence. 
Binding of this series of oligonucleotides is extremely pH dependent, 
with no binding observed at pHs> 3.7 (Fig. 2.20, 2.21). The optimal pH for 
binding should decrease as the cytosine content of the oligonucleotide 
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Figure 2.20. Autoradiogram of 8% polyacrylamide high resolution 
denaturing gel electrophoresis of 32P-endlabeled 628 bp restriction fragment 
from pDMGI0 (EcoR I/Bgi I) indicating DMS footprinting of oligonucleotide 
CC-13 as a function of pH. Oligonucleotides (final concentration 2 I!M) were 
incubated with the duplex DNA for 60 minutes at 0 °c in 20% ethylene glycol, 
100 I!M calf thymus DNA, 100 mM Tris, 100 mM NaCl, and 1 mM 
Co(NH3) 6+3 . DMS foo tprinting was effected by addition of 4 III of a freshly 
prepared 2% aqueous solution of dimethyl sulfate. After 90 seconds at 0 °c, 
reactions were quenched with 5 III of a DMS stop solution and 785 III of 
ethanol.32,33 After washing with 70% ethanol, strand scission was obtained by 
incubation at 90 °C for 30 minutes in 10% aqueous piperidine. Lane 1: Intact 
DNA. Lane 2: Maxam-Gilbert G + A sequencing lane. Lanes 3, 5, 7, 9, 11 and 
13: no oligonucleotide. Lane 4, 6, 8, 10, 12, and 14: 2 IlM oligonucleotide CC-
13. Lanes 3 and 4: pH 2.7; Lanes 5 and 6: pH 3.7; Lanes 7 and 8: pH 4.7; Lanes 9 
and 10: pH 5.7; Lanes 11 and 12: pH 7.0; Lanes 13 and 14: pH 8.0. 
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Fig. 2.21. Relative reactivities of guanines in plasmid pDMGIO to dimethyl 
sulfate as a function of pH and oligonucleotide CC-13 as determined by 
densitometry of autoradiogram from Fig . 2.20. Arrows indicate extent of 
cleavage at base indicated. Boxes indicate oligonucleotide binding site. 
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No Probe. pH 2.7 
Illllli 
32p 5'- TAT A T A TA TA AAAA GGGGGGG GGGTC GA T AGGA TCCTCTACGCCG-3' 3'_ A TA TAT A T A TTTTTCC CCCCCCCCAGCTA TCCTAGGAGA TGCGGC-5' 
Probe CC-13 ; pH 2.7 
!Hut!ll ~ u 
32 p 5'- TAT A TAT A T AAAAAGGGGGGGGGGTCGA T AGGATCCTCTACGCCG-3' 3'_ A TAT A TAT A TTT TCCCCC CCCCCAGCT A TCCTAGGAGA TGCGGC-5' 
No Probe; pH 3.7 
!!.~~~.t~~ ~ ~~ 
32p 5'- TAT A T A TA T A AAAAGG GG G GGGGGTC GA T AGGA TC CTCTACGCCG-3' 3'_ A TAT A TAT A TTTTTCC CC C CC CCC AGCT A TCCTAGGAGA TGCGGC-5' 
Probe CC-13 ; pH 3.7 
h 
32p 5'- TAT A TAT A TAAAAAGGGGGGG GGG TC GA T A GGA TC CTCTACGCCG-3' 
3'_ A TAT A TAT A TTTTTCCCCCCCCCCAGC T A TCCTAG GAGA TGCGGC-5' 
No Probe; pH 4.7 
~! ••••• t~. ! !! 
32p 5'- TAT A TAT A T A AAA AGGGG G GGGGGTCGA T AGGA TCCTC TACGCCG-3' 
3'_ A TAT A TAT A T TTTCC CC C CCCCCAGCT A TCC T AGGAGA TGCGGC-5' 
Probe CC-13 ; pH 4.7 
~t.~~ •• tt~ ! !+ 
32p 5:- TAT A TAT A T AAAAAGG GGGGG G GGTCGA T A GGA TC CTC TACGCCG-3' 
3-ATATA1ATATTTTTCCCCCCCCCCAGCTATCCTAGGAGATGCGGC-~ 
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Figure 2.22. Autoradiogram o f 8% polyacrylamide high resolution 
denaturing gel electrophoresis of 32P-endlabeled 628 bp restriction fragment 
from pDMG10 (EcoR I/Bgi I) indicating DMS footprinting of oligonucleotides 
CC-lS, CC-13 and CC-11 as a function of time of incubation and 
oligonucleotide concentration. Oligonucleotides were incubated with the 
duplex DNA at 0 °C in 20% ethylene glycol, 100 ).J.M calf thymus DNA, 100 
mM Tris, 100 mM NaCI, and 1 mM Co(NH3)6+3 DMS footprinting was 
effected by addition of 4 ).J.I of a freshly prepared 2% aqueous solution of 
dimethyl sulfate. After 90 seconds at 0 °C, reactions were quenched with 5 ).J.I 
of a DMS stop solution and 785 ).J.l of ethanol.32,33 After washing with 70% 
ethanol, strand scission was obtained by incubation at 90 °C for 30 minutes in 
10% aqueous piperidine. 
Lane 1: G reaction is absence of oligonucleotide. Lane 2-6: 2 JlM 
oligonucleotide CC-13. Lane 2: no pre-incubation. Lane 3: DMS reaction 1 
minute after addition of oligonucleotide. Lane 4: DMS reaction 5 minutes 
after addition of oligonucleotide. Lane 5: DMS reaction 15 minutes after 
addition of oligonucleotide. Lane 6: DMS reaction 60 minutes after addition 
of oligonucleotide. Lanes 7-16: DMS reaction 60 minutes after addition of 
oligonucleotide. Lane 7: no addition of oligonucleotide. Lane 8: addition of 2 
).J.M oligonucleotide CC-15. Lane 9: addition of 200 nM oligonucleotide CC-15. 
Lane 10: addition of 20 nM oligonucleotide CC-15. Lane 11: addition of 2 JlM 
oligonucleotide CC-13. Lane 12: addition of 200 nM oligonucleotide CC-13. 
Lane 13: addition of 20 nM oligonucleotide CC-13. Lane 14: addition of 2 JlM 
oligonucleotide CC-ll. Lane 15: addi tion of 200 nM oligonucleotide CC-ll. 













CC-13 , = min. 
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CC-15 CC-13 CC-ll 
I 
78 
Fig. 2.22. Relative reactlvltles of guanines in plasmid pDMG10 to dimethyl 
sulfate as a function of oligonucleotide and oligonucleotide concentration as 
determined by densitometry of au toradiogram in Fig. 2.21. Bars indicate 
extent of inhibition of cleavage at base indicated . Boxes indicate 
oligonucleotide binding site. 
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No Probe 
l!~~~~~~+~ 1 11 
s2p 5'- TAT A T A TA T AAAAAGGGGGGGGGGTCGA T AGGA TC CTCT ACG C CG-3' ~_ATATATATATTTTTCCCCCCCCCCAGCTATCCTAGGAGATGCGGC-~ 
Probe CC-1S; 2 11M 
!~~+++++~l l 11 
np5~TATATATATAAAAAGGGGGGGGGGTCGATAGGATCCTCTACGCCG-~ 
3'- A TAT A TAT A TTTTT C CCC CC CCCAGCTA TCCTAGGAGATGCG GC-5' 
Probe CC-1S; 200 nM 
!~~++ •• ++! ~ l! 
32
p
5'- TAT AT A TAT AAAAA GGGGGGGGGGTCG AT AGGA TCCTCT ACGCCG-3: 
3'- A TAT A TAT A TTTTTCCCCC CC C CC AGC T A TCCTAGGAGA TGCGGC-5 
Probe CC-1S: 20 nM 
!!~.++~~.! ~ 1! 
np5~TATATATATAAAAAGGGGGGGGGGTCGATAGGATCCTCTACGCCG-~ 
3'- A TA TA TAT A TTTrTCC CCC CC CCCAGCT A TC C T AGGAGA TGCGGC-5' 
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Probe CC-13 ; 211M 
1111 ••• 111 I 1\ 
npS~TATATATATAAAAAGGGGGGGGGGTeGATAGGATeeTeTAeGeeG-r 
3'- A TAT A TAT A TTTTTee ee eee eeCAGCT A TCCTAGGAGA TGCGGC-5' 
Probe CC-13 ; 200 nM 
11 ••••• lll I II 
32p 5'- TAT A T A TA T A A AAAGGGGG GG G GG TCGA T AGGA TCCTCTACGCCG-3' 
3~ATATATATATTTTTcccceeCCeCAGCTATCCTAGGAGATGCGGC-~ 
Probe CC-13: 20 nM 
1I1111dli I 11 
32p 5'- TAT A TAT A TAA AAAGG GGGGGGGGTe GA T AGGA Te CTCTACGCeG-3' 
3'- A T A TA TAT A TTTTTee CC cec CCeAGC T A TCC T AGGAGA TGC GGC-S' 
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Probe CC-11 ; 2 ,.M 
t~++t~ 1++ ~ 1! 
32p 5',- T AAT A TAT AT AA AA AGGGGGGG G GGTCGA T AGGA TACCGATCGTAATCGCGCGCGCG-S3; 
3-AT TATATATTTTTCCCCCCCCCCAGCTATCCT G -
Probe CC-11; 200 nM 
!~ttt~ l~~ ! 11 
32p 5'- TAT A TAT A T A AAAA GG GGG GG GGGTCGA T AGGA TCCTCTACGCCG-3' 
3'- A TAT A TAT A TT TTTCC CCC CCCCCAGCT A TCe TAGGAGA TGCGGC-5' 
Probe CC-11; 20 nM 
t!ttt! !++ t it 
32p5'- TAT A TAT AT AAAAAGG GGGGGG GGTC GA T AGGA TC CTC T ACGCCG-3' 
3/- A TAT A TAT A TTTTTCC CCCCC C CCAGC T A TCC T AGGAGA TGC GGC-5' 
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increases, due to the presence on increasing number of protonation sites 
within the triple helical complex,s9,60 The binding of a series of cytosines may 
result in further destabilization of the triplex, due to the stacking of the 
positive charges within the complex. 
The kinetics of hybridization between oligonucleotides CC-13 and CT-13 
and their target sequences differ. A noticeable increase in hyperreactivity is 
observed if the oligonucleotide CC-13 is allowed to equilibrate with its target 
site for at least 60 minu tes prior to reaction, however, prior to that time, no 
change in guanine reactivity to OMS is observed (Fig. 2.22) . In contrast, 
oligonucleotide CT-15 (2 ~M) hybridizes to its target sequence within one 
minute, as determined by a s imil ar assay (vide supra). Binding of 
oligonucleotide CC-13 is monitored a t pH 2.7. It is possible that this change in 
hybridiza tion time is a function of pH, and not of the oligonucleotide under 
study. 
No h yperreactivity was conferred upon hybridization of the 15 base 
oligonucleotide CC-15 (Fig. 2.22). Hybridization of the oligonucleotides CC-13 
and CC-ll results in h yperreactivi ty at guanines located 1 base 3' to the 
binding site for that oligonucleotide (Fig. 2.23). Under slightly different 
conditions (40% ethanol, 1 mM spermine, pH 5.7), the oligonucleotide CC-15-
EDT A • Fe(II) was shown to cleave ON A when activated with Fe(II) and DTI; 
thus, while oligonucleotide CC-15 binds its targe t sequence, no hyperreactivity 
to any of the guanines in the target sequence is conferred. This indicates that 
the oligonucleotide CC-15 binds all 15 base p airs of the target sequence, in 
contrast to the oligonucleotide CT-15. This is now understood to be a result of 
me thylation by dam I of the plasmid pDMAGI0, but not pDMG1036 
Hyperreactivity was largely limited to a single guanine. This indicates 
that the structural disto rtion associated with a transition from triplex to 
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duplex DNA is limited to a single base pair. Such a distinction could not be 
made based on studies with the pDMAG10 plasmid, since guanines are only 
present at every second base pair. 
The binding affinities of the oligonucleotides CC-13 and CC-ll can be 
analyzed due to the presence of a hyperreactive guanine. The affinities of 
these oligonucleotides at pH 2.7 are> 5 x 108 M-l, indicating the stabilization 
of C+G·C base triplets at low pH59,60 
Conclusions 
The binding of oligonucleotides to double helical DNA via triple helix 
formation can be detected using a variety of footprinting agents. This allows 
the determination of oligonucleotide affinity without the incorporation of 
modified nucleosides which may alter binding characteristics under a variety 
of conditions. 
MPE· Fe(II) can be used to determine binding site size, and indicates that 
oligonucleotide binding is solvent, cation, and oligonucleotide concentration 
dependent. Triple helices are stable under conditions of optimal DNase I 
activity (10 mM in each Mg+2 and Ca+2). This study indicates that triplexes 
can be used to inhibit enzyme activity under physiological conditions. 
Oligonucleotide binding results in a conformational change in the DNA, 
which can be detected by dimethyl sulfate (DMS). Guanines located 1 base 
pair beyond the oligonucleotide binding site become hyper-reactive to DMS 
upon triplex formation. This technique indicates that the two terminal 3' 
bases in the oligonucleotide CT-15 do not bind their target sequence. DMS 
footprinting can be used to determine triplex formation under a variety of 
conditions (low pH, presence of various cations) which are not compatible 
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with MPEoFe(II) or DNase I activity. Due to the short reaction time required 
by DMS (90 sec.), this technique can be used to study the kinetics of triplex 
formation. DNase I and DMS indicate that oligonucleotide CT-15 has a 
binding affinity of approximately 1 x 107 M-l. These footprinting techniques 
are used to compare the binding affinities of oligonucleotides of various 
lengths and base composition. Oligonucleotides with higher CIT ratios bind 
with lower affinities at neutral pH. Oligonucleotides shorter than 11 base 
pairs bind with weak affinities. The binding of oligonucleotides containing 
long runs C's (TSGlO) bind with slower kinetics and only at very low pH. 
Materials and Methods 
Reagents. EcoR I, Calf Thymus Alkaline Phosphatase, T4 Polynucleotide 
Kinase, and Bgl I were purchased from Boehringer Mannheim. Klenow 
fragment of DNA polymerase I was obtained from New England Biolabs. 
Ethylene glycol (Mallinckrodt), spermine o4 HCI (Aldrich, 98% pure), 
Fe(NH4)z(S04)z·6H20 (Baker Analyzed reagent), and dithiothreitol (DTT) 
(Bethesda Research Laboratories, ultra pure), were used as obtained. Phenol 
was distilled and stored under buffer at -4 °C for short periods of time. 
Piperidine (Fluka puriss. p. a.) was distilled and stored at -20 °C. A 1 mM 
solution of deproteinized calf thymus DNA was prepared by ultrasonic 
treatment of purchased cal f thymus DNA (Sigma), followed by repeated 
phenolic extraction and lengthy dialysis until a A2601 A280 of at least 1.8 was 
obtained. Aqueous solutions of DTT and Fe(NH4)z(S04)z. 6H20 were 
prepared just prior to u se. General experimental details for working with 
DNA were taken from Sambrook, Frisch, and Maniatis.61 
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Plasm ids. Plasmids pDMAG10 and pDMG10 were obtained from Dave 
Mende1 35,58 Large scale preparation was accomplished as described35 ,58,61 
using the E. Coli strain HB101, which contains dam I methylase activity. 
Plasmids were purified by density gradient centrifugation using a CsCI 
gradient.61 
Oligonucleotide synthesis and purification. The synthesis of all 
oligonucleotides was accomplished on a 1 11m ole scale using a Beckman 
System 1 Plus DNA-synthesizer and the automated solid-phase 
phosphoramidite method. After brief drying in vacuo, the polymer-bound 
oligonucleotide was treated with a 1:2:2 solution of 
thiophenol:dioxane:triethylamine (1.5 m!, 25 °C, 24 hrs.) to demethylate the 
phosphotriester. The polymer was washed with methanol (1.5 m!, 3x) and 
ether (1.5 ml 3x). The support was air dried for one hour. Removal of the 
oligonucleotide from the support was effected using concentrated NH40H (1.5 
ml, 2 hrs.). A second treatment with N~OH (1.5 ml, 2 hrs.) insured that 
removal was complete. The combined supernatants were reduced to dryness 
with a stream of argon, and deprotection of the bases effected using 
concentrated NH40H (1.5 ml, 55 °C, 24 hrs.). 
The oligonucleotides were purified by gel electrophoresis or liquid 
chromatography. Purification by electrophoresis was accomplished using 20% 
polyacrylamide (40x20xO.2 em, 1:20 cross-linked, 40 % urea, TBE buffer; 
electrophoresis for 16 hrs. at 750 V). Bands in the gel were visualized with 
UV light and excised, crushed, and eluted with 0.2 M NaCl, 1 mM EDTA (10 
m!) for 40 hrs. at 37°C. The polyacrylamide was removed using a cellulose 
acetate (Centrex) filter (pore-size 0.45 11m) and the resulting filtrate was 
dialyzed extensively (five days) against water. A Pharmacia Mono Q 5/5 
anion exchange column was used to effect chromatographic separation with 
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the following solvent system: solvent A: 20 mM Tris, pH 8.3; solvent B: 20 
mM Tris, pH 8.3, 1 M KCl. A gradient of 10-70% B over a period of 60 minutes 
was employed. Collections from the FPLC purification were dialyzed as 
described. The concentrations of the single stranded oligodeoxynucleotides 
were determined with the use of the extinction values (260 nm) for the bases 
T (8700) and C (7300). The oligonucleotides were lyophilized and stored dry at 
-20°C. 
Radio-labeling of restriction fragment. A uniquely 5'-end labeled 628 bp 
restriction fragment was obtained by linearization of 15 ~gs of the plasmid 
pDMAGI0 or pDMGI0 with 80 units of EcoR I in 100 J.!l, dilution of the 
reaction with 98 ~l of Ix CAP buffer, and treatment with Calf Alkaline 
Phosphatase (2 units, 1 unit/~l). After phenol extrac tion (2x), ether extraction 
(3x), and precipitation (NaOAc, ethanol), labeling with T4 Polynucleotide 
kinase (20 units) and y_32p-dATP was achieved as directed.61 Unincorporated 
nucleotides were removed by precipitation with NH40Ac (2x) . Cleavage with 
Bgi I afforded two labeled bands, 628 and 934 bp in length, which were 
separated on a non-denaturing 5% polyacrylamide gel (ISO x 140 x 2 mm, 1:20 
cross-linked, TBE buffer) for two hours at 240 V. The radio-labeled DNA was 
visualized by autoradiography (2 min. exposure), the faster running band was 
excised from the gel and eluted from the gel slice with 0.2 M NaCl, 1 mM 
EDTA at 37°C. The gel slices were removed by filtration through a 0.45 11m 
Centrex filter, and the filtrate reduced in volume by butanol extraction. The 
DNA was precipitated twice, washed with 70% ethanol, and dissolved in 10 
mM Tris, pH 7.4 to make a solution with approximately 10,000 cpm/~l. 
Labeling of the 3'-end was accomplished using EcoR I linearized DNA, 
phenol extraction and precipitation of the DNA, radio-labeling of the DNA 
using the Klenow fragment of DNA polymerase I and a_32p dATP. After 
87 
labeling , the DNA was p uri fied, cleaved with Bgl I, and the res triction 
fragment isolated as described. 
Sequencing was carried out as described by Maxam and Gilber P2,61 with 
the following m odifications: (i) G reactions with dimethyl sulfate were 
carried out at O°C for 1 min., (ij) treatment w ith formic acid was done at O°C 
for four minutes to afford a G+A reaction, and (iii) piperidine w ork-up was 
carried out using 0.1 M pipe ridine at 90 °C for 30 minutes. 
MPEoFe(II) fo otprinting. A 4x stock solution containing 400 IlM Calf 
thymus DNA, 400 mM NaCl, 5' or 3' 32p end-labeled DNA (approximately 
40,000 cpm per lane), and 100 mM Tris/ acetate buffer (pH 7.0) was prepared 
just prior to use. The DNA oligonucleotide, ethylene g lycol and ca tions were 
mixed in an Eppendorf tube and the stock solution above added and allowed 
to equilibrate wi th the oligonucleotide at O°C for a t least 60 min. MPEo Fe(II) 
was made as a lOx solution by adding freshly prepared Fe(NRt12(S041206H20 
solution to make a solution of 40 IlM in Fe(II) and 20 IlM in MPE. MPEoFe(II) 
was allowed to equilibrate with the DNA for 15 min. prior to activation with 
the addition of DTT (2 mM final concentra tion). Final reaction volume was 
20 Ill. The reactions were allowed to run for 14 hours at a °C and were 
stopped by precipitation w ith NaOAc and ethanol and washing with 70% 
ethanol. The pellet was dissolved in formamide buffer, and loaded directly 
onto an 8% polyacrylamide sequencing gel for ana lysis. 
Deoxyribonu clease I Footprintin g . Footprin tin g studie s using 
Deoxyribonuclease I (DNase I) were conducted in much the same manner as 
the MPE ° Fe(II) footprinting studies. After the DNA was mixed with the 
proper combination of Tris and ca tions, the oligonucleotide was equilibrated 
with the restriction fragment at O°C for a t least 60 min. prior to addition of 
DNase I. Since the equilibration s tep is slow relative to the footprinting 
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reaction, the final buffer concentrations listed in figure legends represents the 
content of the equilibration buffer. Reactions were effected with the addition 
of 2 ~l o f a 400 ng/ml solution of DNase I (final concentration 40 ng/ml), 
The reactions were run at 4 °C for 12 minutes, and were stopped by 
precipitation of the DNA with the addition of 5 ~l of a 10 M NH40Ac, 200 
mM EDTA solution and 75 ~l of e thanol. The pellet was washed and loaded 
onto a 8% polyacrylamide sequencing gel using formamide loading buffer for 
analysis. Studies at higher temperatures were conducted by allowing the 
oligonucleotide to equilibra te with the targe t DNA at O°C for one hour, then 
transferring the reactions to an equilibrated tempera ture bath for 15 min. 
DMS Protection Experiments. Solu tions were made as described above 
for DNase I foo tp rinting in a final volume of 20 ~J. The oligonucleotide was 
equilibra ted with the restriction fragment for 60 min., after which 4 ~I of a 
freshly prepared 2% aqueous solution of dime thyl sulfate was added. 
Reactions were conducted at 0 °C for 90 seconds and were terminated by the 
addition of 5 ~l of DMS stop solution32,61 and 785 ~I of ethanol. The DNA 
was precipitated and washed (70% ethanol). The pellet was dissolved in 100 
~I of 0.1 M piperidine, and incuba ted at 90 °C for 30 min. After lyophilization, 
the pellet was dissolved in 10 ~I of formamide loading buffer. 
Studies at higher temper a tures were conducted by allowing the 
oligonucleotide to equilibra te w ith the ta rget DN A at O°C for one hour, then 
transferring the reactions to an equilibra ted temperature bath for 15 min. 
Reactions were run at the s tated temperature. Reaction times were adjusted 
to allow for the greater rate of reaction at higher temperatures. 
Polyacrylamide elec trophoresis. Electrophoresis was accomplished using 
a denaturing 8% polyacrylamide gel (50% urea, 1 :20 cross-linked) at 1100 V for 
approximately four hou rs, or until the xylene cyanol migrated 20 cm. 
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Autoradiography was performed using Kodak X-Omat AR film with the aid 
of an intensifying screen. Densitometric traces were obtained from high 
resolution autoradiographs obtained without the use of the intensifying 
screen us ing a LKB Bromma Ultrascan XL Laser Densitometer. 
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Introduction 
Chapter III 
Use of Modified Pyrimidines to Enhance 
Oligonucleotide-Directed Triple Helix Stabilities 
In light of the limited specifici ty (4-8 bp) of restriction enzymes,1 ,2 
oligonucleotide directed triple helix formation offers a motif for the 
recognition of extended (2! 15 base pairs) sequences of DNA.3-S Specificity is 
imparted by the formation of T-A-T and C+G-C Hoogsteen base triplets upon 
binding of the oligonucleotide in the major groove3 ,6-13 The 16 bp specificity 
possible with this motif is in principle 106 times greater than that attainable by 
res triction enzymes. 
Complexes of triple he lical nucle ic acids containing cytosine (C) and 
thymine (T) in the Hoogsteen strand are stable in acidic to neutral solutions 
but dissociate on increasing pH.3 Because the specificity offered by this motif 
could provide a method for the artificial repression of gene expression and 
viral diseases, it is important to understand structural factors which modulate 
triple helix stability. Changes in oligonucleotide structure could be used to 
control oligonucleotide affinity under in vivo conditions, where temporal 
and spatial intracellular pH (7.0 - 7.4) and ionic strength are strictly regulated 
and cannot be altered.14-18 
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Fig. 3.1, Isomorphous base triplets formed by incorporation of a third strand 
in the major groove of double helical DNA parallel to the Watson-Crick 
purine strand via Hoogsteen base pairing. Substituents at pyrimidine 5-
positions protrude from the major groove, affecting affinity, but not 
complementarity. 
Substitution at position 5 of pyrimidines alters the hydrophobic driving 
force, base stacking, and the electronic complementarity (hydrogen bond 
donating and/or accepting ability) of the Hoogsteen pyrimidine-purine base 
pairing for triple strand formation l9 . 21 Incorporation of 5-substituted 
pyrimidines offers a method of modulating binding affinity without 
changing the hydrogen bonding patte rn and sequence specificities of 
pyrimidine oligonucleotides (Fig. 3.1). 
Figure 3,2: (Top) Oligonucleotides 1-6 constructed from deoxyribonucleotide 
phosphoramidites containing 2'-deoxycy tidine (C), 5-methyl-2'-deoxycytidine 
(MeSC), 2'-deoxyuridine (U), thymidine (T), 5-bromo-2'-deoxyuridine (BrSU) 
and thymidine-EDTA (T*) nucleotides. (Bottom) Coarse resolution pattern 
for cleavage of plasmid DNA (4.06 kbp) by oligonucleotide-EDTA 1-6 with 
simplified model of triple helical complex between the Hoogsteen-bound 
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Figure 3.3. Autoradiograms of 0.9 % agarose gels indicating double strand 
cleavage of plasmid DNA by oligonucleotides 1-6. Plasmid pDMAGlO was 
linearized with Sty I and labeled wi th [u32PlTTP, producing a 4.06 kbp 
restriction fragment specifically labeled 1.02 kbp from the target sequence. 
The 32P-end-labeled DNA was dissolved in buffer containing NaCl, Tris, and 
spermine and was mixed with oligonucJeotide-EDTA 1-6 previously 
equilibrated for 60 sec with 1.5 equiv of Fe(II). After incubation at 0 °c for 60 
min, reactions were initiated by the addition of sodium ascorbate (final 
concentrations: 25 mM Tris-acetate, 1 mM spermine, 100 mM NaCl, 0.8 11M 
oligonucleotide-EDTAoFe(II), and 1 mM ascorbate). The cleavage reactions 
were allowed to proceed for 6 h at 24°C, and loaded directly onto an 0.9% 
agarose gel. Electrophoresis a t 120 V for 3 hours effected separation of the 
products. Cleavage conditions: lanes 1-4, 1 0 Fe(II); lanes 6-9, 20 Fe(II); lanes 
11-14,3 oFe(II); lanes 15-18, 4 oFe(II); lanes 20-23, So Fe(II); lanes 25-28, 6 o Fe(II); 
lanes 1,6,11, 15,20, and 25 are at pH 6.6; lanes 2,7,12,16,21, and 26 are at pH 
7.0; lanes 3, 8, 13, 17, 22, and 27 are at pH 7.4; lanes 4, 9, 14, 18, 23, and 28 are at 
pH 7.8. Lanes 5, 10, 19, and 24 are DNA size markers obtained by digestion of 
Sty I linearized pDMAG10 with EcoR I, Pvu I, BamH I, and Xmn I, resulting 
in fragments 4058 (undigested DNA), 3067, 2994, 2371, 1687, 1064, 991, and 664 
bp in length. 
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Results and Discussion 
Oligonucleotides constructed from 2'-deoxyuridine, 5-bromo-2'-deoxyuridine 
and 5-methyl-2'-deoxycytidine. 
Six oligonucleotides containing combinations of uracil/cytosine (U/C, 1), 
uracil/5-methylcytosine (U /MeSC, 2), thymine/ cytosine (T /C, 3), thymine/5-
methylcytosine (T /MeSC, 4), 5-bromouracill cytosine (BrSU IC, 5), and 5-
bromouracil/5-methylcytosine (BrSU/MeSC,6) bases were synthesized by 
automated methods with thymidine-EDTA (1"")22 at the 5' end (Pig. 3.2, top). 
The efficiency of double strand cleavage of DNA by oligonucleotide-
EDTAoPe(II) 1-6 was analyzed over the pH range 6.6 - 7.8 at 25°C on plasmid 
DNA (4.06 kilobase pairs) containing the 15 base pair homopurine target 
sequence, 5'-As(GA)s-3' (Pig. 3.2, bottom)23 The DNA cleavage products were 
separated by agarose gel electrophoresis and quantitated by scintillation 
counting of each band. 
Oligonucleotide-EDT A ° Pe 1-6 cleave double-stranded DNA at a single 
site corresponding to the target sequence (Fig. 3.3)3 The cleavage efficiency of 
3 containing C and T decreases sharply above pH 7.0.3 Since the ability of the 
EDTAoPe(II) moiety to cleave DNA in Tris buffer increases from pH 6.6 to 7.4, 
the decrease in cleavage efficiency observed is likely due to a decrease in the 
binding affinity of the oligonucleotide for its target sequence24 
Replacement of C with MeSC (oligonucleotides 2,4, and 6) increases the 
oligonucleotide affinity and extends the pH range for binding. Substitution of 
BrSU for T (5) increases binding affinity but does not change the pH profile 
greatly. Incorporation of both Me5C and BrSU (6) results in a large increase in 
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cleavage efficiency over an extended pH range. Oligonucleotides 1 and 2, 
constructed with U/C and U/Me5C, show lower binding affinities (Table 3.1). 
cleavage efficiency, pH 
Oligo (base) X Y 6.6 7.0 7.4 7.8 
1 (U,C) H H • • 
2 (U, Me5C) H Me • • • • • 
3 (T,C) Me H • • . -
4 (T,Me5C) Me Me -. - --- -5 (Br5U,C) Br H --- --- -6 (Br5U,Me5C) Br Me • • • • •••• --- -
Table 3.1. Absolute cleavage efficiencies of oligonucleotides 1-6 as determined 
by scintillation counting of bands cut from dried gels: - = 2-4%, - - = 5-7%, - --
= 8-10%, - - - - = 10-20%. 
The relative stabilities of base triplets are BrSU -AT > T-AT > U-AT and 
M&C-GC > C+-GC (Fig. 3.4). 
Effect of 5-Br substituent on x5 U - A Hoogsteen base pairing. The 
substitution of bromo for methyl might effect the electronic complementarity, 
hydrophobicity, and polarizability (base stacking) the resulting 
oligonucleotide. 
There are two opposing electronic effects to consider for Hoogsteen 
hydrogen bonding between X5U and A. The electron-withdrawing bromo 
substituent increases the acidity at N3H (better hydrogen donor) but decreases 
the electron-donating properties of the carbonyl lone pair (poorer hydrogen 
acceptor). Methylation has the opposite effect. The pKa's of deoxyuridine, 
thymidine, and 5-bromodeoxyuridine are 9.3,25 9.8,25 and 8.1 20 
5 
°d~~~ pH H 
6.6 r.o pH 






6.6 7.0 pH pH 
7 .4 
7.8 
Fig. 3.4. Absolute cleavage efficiencies of oligonucleotides 1-6 quantitated by 
scintillation counting as a function of pH. 
Enhancement of binding by bromo substitution might be due to 
increased acidity at N3 or enhanced hydrophobicity or both. Polynucleotides 
containing Br5U are known to form more stable duplexes than their 
thymidine an alogues 2 6-30 NMR da ta of nucleosides in chloroform indicate 
that 1-cyclohexyl-5-bromouracil associa tes with 9-ethyl-adenine about 2.4 
times as s trongly as does l-cyclohexyl-thymine26,27,31 This N MR d ata sugges t 
that the increase in complex stability is due to an increase in the hydrogen 
bo nd interactions between the bases. In these s tudies, the Hoogsteen-
hydrogen bonded complexes are found to be m ore stable than Watson-Crick 
co mplexes 32.33 Thus, N MR d a ta con cerning the h ydrogen-bonding of 
modified pyrimidines m ay actually be a be tter predictor of triplex affinities 
than duplex stabilities. 
The 5-bromo substituent has also been sugges ted to increase the stacking 
interactions within p oly Br5U s trands upon complex formation 21 Higuchi 
and co-workers have found that poly Br5U forms a 2:1 complex with poly (6-
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methyl-A), whereas poly (U) forms only a 1:1 complex.26,27,34-36 Methylation 
at N-6 of adenine is expected to disrupt hydrogen bonding with either the 
Hoogsteen or Crick pyrimidine strand. The stability of the 2:1 Br5U:6-Me-A 
complex was interpreted as an indication of the stability imparted by base 
stacking in poly Br5U complexes. 
Incorporation of Br5U into DNA is known to result in a higher rate of 
mutagenesis. 37-39 A variety of mechanisms, including ionization of the 
base20,4o and tautomerism to the enol form,41,42 have been invoked to explain 
the increase in misincorporation of bases. It has been calculated that at 
neutral pH, 7.4% of 5-bromo-2'-deoxyuridine residues are ionized, as opposed 
to 0.16% of residues 40 The enol tautomer is also known to be more than ten 
times as favored for Br5U as it is for T.41 These considerations may make 
triple helix forming oligonucleotides containing Br5U less specific than their 
T counterparts. No quantitative d a ta concerning the specificity of these 
oligonucleotides has been gathered. UV melting data suggests that Br5U is as 
specific as T,43 while Br5U /Me5C oligonucleotides have been found to bind to 
a large number of secondary sites on large DNA.44 The sequence and number 
of mismatches present at these sites is unknown. 
Effect of 5-methyl substituent. Methylation of C also has two electronic 
effects: electron donation stabilizes protonation at N3 in the triplex, but 
decreases the acidity of the N4 exocyclic amino group (poorer hydrogen bond 
donor). In addition, methylation at C causes extension of the pH range (- 0.4 
units) for triple helix stability. This might be explained by an increase in the 
pKa of N3H+ in the triplex25 Stabilization of protonation at N3 is modest in 
the uncompl exed C; the reported pKas of deoxycytidine and 5-
methyldeoxycytidine are 4.3 and 4.42 5 
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Methylation of uracil exerts the opposite electronic effect as bromination, 
decreasing the acidity at N3H (poorer hydrogen donor) but increases the 
electron-donating properties of the carbonyl lone pair (better hydrogen 
acceptor). Since both methylation and bromination of uracil bases results in 
increases in pyrimidine oligonucleotide binding affinity, at least part of this 
stabilization must arise as a result of effects which are not electronic in 
nature. 
Oligonucleotides 2 and 3, which involve the triplet changes 
Me5C+GC/U-AT to C+GC/T - AT, show approximately equal binding 
affinities at or below pH 7.0. This suggests that methylation results in 
increased binding affinity irrespec tive of the methylated pyrimidine (Fig. 3.3). 
Methylation exerts a similar effect on duplex stability. Poly(T)45-47 and 
poly(Me5C)48.51 form duplexes of greater s tabilities with their complementary 
polymers than do poly(U) and poly(C). Methylation also promotes the 
stabilities of self-associated complexes and complexes with other purines.31,52 
Lee and Morgan observed that polynucleotide triplexes containing Me5C in 
both pyrimidine strands (Me5C-G-Me5C base triplets) are stable to pH 8.0.53 It 
was not clear if this effect was observed due to the effect of methylation in the 
Crick strand, Hoogsteen s trand, or both s trands. The data presented here, 
which indicates that methylation of the Hoogsteen strand stabilizes triplexes, 
in conjunction with previous data, in which one of the duplex strands is 
methylated, support the contention tha t methylation promotes complex 
formation in general, regardless of the type of complex formed (duplex or 
triplex) . 
One possible interpre ta tion is that substitution of methyl for hydrogen at 
C-5 of pyrimidines promotes binding of the oligonucleotide via a 
hydrophobic effect. The observation that methylated polymers form more 
103 
stable duplexes with sequences where the methylated residues are stacked 
supports the contention that methyl-methyl contacts playa role in stabilizing 
duplexes. 50,S1 For ins tance, poly(dMeSC) ·poly(dG) melts at higher 
temperature than poly(dMeSC-dG)· poly(dG-dMeSC). The unmethylated 
polynucleotide poly(dC)·poly(dG) melts at a lower temperature than poly(dC-
dG) .poly(dG-dC).50,51 Data suggestive of similar stabilizing contacts in the 
Hoogsteen strand of the triple helix has been reported.43 
In the case of mixed oligonucleotides containing BrsU and Me5C (6) it is 
not inconceivable that a "hydrophobic spine" is created by the Br and methyl 
moieties aligned on the Hoogsteen strand in the major groove of DNA. 
5'-*TT TT T C CC CC CC CC C-3' CC-15 
McMeMcMcMcNfcMclv1cMe 
5'-*TT TT TC CC CCCC CC C -3 ' MM-15 
5' .... TAT AT A TA TA T AAAAAG GGGGGGGGG CG A TAG .... 3' 
3' .... A TA T A TAT AT A TTTT TCCCCC:Ccccc G CT A TC .... 5' 
'--_ ...... 1 = triplex site 
Fig. 3.5. Oligonucleotides CC-15 and MM-lS designed to bind to sequence 
ASGlO within plasmid pDMGI O. 
The sequence ASGlO, present in plasmid pDMAGIO, has been studied by 
footprinting (chapter 2) and affinity cleavingS4 Binding of oligonucleotide 
CC-15 occurs only below pH 5.8 or in the presence of high ethanol (40%) 
concentrations at close to neutral pH (pH 6.6), presumably due to the presence 
of ten protonation s ites within the triple helical complex. The 
oligonucleotide MM-15 was synthesized to determine if the use of 5-methyl-
2'-deoxycytidine might allow for the recognition of extended G sequences 
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under neutral conditions. No cleavage was observed in an aqueous solution 
at pH 6.6. It is possible that the GlO sequence adopts an exceptionally stable 
duplex conformation, which is difficult to disruptl9,55 The use of 5-
methy1cytosine bases results in a 50-fold increase in the binding affinity of an 
oligonucleotide 21 nuc1eotides in length containing 10, and 4 consecutive, 
cytosine basess6 
To better understand those factors which influence triple helix 
formation, oligonucleotides incorporating a more extensive series of 5-
substituted pyrimidines were tes ted. Two types of modifications were 
studied. Based on the su ccess of the 5-bromouracil containing 
oligonucleotides, a series of oligonucleotides containing halogenated uracil 
and cytosine bases was examined. The observation that methylation of either 
pyrimidine results in increased binding affinity led to the study of 
pyrimidines containing larger alkyl and alkynyl substituents at the 5 position. 
Oligonucleotides Containing HaloSpyrirnidines 
The synthesis of 5'-O-DMT-5-fluoro- (F5U) and 5'-O-DMT-5-iodo-2'-
deoxyuridines (I5U) phosphoramidites followed usual procedures from the 5-
iodo-2'-deoxyuridine and 5-fluoro-2'-deoxyuridine nucleosides obtained from 
Sigma. 57-60 These phosphoramidites, as well as 5-bromo-2'-deoxycytidine 
(Br5C) phosphoramidite, are commercially available. 
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FFFF F F F F 
5'-*T U uuue ue ue ueue T -3 ' 
F F F F MeF Me F Me FMeF Me 
5'-*T uuuue ueUeUeUeT-3' 
1[ [[ I I I I 
5'-*T U U U ue ue ue ueu eT -3' 
I I I [Me [Me I Me [ Me I Me 
5'-*T U u u ue ue ue ueue T -3' 
BT Sr Br Br BT 
5'-*T T T T T eTC T eTc T e T -3' 
Br BT BT BT BT BT BT BrBr Br BT BT BT 







5' .... TAT A TAT A TAT AA AAA . Aq,:\GAqAGA T eGA TAG .... 3' 
3' .... A TA TA TA TAT ATTTTC .TCYCYCYCT AG eT ATe .... 5' 
'--_--'I = triplex site 
Fig. 3.6. Oligonucleotides 7-12 constructed from deoxyribonucleoside 
phosphoramidites containing thymidine (T), 5-fluoro-2'-deoxyuridine (FSU), 
5-iodo-2'-deoxyuridine (lsU), 2'-deoxycytidine (C), 5-methyl-2'-deoxycytidine 
(M eSC), 5-bromo-2'-deoxycytidine (B rSC), and thymidine-EDTA (1*). 
Oligonucleotides 7-12 bind the ta rget sequence AS(GA)s in plasmid 
pDMAGI023 
Oligonucleotides 7-12 containing combinations of FSU/C (7), FSU/ MeSC 
(8), ISU/ C (9), ISU/ MeSC (10), T / BrSC (11) and BrsU/BrSC (12) were synthesized 
by automated methods with th ymidine-EDTA (T*)22 at the 5' end. 
Oligonucleo tide concentrations were calculated using extinction coefficients 
obtained from UV analysis of the individual monomers in water and those 
found in the literature (Table 3.2)25,39,61 .63 
260 nm 280 nm 260 nm 280 nm 
cC 7300 7000 Br·5·dU 4600 9200 
T 8800 6400 F·5·dU 7500 7200 
U 9900 [·5·dU 3600 6900 
Me·5·dC 5700 8300 Br·5·dC 3300 5800 
Table 3.2. Extinction coefficien ts (M-l cm-1) at 260 and 280 nm for 5-substituted 
nucleosides. 
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Figure 3.7. Autoradiograms of 0.9% agarose gels indicating double strand 
cleavage of plasmid DNA by oligonucleotides 7-12. Plasmid pDMAGlO was 
linearized with Sty I and labeled with [a_32p} dATP, producing a 4.06 kbp 
restriction fragment specifically labeled 3.04 kbp from the target sequence. 
The 32P-end-Iabeled DNA was dissolved in buffer containing NaCI, Tris, and 
spermine and was mixed with oligonucleotide-EDT A 7-12 previously 
equilibrated for 60 sec with 1.5 equiv of Fe(II). After incubation at O°C for 60 
min, reactions were initiated by the addition of sodium ascorbate (final 
concentrations: 25 mM Tris-aceta te, 1 mM spermine, 100 mM NaCI, 0.8 IlM 
oligonucleotide-EDTA·Pe(I!), and 1 mM ascorbate). The cleavage reactions 
were allowed to proceed for 6 h at 24°C. The reactions were loaded directly 
onto an 0.9% agarose gel. Electrophoresis at 120 V for 3 hours effected 
separation of the products. 
Cleavage conditions: 
Gel A.lanes 1-4, 7·Pe(II); lanes 7-10, S·Pe(I!); lanes 2 and 7 are at pH 6.6; lanes 
3 and 8 are at pH 7.0; lanes 4 and 9 are at pH 7.4; lanes 5 and 10 are at pH 7.8; 
lane 1 is untreated DNA; lane 6 contains DNA size markers obtained by 
digestion of Sty I linearized pDMAG10 with EcoR I, Pvu I, BamH I, and Xmn 
I, resulting in fragments 4058 (undigested DNA), 3569, 2992, 2369, 1685, 1460, 
1066, 670, and 489 base pairs in length. 
Gel B. lanes 1-4, 9·Pe(II); lanes 7-10, 10.Pe(II); lanes 2 and 7 are at pH 6.6; 
lanes 3 and 8 are at pH 7.0; lanes 4 and 9 are at pH 7.4; lanes 5 and 10 are at pH 
7.8; lane 1 is untreated DNA; lane 6 contains DNA size markers obtained by 
digestion of Sty I linearized pDMAGI0 with EcoR I, Pvu I, BamH I, and Xmn 
I, resulting in fragments 4058 (undigested DNA), 3569, 2992, 2369, 1685, 1460, 
1066, 670, and 489 base pairs in length. 
Gel C. lanes 1-4, ll·Pe(II); lanes 7-10, 12·Pe(II); lanes 2 and 7 are at pH 5.8; 
lanes 3 and 8 are at pH 6.2; lanes 4 and 9 are at pH 6.6; lanes 5 and 10 are at pH 
7.0; lane 1 is untreated DNA; lane 6 contains DNA size markers obtained by 
digestion of Sty I linearized pDMAGI0 with EcoR I, Pvu I, BamH I, and Xmn 
I, resulting in fragments 4058 (undigested DNA), 3569, 2992, 2369, 1685, 1460, 
1066, 670, and 489 base pairs in length. 
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A. 
Probe F/C Probe F/M 
i ii i 
CuLQULllMuLQUU 
1 2 3 4 5 6 7 8 910 




Probe IIC Probe 11M 
I I I I c uLQULll M uLQULll 
2 3 4 5 6 7 8 
-- ---------
c. 
Probe TI Br Probe Brl Br 
I I I I 
C Q.JlUuLQ M Q.JlUuLQ 
2 3 4 5 6 7 8 9 10 
-
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Oligonucleotides 7 - 12 cleave double-stranded pDMAGI0 DNA at a 
single site corresponding to the target sequence (Fig. 3.7). Cleavage efficiencies 
for these oligonucleotides as determined by scintillation counting of the 
bands cut from dried gels are indicated in Table 3.3. 
cleavage efficiency, pH 
Oligo (base) X Y 6.6 7 7.4 7.8 
7 (F5U,C) F H -- -8 (F5U, Me5C ) F Me --- --9 (l5U,C) I H -- -- -10 (I5U,Me5C) I Me --- --- --
11 (T,Br5C) M e Br 
12 (Br5U,Br5C) Br Br -
Table 3.3. Absolute Cleavage Efficiencies of Oligonucleotides 7-12 as 
determined by scintillation counting of bands cut from dried gels: - = 2-4%, --
= 5-7%, "- - = 8-10%. 
Incorporation of 5-iodo-2' -deoxyu ridine. Comparison of halogenated 
deoxyuridine derivatives in d icates that the relative stabilities of the base 
triplets are Br5U-AT > l5U-AT > T (Me5U)"AT > F5U-AT (Fig. 3.8). The 
greater electron withdrawing capability of the bromo substituent results in an 
increased acidity of the N-3 bond, and form ation of stronger Hoogsteen 
hydrogen bonds with thymidine 20,21,25,27,31,35 Due to the lower electron 
affinity of l, the iodo subs tituent does not increase the strength of this 
interaction relative to T as g rea tly as Br. The pKas of these nUcleosides have 
been determined to be 8.1 for Br5U 20,63 and 8.3 for r5u63 N MR studies of the 
bases in chloroform indica te that 5-iodouracil associates with adenine with a 
relative affinity 2.2 times greater than thymine-adenine, and 0.9 that of 5-
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bromouracil-adenine 3 ! This result is almost exactly what is observed for the 





Fig. 3.8. Absolute cleavage efficiencies of oligonucleotide 5-10 as determined 
by scintillation counting as a function of substitution at 5-uridine positions 
and pH. 
Incorporation of 5-fluoro-2' -deoxyuridine. 5- Fl uoro-2 '-deoxyuridine 
containing oligonucleotides bind with lower affinities than thymidine 
oligonucleotides. Fluorouridine has a pKa of 7.759,63 indicating that, at 
slightly alkaline pH, a significant fraction of these residues may be 
ionized. 40,59,6! Lack of a large substituent at the 5-position may result in loss 
of van der Waals interactions between 5-substituted bases within the triplex. 
The van der Waals radius of F is 1.35 A, closer to that of H 0.20 A) than that 
of m ethyl (2.00 A).64 The stability of the FSU. A-T triplet again parallels that 
observed with FSU-A base pairs, which are less stable than T-A base pairs,59 
Incorporation of 5-bromo-2 '-deoxycytidine. 5-Bromo-2'-deoxycytidine 
was incorporated into oligonucleotides to determine if the increased binding 
observed with 5-bromouridine was due to an electronic effect or to non-base 
specific van der Waals or hydrophobic interactions in the major groove. 
00 








c:: ": t- 'X1 t-::r:: ::r:: t-0. 
::r:: 0. 
0. 
Fig. 3.9 Absolute cleavage efficiency of oligonucleotides 3,4, 5, 6, 11, and 12 as 
determined by scintillation counting of dried gels as a function of pH and 
substitution at 5-cytosine posi tions. 
Comparison of 5-subs tituted cytidines reveals base triplet stability 
decreases in the order Me5C+G-C > C+G-C » Br5C+G-C (Fig. 3.9). This is in 
contrast to base pair stabilities, in which the Br5C-G base pair is more stable 
than C_G48 Destabilization of C+G-C base triplet by bromination on the 
Hoogsteen strand must arise from a predominantly electronic effect. The 
pKa of 5-bromocytidine has been reported to be 3.0,61 indicating that 
protonation of Br5C, required for Hoogsteen base pairing, becomes more 
difficult. This is the only 5-pyrimidine substitution which results different 
effects on Watson-Crick duplex formation and Hoogsteen triplet formation, 
and arises from the change in the hydrogen bonding pattern in C recognition 
of G-C base pairs, which requires protonation, and C recognition of G in 
duplex DNA. 
Effects which are base specific and not general to both triplex and duplex 
stabilities are most likely due to elec tronic effects. Substitution at the 5 
position of cytosine mos t likely exerts a large electronic effect, since 
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protonation and accommodation of a positive charge within the triplex is 
required for C+G-C base triplets. 
Studies of 5-alkyl and 5-alkynyl-2'-deoxyuridines 
5'-*T T T T T C T C T C T C T C T -3' 
EtyEtyEtyEty Ety Ety Ety Ety 
5'-*T UUUUC UC U C UC U CT -3' 
Et Et Et Et Et Et Et Et 
5'-*T U UU UC UC UCUC UC T -3' 
PtyPtyPtyPty Pty Pty Pty Pty 
5'-*T UUUUC UC U C UC U CT -3' 
Pt Pt Pl PL Pl Pt Pt Pt 
5'-*T UUU UC UC U C UCUCT -3' 
<I> <I> <I> <I> <I> <I> <I> <I> 
5'-*T UUU UC UC UC UC UC T -3' 
CF3 CF3 
CF3 CF3 CF3 CF3 CF3 CF3 








5' .... TAT ATATAT A TAAAAAG AGAG.AGAGA TC GA TAG .... 3' 
3' .. .. ATA TA TATATA TTTT C TCTCTCirCTAG CT ATC .... 5' 
'--~.;.JI = triplex site 
Fig. 3.10. Oligonucleotides 3 and 13 - 18 constructed from deoxyribonucleotide 
phosphoramidites containing 2'-deoxycytidine (C) and thymidine (T), 5-
ethynyl-2'-deoxyuridine (Ety), 5-ethyl-2'-deoxyuridine (Etl, 5-pentynyl-2'-
deoxyuridine (Pty), 5-pentyl-2'-deoxyuridine (Pt), 5-(2-phenyl-ethynyl)-2'-
deoxyuridine (<1», 5-trifluoromethyl-2'-deoxyuridine (CF3), and thymidine-
EDT A (T*). 
Methyl group substitution at the 5 positions of cytosine or uracil results 
in an increase in binding affinity, indicating that the presence of a substituent 
larger than hydrogen at the 5-position of pyrimidines may promote triple 
helix formation. This could be due to formation of a hydrophobic spine or 
disruption of water binding in the major groove.50 This observation 
stimulated the synthesis of oligonucleotides containing 5-alkyl and 5-alkynyl 
substituents of different sizes. 
c,d 
Fig. 3.11. Scheme for the synthesis of 5'-O-DMT-5-alkynyl- and 5'-O-DMT-5-
alkyl-2'-deoxyuridine phosphoramidites. a) terminal alkyne in a Pd(O) 
catalyzed reaction; b) Pd/C, H2; c) DMTCl, pyr.; d) N,N-d iisopropyl-2-
cyanoethylchloro phosphoramidite, DIPEA, MeCI2. 
o 




Fig. 3.12. Scheme for the synthes is of 5'-O-DMT-5-(2-phenyl-ethynyl)-2'-
deoxyuridine phosphoramidite: a) phenylacetylene, Pd(O), CuI; b) N,N-
diisopropyl-2-cyanoethylchloro phosphoramidite, DIPEA, MeCI2. 
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Oligonucleotides containing 5-ethyl-, 5-ethynyl-, 5-(pent-1-ynyl)-, 5-
pentyl- 5-(2-phenyl-ethynyl)-2'-deoxyuridines, and 5- trifluoromethyluracil 
bases were assayed for their ability to bind and cleave pDMAG10 double 
helical DNA (Fig. 3.9). For ease of discussion, 5-(pent-1-ynyl)-2'-deoxyruidine 
will be noted as simply 5-pentynyl-2'-deoxyuridine. 
Synthesis of nucleosides. 5-Ethynyl-2'-deoxyuridine (Ety5U) and 5-
pentynyl-2'-deoxyuridine (Pty5U) were synthesized by the coupling of 
propargyltrimethylsilane and 1-pentyne to 5-iodo-2'-deoxyuridine using a Pd 
catalyzed coupling as described by Robins and Barr, and by Hobbs (Fig. 
3.11)65-69 5-Ethyl-2'-deoxyuridine (Et5U) and 5-pentyl-2'deoxyuridine (Pt5U) 
were obtained by reduction of 5-ethynyl-2'-deoxyuridine and 5-pentynyl-2'-
deoxyuridine respective ly with Pd/C and H267 5'-O-DMT-5-(2-phenyl-
e thynyl)-2 '-deoxyuridin e (<!>5U) was obtained b y directly coupling 
phenyl acetylene to 5'-O-DMT-5-iodo-2'-deoxyuridine (Fig. 3.12)67,70 
Fig. 3.13. Scheme for the synthesis of 5'-O-DMT-5-trifluoromethyl-2'-
deoxyuridine phosphoramidites for the automated synthesis of 
oligonucleotides containing 5-trifluorouridines. (a) DMTCI, pyr; (b) N,N-
diisopropyl-2-cyanoethyl-chlorophosphoramidite, MeCI2, DIPEA. 
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The nucleoside 5-trifluoromethyl-2'-deoxyuridine is commercially 
available. Protection (5'-O-DMT) and activation (3'-N,N-
diisopropylphosphoramidite) affords a nucleoside compatible with 
automated synthesis (Fig. 3.13)57 
260 nm 280 nm 
Ethynyl-5 -dU 3,800 9700 
Ethyl-5 -d U 8,700 6400 
Pentynyl-5 -dU 3,800 8200 
Pentyl-5-dU 7,900 7600 
2- Ph-Ety-5 -dU 12 ,700 12,200 
CF3-5-dU 8,500 2170 
Table 3.4. Extinction coefficients (M-1 cm-1) determined for 5-substituted-2'-
deoxyuridines. 
The extinction coefficients of each of the nucleosides were determined at 
260 nm and 280 nm, and agreed with those calculated from published values. 
The extinction coefficients for 5-(2-phenyl-ethynyl) -2'-deoxyuridine were 
estimated from published values,67 since the free nucleoside was not 
synthesized. The results of these determinations are listed in Table 3.4, and 
were used to quantitate oligonucleotide concentrations. 
The cleavage efficiencies of these oligonucleotides as a function of pH 
was determined using affinity cleaving (Fig. 3.14). The binding affinities of 
these oligonucleotides as a function of pH are shown in Table 3.5. All of these 
oligonucleotides contain cytosine bases for the recognition of G-C base pairs. 
Cleavage efficiency of the oligonucleotide Tie (3) is shown for comparison. 
Affinity cleaving indicates that the relative stabilities of base triplets is 
ethyn 5U oAT > T oAT > pentynyl5UoAT > 2-phenyl-ethynyI5UoAT> 
ethyl5U oAT> pentyl5U oAT (Fig. 3. 14). Only the oligonucleotide containing 
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Figure 3.14. Autoradiograms of 0.9% agarose gel indicating double strand 
cleavage of plasmid pDMAG10 by oligonucleotides 3, and 13-18. Plasmid 
pDMAG10 was linearized with Sty I and labeled with [a32pj dATP, producing 
a 4.06 kbp restriction fragment specifically labeled 3.04 kbp from the target 
sequence. The 32P-end-labeled DNA was dissolved in buffer containing NaCI, 
Tris, and spermine and was mixed with oligonucleotide-EDTA 3, 13-18 
previously equilibrated for 60 sec with 1.5 equiv of PeOI). After incubation at 
o °c for 60 min, reactions were initiated by the addition of sodium ascorbate 
(final concentrations: 25 mM Tris-acetate, 1 mM spermine, 100 mM NaCl, 0.8 
11M oligonucleotide-EDTAoFe(II), and 1 mM ascorbate). The cleavage 
reactions were allowed to proceed for 6 h at 24 °C. The reactions were loaded 
directly onto an 0.9% agarose gel. Electrophoresis at 120 V for 3 hours effected 
separation of the products. 
Cleavage conditions: 
Gel A. lanes 1-5,3 o Fe (II); lanes 8-12, 18 oPe(II); lanes 2 and 8 are at pH 5.8; 
lanes 3 and 9 are at pH 6.2; lanes 4 and 10 are at pH 6.6; lanes 5 and 11 are at pH 
7.0; lanes 6 and 1l are at pH 7.4; lane 1 is untreated DNA; lane 7 contains DNA 
size markers obtained by digestion of Sty I linearized pDMAG10 with EcoR I, 
Pvu I, BamH I, and Xmn I, resulting in fragments 4058 (undigested DNA), 
3569,2992,2369,1685,1460,1066,670, and 489 base pairs in length. 
Gel B. lanes 1-4, 13 oFe(II); lanes 7-10, 14 oFe(II); lanes 2 and 7 are at pH 6.6; 
lanes 3 and 8 are at pH 7.0; lanes 4 and 9 are at pH 7.4; lanes 5 and 10 are at pH 
7.8; lane 1 is untreated DNA; lane 6 contains DNA size markers obtained by 
digestion of Sty I linearized pDMAG10 with EcoR I, Pvu I, BamH I, and Xmn 
I, resulting in fragments 4058 (undigested DNA), 3569, 2992, 2369, 1685, 1460, 
1066, 670, and 489 base pairs in length. 
Gel C. lanes 1-5, 15 ° Fe(II); lanes 8-12, 17 oFe(II); lanes 2 and 8 are at pH 5.8; 
lanes 3 and 9 are at pH 6.2; lanes 4 and 10 are at pH 6.6; lanes 5 and 11 are at pH 
7.0; lanes 6 and 11 are at pH 7.4; lane 1 is untreated DNA; lane 7 contains DNA 
size markers obtained by digestion of Sty I linearized pDMAGI0 with EcoR I, 
Pvu I, BamH I, and Xmn I, resulting in fragments 4058 (undigested DNA), 
3569,2992,2369,1685,1460, 1066,670, and 489 base pairs in length. 
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CF3 /c TIc 
pH C 5.8 6.2 6.6 7.0 7.4 
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5-ethynyluracil bases displays a greater binding affinity than oligonucleotide 3 
(T IC). Oligonucleotide 17 containing 5-(2-phenyl-e thynyl)-2' -deoxyuridine 
binds with significantly lower affinities than oligonucleotides containing TIC 
bases. 5-Trifuoromethyluracil oligonucleotides display weak binding. 
cleavage efficiency, pH 
Oligo (base) X Y 5.8 6.2 6.6 7.0 7.4 
3 (T,C) Me H 00 o 0 
13 (5-ethynylU,C) Ethyn H •••• 000 000 000 0 
14 C5-ethylU,C) Ethyl H 0 0 
15 (5-pentynylU,C) Pentyn H 000 •• 0 • • • 
16 C5-pentylU,C) Pentyl H 
17 C5-phenylU,C) Phenyl H •••• • ••• .0. 0 
18 C5-CF3U,C) CF3 H •• • • 0 
Table 3.5. Absolute double strand DNA cleavage efficiencies of 
oligonucleotides 13-18: o = 2-4%, .0 = 5-7%, .00 = 8-10%, •• 00 = 10-20%. 
Effect of 5-alkyl substitution. Alkyl substitution results in 
oligonucleotides with greatly reduced binding affinities. Oligonucleotides 
containing 5-ethyl-2'-deoxyuridines display very weak binding, even at pH < 
6.2. At these pHs, binding to secondary sites is observed, resulting in loss of 
specificity. No cleavage was observed with oligonucleotides containing 5-
pentyl-2'-deoxyuridines. 
The effect of substitution at the 5-position of pyrimidines on the stabili ty 
of X5U 0 AT triplets parallels the effect on XSU-A base pairs. Incorporation of 
ethylSU into DNA results in a decrease in duplex stability.37,46.71-73 Triplexes 
of the type polyCEtSU) opolyCA)-polyCEtSU) also display lower melting 
temperatures than polyCMeSU) . polyCA)-polyCMeSU) triplexes.46,72 Duplex 
stability is also decreased by incorporation of larger alkyl g roups.72,74,75 Even 
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modest changes in the 5-methyl group, such as change to 5-hydroxymethyl 
group, results in loss of duplex stability.47 It is unlikely that a large change in 
the hydrogen bonding interactions occurs upon incorporation of as-ethyl 
substituent.71 The loss of complex stability has been attributed primarily to a 
change in the stacking interactions in poly Et5U. 46,71,72 
The incorporation of T*22 into oligonucleotides has been shown to lower 
the melting temperature of the duplex form ed with a complementary 
oligonucleotide.76 Incorporation of more than two T* residues into a triple 
helix forming oligonucleotide (18 bases long) decreases the amount of 
cleavage observed. 77 These observations are consistent w ith and can be 
understood on the basis of the observation that subs titution by large alkyl 
groups at the 5-position of 2'-deoxyuridines decreases the stabilities of both 
duplexes and oligonucleotide-directed triplexes. 
Effect of 5-alkynyl substitution . Oligonucleotides containing 5-alkynyl-
uracil bases bind with much higher affinities that their 5-alkyl counterparts. 
Oligonucleotides constructed from 5-ethynyl-2'-deoxyuridine not only bind 
better than oligonucleotides containing 5-ethyl-2'-deoxyuridine, but 
thymidine as well. Longer alkynyl chains again lower binding affinity 
(ethynyl » pentynyl) . Longer unsaturated chains have not been studied. 
The 2-phenyl-ethynyl subs tituent represents modification with a large 
planar group. Modelling of the triple helical complexes formed by this 
oligonucleotide indicates that these groups probably do not stack on one 
another wi thin a triplex, due to the 30° rotation about the helical axis between 
each residue. Oligon ucleotides con taining 5-(2-phen y l-ethynyl)-2'-
deoxyuridines bind with lower affinities than thymidine containing 
oligonucleotides, but with higher affinities than oligonucleotides constructed 
from 5-alkyl-2'-deoxyuridines . 
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5-Trifluoromethyl-2 '-deoxyuridine. The trifluoromethyl substituent 
could incorporate both the electron withdrawing and the steric characteristics 
thought to increase the binding affinity of uri dine nucleosides in triple helix 
formation. Two explanations for the low binding affinity of oligonucleotide 
18 are that the pKa (the pKa of 5-trifluorouracil is 7.3564) of this derivative 
results in deprotonation at neutral pH, or the substituent may be too large to 
fit within the major groove (the van der Waals radius is 2.44 , as compared to 
2.00 for the methyl group on thymidine64). 5-Trifl uorometh yl-2'-
deoxyuridine is also known to undergo a variety of degradation reactions 
under basic conditions 78-81 At the time these experiments were completed, 
no analysis (HPLC) was conducted on the purified oligonucleotide to 
determine its nucleoside content, and decomposition of the base during 
oligonucleotide deprotection may have occurred. Literature precedents 
suggest that under the basic conditions used to deprotect oligonucleotides, the 
5-trifluoromethyl-2:-deoxynucleoside is completely degraded to 5-carboxy or 
5-car boxy ami do-2' -deoxyuridine. 78-81 
Design of other modified nucleosides. Incorporation of 5-ethylcytosine 
bases into polymers also lowers the ability of the polymer to form duplex 
DNAs 82 This suggests that it is unlikely that 5-alkyl substitution at cytidine 
will drastically increase oligonucleotide directed triple helical stability. Alkyl 
substitution at position 8 of purines, however, results in increases in duplex 
stabilities. This suggests that the use of 8-alkyl purines may increase purine 
oligonucleotide binding affinity in oligonucleotide-directed triple helices of 
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Fig. 3.15. 5-(4-AminobutylaminomethyJ)uracil base found in the DNA of the 
bacteriophage CPW-14 . 
One organism (the bacteriophage CPW-14) with 5-modified uridines 
displays an increase in melting temperature of its DNA. The modified base 
was identified as a-putrescinyJ-thymine 84,85 DNA containing this modified 
thymidine displays increased stability and a lower dependence of Tm on salt 
concentration. Properly substituted amino-thymidines may display similar 
effects in triple helix formation. 
Conclusions 
5-substituted pyrimidines can be used to alter the stabilities of 
oligonucleotide-directed triple helical complexes. Table 3.6 summarizes the 
cleavage efficiencies observed for the oligonucleotides studied. 
Oligonucleotides constructed with 5-methyl substituted pyrimidines 
(thymidine or 5-methyl-2'-deoxycytidine) form more stable complexes than 
unmethylated pyrimidines (To A-T and Me5C+G-C are more stable than 
UoA-T or C+G-C base triplets). 5-iodouracil and 5-ethynyluracil bases form 
better triplets with A-T than T, but poorer than BrSU. Substitution by larger 
alkynes (5-{2-phenyl-ethynyJ)uracil and 5-pentynyluracil bases) results in 
decreases in binding affinities. 5-alkyluracil bases (5-ethyluracil and 5-
pentyluraciJ) form very weak triple helical c complexes. These results parallel 
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Cleavage efficiency, pH 
Oligo (Base) X Y 5.8 6.2 6.6 7 7.4 7.8 
1 (U,C) H H • • 
2 (U,Me5C) H Me •• •• • 
3 (T,C) Me H •• •• 
4 (T,Me5C) Me Me ••• • •• • 
5 (Br5U, C) Br H ••• • •• • 
6 (Br5U,Me5C) Br Me •••• • ••• • •• 
7 (F5U,C) F H •• • 
8 (F5U,Me5C) F Me ••• •• 
9 (I5U,C) I H •• •• • 
10 (I5U,Me5C) I M e ••• • •• •• 
11 (T,Br5C) Me Br 
12 (Br5U,Br5C) Br Br • 
13 (Ety5U,C) Ethyn H •••• ••• • •• • •• • 
14 (Et5U,C) Ethyl H • • 
15 (Pty5U,C) Pen tyn H ••• • •• •• • 
16 (Pt5U,C) Pentyl H 
17 (PhEty5U,C) Phenyl H •••• • ••• • •• • 
18 «CF3)5U,C) CF3 H •• • • • 
Table 3.6. Summary of absolute double strand DNA cleavage efficiencies of 
oligonucleotides 1-18: - $ 2%, • = 2-4%, •• = 5-7%, ••• = 8-10%, •••• = 10-
20%. Blank boxes indicate cleavage efficiency was not measured at that pH. 
what is observed for duplex formation. 5-bromocytidine is known to stabilize 
duplex formation, but destabilizes triplex forma tion. 
Substitution results in changes in the electronic complementarity (H-
bonding potential), polarizability (base stacking), and hydrophobicity of the 
bases. While it is difficult to determine which effects predominate, we 
conclude: (a) substitution on C by electron withdrawing groups dramatically 
decreases triplex stability at neutral pH, due to the need for protonation at N -
3. The opposite is observed in duplex formation; (b) the presence of a group 
• 
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larger than H at the 5 position stabilizes nucleic acid complexes, due to non-
electronic effects; (c) substitution by alkyl chains longer than methyl results in 
decreased complex stability, an effect most probably due to changes in base 
stacking interactions. 
Materials and Methods 
IH nuclear magnetic resonance (NMR) spectra were recorded on a Jeol 
JNM-GX400 FT 400 MHz spectrometer and are reported in parts per million 
(ppm) from tetramethylsilane. 31p NMR spectra were recorded on a Varian 
Associates EM-390 and are reported in parts per million from phosphoric acid. 
Ultravioltet-visible (UV-Vis) spectra were recorded on a Perkin-Elmer 
Lambda 4C UV IVis spectrophotometer. Mass spectral determinations were 
conducted at the regional mass spectroscopy facility at the University of 
California, Riverside. Flash chromatography was carried out under positive 
air pressure using EM Science Kieselgel 60 (230-400 Mesh). Elemental analysis 
were performed by the analytical laboratory, California Institute of 
Technology. 
Reagents. Dry DMF, methylene chloride and acetonitrile were obtained 
from Fluka over molecular sieves. 5-iodo-2'-deoxyuridine and 5-
trifluoromethyl-2'-deoxyuridine were obtained from Sigma. CuI, 
triethylamine, I-pentyne, propargyltrimethylsilane, phenylacetylene, 
palladium on charcoal (Pd/C), and tetrakis(triphenylphosphine)paliadium(O), 
di methoxy tri tylch lori de, N, N-diisopropyl-2-cyanoethyl-
chlorophosphoramidite were purchased from Aldrich and used as received. 
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Diisopropylethylamine was distilled from CaH2 and stored under argon. 2'-
Deoxyuridine, thymidine, 5-bromo-2'-deoxyuridine, 2'-deoxycytidine, and 5-
methyl-2'-deoxycytidine phosphoramidites were purchased from Cruachem. 
5-Fluoro-2'-deoxyuridine and 5-iodo-2'-deoxyuridine phsophoramidites were 
synthesized from 5-fluoro-2'-deoxyuridine and 5-iodo-2'-deoxyuridine by 
protection of the 5' hydroxyl with dimethoxytrityl chloride and activiation 
using 2-cyanoethyl-N,N-diisopropylchloro phosphoramidite via standard 
procedures.s7 These phosphoramidites are now available from Cruachem. 5-
Bromo-2'-deoxycytidine phosphoramidite was purchased from Pharmacia. 
Restriction enzymes were obtained from New England BioLabs or 
Boehringer Mannheim and used with the manufacturer's supplied buffers. 
Polynucleotide kinase and the Klenow fragment were obtained from 
Boehringer Mannheim. Radioactive nucleotides (32p-y-ATP, 32P-a-dA TP, 
and 32P-a-TTP), were purchased from Amersham. Cobalt (III) hexamine 
trichloride was obtained from Kodak. Water was doubly distilled from a 
Corning Automatic Collection System. 
Nucleoside Synthesis 
5-Trimethylsilyl-ethynyl-2'-deoxyuridine. 5-Iodo-2'-deoxyuridine (2.80 g, 
7.9 mmol) was dissolved in dry DMF (40 mL) under argon. CuI (327 mg, 1.71 
mmol), triethylamine (2.4 mL, 17.2 mmol) and propargyltrimethylsilane (4.1 
mL, 29.0 mmol) were added. Tetrakis(triphenylphosphine)palladium (0) (1.0 
gms, 0.87 mmol) was added and the solution stirred at room temperature for 
12 hours. The solution was diluted with methanol (25 mL) and methylene 
chloride (25 mL), and NaHC03 (4 gm) and polymer supported 
triphenylphosphine (1 gm) were added. After 30 min., the solution was 
filtered and concentrated under reduced pressure. The DMF was removed by 
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vacuum distillation (45 °C, < 1 mm Hg). Flash chromatography in methylene 
chloride (500 mL), followed by 3% methanol in methylene chloride (500 mL) 
afforded pure product in 84.6 % yield (2.16 gms). IH NMR and UV spectra 
were consistent with reported va lues65-67 
5-Ethynyl-2'-deoxyuridine. Sodium metal (462 mg, 20 mmo!) was 
dissolved in MeOH (100 mL) to afford a 2 N solution of sodium methoxide. 
5-(Trimethylsily!)e thynyl-2'-deoxyuridine (1.6 gms. 4.9 mmo!) was dissolved 
in methanol. The NaOMe solution (50 mL) was added to the nucleoside 
solution and stirred for five hours. TLC showed complete conversion to a 
single product. Amberlite G-50 res in was added to neutralize the solution. 
The resin was removed, washed with methanol, and the filtrate concentrated 
under reduced pressure. The product was dissolved in 95% ethanol and 
precipitated with diethyl e ther to yield 740 mgs (60% yield) of the product as a 
crystaline solid. NMR and UV were consistent with reported values65-67 
5-E th yn y 1-5' -0- (4,4' -dim e th oxytri ty 1)-2' -d eo xyuri dine. 5-E th yn y 1-2'-
deoxyuridine (207 mg, 0.82 mmo!) was dissolved in dry pyridine (7 mL) . 
Dimethoxytrityl chloride (390 mg, 1.15 mmo!) was added, and the solution 
stirred overnight at 4°C. Water (12 mL) was added and the product extracted 
with diethyl ether (3 x 30 mL). After concentration, the product was purified 
by flash chromatography (64:34:4 e thyl acetate:hexane:methano!) to provide 
428 mg of product (95% yield). IH NMR (CDCI3) 0 8.07 (s, IH), 7.41 (d, 2H), 
7.20-7.33 (m, 8H), 6.83 (d, 4H), 6.27 (t, J = 7 Hz, IH, HI'), 4.55 (m, IH, H3'), 4.12 
(m, IH, Hr), 3.79 (s, 6H, OMe), 3.36-3.42 (m, 2H, Hs'), 2.90 (s, IH,) 2.47-2.51 (m, 
IH, H z ,), 2.25-2.32 (m, IH, H2). MS: (positive ion FA B) m /z 554 (M+, 2), 304 
(25),303 (100), 154 (12), 137 (7), 136 (10). HRMS calc. for C32H 3007N2 (M+): 
554.2054. Found 554.2062. 
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S-Ethynyl-S'-0-(4,4'-dimethoxytrityl)-3'-(Z-cyanoethyl-N,N-diisopropy-
p hos phorami di te) -Z' - de 0 xyurid ine. 5-E th Y 1-5' -0- (4,4' -dimethoxytri ty!)-2'-
deoxyuridine (382 mg, 0.68 mmol) was dissolved in dry methylene chloride (5 
mL). Oiisopropylethylamine (510 ).1L, 2.93 mmo!) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (340 ).1L, 1.5 mmo!) were added, and the 
reaction stirred for three hours. The reaction was quenched with ethanol (0.5 
mL) and stirred for five minutes. The reaction was diluted with ethyl acetate 
(15 mL), washed twice with an aqueous solution of satd. NaHC03 and twice 
with an aqueous solution of sa td. NaC!. After drying (Na2S04) and 
concentration under reduced pressure, flash chromatography (64:32:5:1, ethyl 
acetate:hexane:triethylamine:methano!) afforded a white foam. IH NMR 
(COC13) 1) 8.14 (d, IH), 7.42 (d, 2H), 7.21-6.34 (m, 8H), 6.82-8.85 (m, 4H), 6.27 (m, 
IH), 4.63 (m, IH), 4.17, 4.22 (d, IH), 3.79 (s, 6H), 3.58-3.69 (m, 4H), 3.36 (d, 2H), 
2.90 (d, IH), 2.63 (t, IH), 2.46 (t, IH), 2.32 (m, 2H), 1.07-1.28 (m, 12H). 31p NMR 
(COC!3) 1) 149.42, 149.Ql. 
S-Ethyl-Z'-deoxyuridine. 5-Ethynyl-2'-deoxyuridine (339 mg, 1.35 mmo!) 
was dissolved in ethanol and 10% Pd/C (200 mg) added. Hydrogenation was 
effected under 50 psi of H2 on a Parr rocker. After 18 hours, TLC indicated 
complete conversion to a single product. The Pd/C was removed by filtration 
through Celite. Concentration afforded pure product. NMR and UV were 
consistent with reported values6 5-67 
S-E th y I-S' -0-( 4,4 '-dime thox ytrity D-Z' -deoxyurid ine. 5-E th Y 1-2'-
deoxyuridine (238 mg, 0.93 mmol) was dissolved in dry pyridine (5 mL). 
Oimethoxytrityl chloride (440 mg, 1.30 mmo!) was added, and the solution 
stirred overnight at 4 0c. Water (15 mL) was added and the product extracted 
with diethyl ether (4 x 80 mL). After concentration, the product was purified 
by flash chromatography with 64:32:5 ethyl acetate:hexane:methanol to yield 
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405 mg of product in 78 % yield. IH NMR (CDC13) 1i 8.24 (bs, 1H), 7.42 (s, 1H, 
H6), 7.38 (d, 2H), 7.24-7.31 (m, 7H), 6.83 (d, 4H), 6.41 (t, 1H, Hd, 4.55 (m, 1H, 
H3'), 4.04 (m, 1H, H4'), 3.79 (s, 6H, OMe), 3.46 (m, 1H, Hs'), 3.37 (m, 1H, Hs'), 
2.29-2.36 (m, 2H, H2'), 1.93 (m, 2H, CH2_CH3), 0.85 (t, 3 H). MS: (positive ion 
FAB) m/z 558 (M+, 3), 304 (25), 303 (100), 154 (7), 136 (6). HRMS calc. for 
C32H3407N2 (M+): 558.2367. Found 558.2386. 
S-Ethyl-S'-O-(4,4'-dimethoxytrityl)-3'-(Z-cyanoethyl-N,N-diisopropy-
phosphoramid i te)-Z' -deoxyuridine. 5-E th Y 1-5' -0-( 4,4' -dimethoxytri ty 1) -2'-
deoxyuridine (380 mg, 0.68 mmo1) was dissolved in dry methylene chloride 
(5 mL) Diisopropylethylamine (510 ilL, 2.93 mmol) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (330 ilL, 1.48 mmol) were added, and the 
reaction stirred for three hours. The reaction was quenched with ethanol (0.5 
mL) and stirred for five minutes. The reaction was diluted with ethyl acetate 
(15 mL), washed twice with an aqueous solution of satd. NaHC03 and twice 
with an aqueous solution of satd. NaCl. After drying (Na2S04) and 
concentration, flash chromatography (64:32:5:1, ethyl 
acetate:hexane:triethylamine:methano1) afforded a white foam. IH NMR 
(CDCI3) 1i 8.30 (bs, 1H), 7.48 (d, 1H), 7.39 (d, 2H), 7.23-7.29 (m, 7H), 6.83 (m,4H), 
6.41 (m, 1H), 4.64 (m, 1H), 4.14 (d, IH), 3.80 (s, 3H), 3.79 (s, 3H), 3.46-3.79 (m, 
4H), 3.29 (m, 2H), 2.62 (t, 1H), 2.42 (t, 1H), 2.30 (m, 2H), 1.80-1.93 (m, 2H), 1.04-
1.29 (m, 12H), 0.83 (m, 3H). 31p NMR (CDCl) 1i 149.32,148.88. 
S-<Pent-l-ynyl)-Z'-deoxyuridine. 5-Iodo-2'-deoxyuridine (2.16 gms, 6.1 
mmol) was dissolved in dry DMF (5 mL) under argon. CuI (233 mg, 1.22 
mmo1), triethylamine (1.7 mL, 12.15 mmo1) and I-pentyne (1.8 mL, 18.3 
mmol) were added. Tetrakis(triphenylphosphine)palladium (0) (703 mg, 0.61 
mmo1) was added and the solution stirred at r. t. for nine hours. NaHC03 (4 
gms) and polymer supported triphenylphosphine (1 gm) were added. After 
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30 min. the solution was filtered and concentrated by rotory evaporation, and 
the DMF removed by vacuum distillation (45 °C, < 1 mm Hg). Flash 
chromatography in 500 mL of methylene chloride, followed by 500 mL of 10% 
methanol in methylene chloride afforded pure product in 70.2 % yield (1.26 
gms). NMR and UV are consistent with reported values66,67 
5-P en tyn y 1-5' -0-( 4,4' -d ime thoxytrity 1)-2' -deoxyuridine. 5-Pen ty 1-2'-
deoxyuridine (342 mg, 1.16 mmol) was dissolved in anhydrous pyridine (5 
mL). Dimethoxytri tv l chloride (474 mg, 1.40 mmol) was added and the 
solution stirred for 16 hours at 4 0c. Analysis by TLC (10% MeOH/MeCI2) 
indicated some starting material remaining. Methanol (15 mL) was added, 
and the solution concentrated by rotoevaporation. The product was dissolved 
in diethyl ether, and washed with water and brine. The organic layer was 
dried over Na2S04 and concentrated. Flash chromatography in 64:32:2 ethyl 
acetate:hexane:methanol afforded 550 mg of pure product (79% yield). IH 
NMR (CDCI3) 1) 8.07 (s, lH), 7.95 (s, lH), 7.43 (d, 2H), 7.22-7.35 (m, 7H), 6.84 (d, 
4H), 6.30 (t, J = 6 Hz, lH), 4.53 (m, lH), 4.06 (m, lH), 3.80 (s, 6H), 3.33-3.42 (m, 
2H), 2.45 (m, lH), 2.29 (m, lH), 2.08 (m, 2H), 1.84 (m, lH), 1.28 (q, 2H), 0.80 (t, 
3H). MS: (positive ion FAB) m/z 596 (M+, 1),304 (25), 303 (100), 154 (6), 137 (4), 
136 (5). HRMS calc. for C3SH3607N2 (M+): 596.2524. Found 596.2552. 
5-Pentynyl-5'-0-(4,4'-dimethoxytrityl)-3'-(2-cyanoethyl-N,N-diisopropy-
phosphoramidite)-2'-deoxyuridine. 5-( 1-Pen tyn y 1)-5' -0-( 4,4' -dimethoxytri tyl)-
2'-deoxyuridine (661 mg, 1.11 mmol) was dissolved in dry methylene chloride 
(5 mL). Diisopropylethylamine (800 ~L, 4.48 mmol) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (570 ~L, 2.56 mmo!) were added, and the 
reaction stirred for 30 minutes. The reaction was quenched with ethanol (0.5 
mL) and stirred for five minutes. The reaction was diluted with ethyl acetate 
(15 mL), washed twice with an aqueous solution of satd. NaHC03 and twice 
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with an aqueous solution of sa td. NaC! . After drying (Na2S04) and 
concentration, flash chromatography (1,5% triethylamine in methylene 
chloride) afforded a white foam. lH NMR (CDCI3) 88.02 and 7.98 (d, 1H), 7.44 
(d, 2H), 7.21-7.36 (m, 7H), 6.83 (m, 4H), 6.31 (m, 1H), 4.59 (m, 1H), 4.15 and 4.20 
(dm, 1H), 3.78 (s, 3H), 3.79 (s, 3H), 3.50-3.75 (m, 4H), 3.42 (m, 1H), 3.29 (m, 1H), 
2.42-2.65 (m, 3H),2.62 (t, IH), 2.43 (t, 1H), 2.28 (m, 1H), 2.05 (m, 2H), 1.06-1.28 
(m,14H), 0.76 (q, 3H). 31p NMR (CDCI3) 8149.25,148.81. 
5-Pentyl-2'-deoxyuridine. 5-(1-Pentynyl)-2'-deoxyuridine (380 mg, 1.3 
mmol) was dissolved in ethanol and 5% Pd/C (150 mg) was added. 
Hydrogenation was affected under 50 psi of H2 on a Parr rocker for one hour. 
The Pd/C was removed by filtration through Celite. Concentration afforded 
360 mg of pure product (95 % yield). NMR and UV were consistent with 
reported values66•67 
5- P en tyl-5' -0-( 4,4' - dim ethox ytri t Y 1)-2' -d e oxyuri dine. 5-Pen ty 1-2'-
deoxyuridine (300 mg, 1.0 mmol) was dissolved in anhydrous pyridine (5 mL) 
at 0 0c. Dimethoxytrityl chloride (481 mg, 1.42 mmol) was added and the 
solution stirred for 16 hours a t 4 0c. Water (15 mL) was added, and the 
product extracted into 3 x 50 ml aliquots of diethyl ether. After concentration 
under reduced pressure, the product was purified by flash chromatography 
(64:32:2 ethyl acetate:hexane:methanol) to afford 500 mg of pure product (90% 
yield). lH NMR (CDCl3) 8 8.03 (s, IH), 7.44 (s, 1H, H,;), 7.39 (d, 2H), 7.23-7.31 (m, 
7H), 6.83 (d, 4H), 6.38 (t, J = 7 Hz, 1H, H1'l, 4.56 (m, 1H, H3'), 4.02 (m, 1H, ~.), 
3.79 (s, 6H), 3.45-3.49 (m, 2H, HS'), 2.31-2.38 (m, 2H, H2'), 1.90-2.02 (m, 1H), 1.89 
(m, 1H), 1.75 (m, 1H), 1.25 (m, 2H), 1.11 (m, 2H), 1.03 (m, 2H), 0.77 (t, 3H). MS: 
(positive ion FAB) mlz 600 (M+, 3), 304 (25),303 (100), 183 (3), 154 (4), 136 (4). 
HRMS calc. for C3SH4007N2 (M+): 600.2837. Found 600.2861. 
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5-Pentyl-5'-0-(4,4'-dimethoxytrityl)-3'-(2-cyanoethyl-N,N-diisopropy-
phosphoramidite )-2' -deoxyuri dine. 5-Pen ty 1-5' -0- (4,4' -dimethoxytri ty!)-2'-
deoxyuridine (498 mg, 829 J.Lmoles) was dried overnight under vacuum, and 
dissolved in dry methylene chloride (5 mLl. Oiisopropylethylamine (590 J.LL, 
3.39 mmo!) and 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (380 
J.LL, 1.7 mmo!) were added, and the reaction stirred for one hour. The reaction 
was quenched with ethanol (1 mL) and stirred for five minutes. The reaction 
was diluted with ethyl acetate (15 mL), washed twice with an aqueous 
solution of satd. NaHC03 and twice with an aqueous solution of satd. NaCI. 
After drying (Na2S04) and concentration, flash chromatography (64:32:5, ethyl 
acetate:hexane:triethylamine) afforded a white foam. lH NMR (COCl3) 0 7.95 
(bs, IH), 7.50 (d, IH), 7.39 (d, 2H), 7.26-7.29 (m, 7H), 6.82 (m, 4H), 6.38 (m, IH), 
4.64 (m, IH), 4.14 (dm, IH), 3.78 (s, 6H), 3.46-3.63 (m, 5H), 3.29 (m, IH), 2.62 (t, 
IH), 2.42 (t, IH), 2.25-2.50 (m, 2H), 1.96 (m, IH), 1.68 (m, IH), 0.84-1.25 (m, 18H), 
0.74 (t, 3H). 31p NMR (COCI3) 0149.25,148.78. 
5-Trifl uorometh yl-5' -0-(4,4' -dimethoxytrityD-2' -deoxyruridine. 5-
Trifluoromethyl-2'-deoxyruridine (1.0 gms, 3.38 mmo!) was dissolved in 
pyridine (7 mL) and chilled to 0 0c. Oimethoxytrityl chloride (1.15 gms, 3.38 
mmo!) was added, and the solution stirred for 14 hours at 4 0c. TLC (64:32:5, 
ethyl acetate:hexane:methanol) indicated the reaction was complete. The 
reaction was diluted with methanol (10 mL), concentrated and the pyridine 
removed under vacuum. The product was dissolved in methylene chloride 
and washed twice with water. After concentration, flash chromatography 
using 60:40:4 ethyl acetate:hexane:methanol afforded 910 mg of product (45 % 
yield). lH NMR (COCI3) 09.06 (bs, IH), 8.11 (s, IH), 7.36 (d, 2H), 7.20-7.29 (m, 
7H), 6.82 (d, 4H), 6.21 (t, J = 7 Hz, IH, H1'l, 4.42 (m, IH. H3'), 4.13 (m, IH, ~,), 
3.78 (s, 6H), 3.41 (m, 2H, Hs.j, 2.53-2.59 (m, IH). 2.23 (m, IH). MS: (positive ion 
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FAS) m/z 598 (M+, 4), 319 (3), 305 (5),304 (25), 303 (100),289 (4),273 (4), 213 (3), 
165 (4), 154 (14), 138 (6), 136 (12), 135 (8), 109 (5), 107 (5). HRMS calc. for 
C31H2907N2F3 (M+): 598.1928. Found 598.1907. 
5-Trifluoromethyl--5'-O-(4,4'-dimethoxytrityl)-3'-(2-cyanoethyl-N,N-
diisopropy-p hosp horamid ite)-2 '- deoxyuridine. 5-Trifl uorometh yl-5' -0-( 4,4'-
dimethoxytrityl)-2'-deoxyuridine (296 mg, 0.49 mmol) was dissolved in dry 
methylene chloride (3 mL). Diisopropylethylamine (700 ilL, 4.02 mmol) and 
2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (310 ilL, 1.39 mmol) 
were added, and the reaction stirred for 15 minutes. TLC (64:32:5, ethyl 
acetate:hexane:methanol) indicated> 80% conversion of starting material to 
product. The reaction was quenched with ethanol (0.5 mL) and stirred for 
five minutes. The reaction was diluted with ethyl acetate (25 mL), washed 
twice with an aqueous solution of satd. NaHC03 and once with an aqueous 
solution of satd. NaCl. After drying (Na2S04) and concentration, flash 
chromatography (97:2:1 methylene chloride:methanol:triethylamine) afforded 
210 mg of a white foam (53% yield), which was used directly in 
oligonucleotide synthesis. 
5-(2-Phenyl-ethynyl)-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyruridine. 5-Iodo-
5'-0-(4,4'-dimethoxytrityl)-2'-deoxyuridine (1.82 gms, 2.77 mmol) was 
dissolved in dry DMF (15 mL) under argon. CuI (353 mg, 1.85 mmol), 
triethylamine (0.85 mL, 6.10 mmol) and phenyl acetylene (0.95 mL, 8.7 mmol) 
were added. Tetrakis(triphenylphosphine)palladium (0) (1.07 gms, 0.93 
mmol) was added and the solution stirred at r. t. for nine hours. The reaction 
was diluted with ethyl acetate (400 mL) and washed with water (60 mL, 5x), 
once with an aqueous solution of satd. NaHC03, and once with an aqueous 
solution of satd. NaCl. After drying over Na2S04 and concentration, flash 
chromatography in 60:40:5 ethyl acetate:hexane:methanol afforded 610 mg of 
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pure product (35% yield). 1H NMR (CDCI3) 89.15 (bs, 1H), 8.16 (5, 1H), 7.43 (d, 
2H), 7.04-7.35 (m, 12 H), 6.76 (t, 4H), 6.36 (t, J = 7 Hz, 1H, H1'), 4.56 (m, 1H, H3'), 
4.14 (m, 1H, 1-4'), 3.68 (5, 3H), 3.66 (5, 3H), 3.42 (m, 1H, HS'), 3.31 (m, 1H, HS'), 
2.55 (m, 1H, H2'), 2.31 (m, 1H, H2'). MS: (positive ion FAB) m/z 630 (M+, 0.4), 
363 (2.7),339 (2.5),303 (100),279 (11.3), 213 (4.9), 195 (3.0), 165 (4.3), 135 (6.7) . 
HRMS calc. for C3SH3407N2 (M+): 630.2367. Found 630.2361. 
5-(2-Phenyl-ethynyl)-5'-O-(4,4'-dimethoxytrityl)-3'-(2-cyanoethyl-N,N-
diisopropy-phosphoramidite)-2'-deoxyuridine. 5-(2-Phenyl-ethynyl)-5'-O-
(4,4'-dimethoxytrityl)-2'-deoxyuridine (390 mg, 0.62 mmol) was dissolved in 
dry methylene chloride (3 mL). Diisopropylethylamine (800 ~L, 4.6 mmol) 
and 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (240 ~L, 1.0 mmo!) 
were added, and the reaction stirred for 20 minutes. TLC (64:32:5, ethyl 
acetate:hexane:methanol) indicated reaction was complete. (The reaction was 
quenched with ethanol (0.5 mL) and stirred for five minutes. The reaction 
was diluted with ethyl acetate (25 mL), washed twice with an aqueous 
solution of satd. NaHC03 and once with an aqueous solution of satd. NaC!. 
After drying (Na2S04) and concentration, flash chromatography (2 % 
triethylamine in methylene chloride) afforded a white foam, which was 
lyophilized from dioxane, and used directly in oligonucleotide synthesis. 
DNA Manipulations 
Oligonucleotide Synthesis. OV nucleotides were synthesized on 1 ~M 
scale using a Beckman Plus 1 DNA ··hesizer. Monomers were diluted to 
0.1 M concentration in dry acetonitrile and coupled with no modification in 
the synthesis program. Deprotection was effected using 0.1 N NaOH for 24 
hrs. at 55 °C. The solution was neutralized with 6 ~L of glacial acetic acid, 
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desalted with Sephadex, lyophilized to dryness, and the oligonucleotide 
purified on a 20% polyacrylamide gel. The product was visualized by UV 
shadowing of the product band, and elution of the DNA with 0.2 M NaCI, 1 
mM EDTA at 37°C for 24 hrs. Filtration of the gel slice through a 0.45 11m 
cellulose acetate (Centrex) filter, followed by extensive dialysis against water 
(> five days, changing dialysis water three times daily) yielded pure metal-free 
oligonucleotides. 
DNA preparation. Plasmid pDMAG10 was grown and amplified as 
described previously.23,86 pDMAG10 was purified using two CsCI gradients 
(first gradient, 24 hrs, 42,000 rpm; second gradient, 12 hrs., 55,000 rpm) . 
Plasmid DNA was linearized with Sty I, which produces overhangs which 
can be uniquely labeled on either end. Labeling with either [a-32p] TIP or [a-
32p] dATP using the Klenow fragment87 produces a 4.06 kb restriction 
fragment specifically labeled 1.02 or 3.04 kb from the target sequence. 
Unincorporated nucleotides were removed using a 1 ml Sephadex G-50-80 
spin column.87 
Affinity cleaving reactions, The 32P-end-labeled DNA was dissolved in 
buffer containing NaCl, Tris, and spermine and was mixed with 
oligonucleotide-EDTA 1-18 previously equilibrated for 60 sec with 1.5 equiv of 
Fe(I!) . After incubation at 0 °C for 60 min, reactions were initiated by the 
addition of sodium ascorbate (final concentrations: 25 mM Tris-acetate, 1 mM 
spermine, 100 mM NaCl, 0.8 11M oligonucleotide-EDTAeFe(II), and 1 mM 
ascorbate). The cleavage reactions were allowed to proceed for six hours at 24 
0c. After addition of ficoll loading buffer, reactions were loaded directly onto 
an 0.9% agarose gel and electrophoresed at 120 V for three hours. 
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Chapter IV 
Efficient Base Specific Alkylation of Double Helical DNA 
by N-Bromoacetyloligonuc1eotides 
Introduction 
Attachment of a non-specific cleaving moiety capable of generating a 
diffusible cleaving species to a DNA binding molecule allows for the 
elucidation of the structural principles for DNA recognition, a technique 
termed affinity cleaving.l ,2 The determination of the sequence specificities, 
groove locations, and binding orientations of peptid~ analogues,3-12 protein-
DNA binding complexesY-17 and oligonucleotide-triple helix structures18-24 
has provided reliable models for the sequence specific recognition of double 
helical DNA. 
Pyrimidine oligonucleotide-directed triple helix formation is a motif for 
the recognition of double helical DNA, which allows the' facile construction 
of molecules (oligonucleotides) capable of binding a wide variety of DNA 
sequences .18,25-27 Within this motif, a pyrimidine oligonucleotide binds in 
the major groove parallel to the Watson-Crick purine strand.18,25-27 
Generality and specificity are imparted by the existence of a Hoogsteen base 
pairing code, wherein thymidine binds specifically to adenine-thymine base 
pairs (T-A-T triplet formation) and protonated cytosine recognizes 
guanosine-cytosine base pairs (C+G-C triplet formation) .18,25-28 The recent 
discoveries of other base triplets, such as GeTA,20 the development of 3'-3' 
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linked oligonucleotides for alternate-strand triple helix formation,21 and the 
formation of novel triple helical structures24,29,30 has greatly extended the 
number of sites capable of being recognized. Triple helix formation is both 
generalizable (in principle, the recognition of any purine- or purine-
pyrimidine sequence is possible) and, by virtue of its> 15 base pair specificity, 
more than a million fold more specific than conventional 6-base pair 
restriction enzymes. This specificity is sufficient for the recognition of single 
sites in genomic DNA.27,31 
Studies using oligonucleotides equipped with a non-specific cleaving 
functionality (EDTA·Fe(II) indicate that recognition of and cleavage at a 
single site within the 48,000 base pairs of the lambda phage genome is 
possible.32 Furthermore, the cleavage of a yeast chromosome (340 kbp) at an 
engineered site, albeit in low yield (6%), has been accomplished.25 Cleavage 
at secondary sites is observed.25 Presumably, these sites are largely 
complementary in a Hoogsteen sense to the oligonucleotide-EDT A • Fe(II). 
The number of such sites found (four secondary sites were observed within 
the 340 kbp of chromosome III, indicating an approximate ratio of one site per 
100,000 base pairs of DNA) may be due to the known high incidence of 
polyp urine runs in genomic DNA.33,34 This study indicates that there are 
limits to the specificity of oligonucleotide-EDTA.Fe(II) molecules. 
These experiences indicate that specificity and yield are key issues in the 
design of molecules capable of and useful for the modification of DNA on the 
chromosomal level. Recent studies indicate that molecules which have 
evolved through selection to effect DNA modification, such as the restriction 
endonuclease EcoR I, derive their specificities not only from their lower 
binding affinities for mismatched sites, but also due to a loss of hydrolytic 
activity at such sites.35 For instance, binding at sites with a single mismatch is 
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disfavored by 4 to 6 kcal/mol. The specificity of the enzyme couples this 
decrease in binding affinity with an additional 4 to 7 kcal penalty for 
transition state destabilization at secondary sites. Thus, restriction enzyme 



















Fig. 4.1. Replacement of a diffusible nonspecific DNA cleaving moiety 
generated by EDTA· Fe(I!) (hydroxyl radical), useful for studying DNA 
recognition (affinity cleaving) to a non-diffusible base-specific moiety. This is 
a key issue with respect to the design of sequence-specific DNA cleaving 
molecules. Sequence dependent recognition is coupled with sequence 
dependent cleavage. 
Once the structural principles for double strand DNA recognition have 
been determined, it becomes possible to design and attach structural domains 
designed to carry out a desired DNA modification (Fig. 4.1). Early examples 
were the conversion of distamycin-EDTA. Fe(II) to N-
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bromoacetyldistamycin36-38 and Fe (II)eEDTA-Hin(139-190) to Cu/NieGGH-
Hin(139-190).39,40 
Cleavage of DNA can be achieved by modification of the intact duplex at 
the sugar (oxidative reaction), phosphate backbone (nucleophilic attack 
and/ or hydrolysis), or at the bases (electrophilic attack) followed by base 
treatment. Of these, only attack at the bases offers the possibility of additional 
sequence discrimination during the cleavage reaction. Analysis of DNA 
reactivity data suggests that attack at N-7 of guanine offers the greatest 
opportunity for high yield reaction.41 -45 Methylation by relatively non-
specific alkylation agents (methyl methanesulfonate) results in > 89% reaction 
at N-7 of guanine.41 -43 
The sequence and base specific modification of single stranded DNA has 
been achieved by complementary oligonucleotides bearing a number of 
reactive functional groups. Belikova originally proposed the modification of 
a complementary single stranded DNA using a modified oligonucleotide-
electrophile via Watson-Crick duplex formation in 1967.46 Vlassov and co-
workers have targeted single stranded DNA's with platinum derivatives,47 
and an aromatic 2-chloroethylamino electrophile.48-52 The use of a halo-
acetyl moiety was originally proposed by Summerton and Bartlett53 and has 
recently been used to modify single stranded DNA in high yield.54 
Modification of a complementary guanine via an cytosine-aziridine 
moiety55,56 has been reported. Methylation of DNA by an oligonucleotide-
methyl thioether results in exclusive modification at the N-7 position of 
guanine bases; properly positioned adenines are not alkylated.57,58 All of 
these functionalities target the N-7 atom of guanine for electrophilic attack. 
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More recent work has targeted double helical DNA via triple helix 
formation using an oligonucleotide linked at the 5' end to an aromatic 2-
chloroethylamino moiety.59,60 
This chapter presents data which indicate that N-
bromoacetyloligonucleotides are capable of: (i) near quantitative modification 
of double helical DNA; (ii) at a single base position; (iii) in a manner which 
produces ends which are "clonable" with compatible ends produced by 
conventional restriction enzyme digestion. Furthermore, the specificity of N-
bromoacetyloligonucleotides is sufficient to produce efficient chemical 
cleavage at a single site within a yeast chromosome. The effective molarity 
obtained by using organic synthesis to tether a reactive functionality to a DNA 
binding molecule is measured. Finally, the utility of the N-bromoacetyl 
moiety as a reporter group for studying small changes in oligonucleotide 
binding affinities is demonstrated in studies concerning the cleavage 
efficiency of N-bromoacetyloligonucleotides as a function of oligonucleotide 
length, and in studies which quantitate the cooperativity observed by binding 
of two oligonucleotides to abutting sites. 
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Part I 
Single Strand Alkylation of Double Helical DNA 
Using N-Bromoacetyloligonudeotides 
Design of Electrophile-Oligonudeotide Conjugates for the Efficient Base 
Specific Alkylation of Double Helical DNA.61 
The judicious attachment of an electrophile allows targeting for 
alkylation of a specific guanine base adjacent to a triple helix site on double 
helical DNA. N-Bromoacetyloligonucleotides were designed to combine the 
specificity of triple-helix formation with the requirement for the presence of a 
properly positioned guanine base. A moderate electrophile, such as a 
bromoacetyl moiety, was chosen to minimize loss o(yield due to competing 
reactions with solvent, buffers, or other reaction components. 
Model building of a triple helical complex indicates that a pyrimidine 
oligonucleotide bound in the major groove parallel to the purine strand of 
the duplex could be equipped with a bromo acetyl moiety at the 5'-end such 
that the electrophile is proximal to a guanine base located two base pairs to 
the 5'-side of the target sequence (Figures 4.2 and 4.5). Reaction of the 
electrophile carbon with N-7 of guanine adjacent to the triple helix would 
result in covalent attachment of the oligonucleotide to the duplex (Fig. 4.2) . 
Upon warming and base treatment,. depurination and cleavage of the DNA 
backbone at the position of alkylation is expected.62,63 
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Fig. 4.2. Scheme for alkylation and cleavage of DNA using a moderate 
electrophile (N-bromoacetyl) for the base specific and high yield modification 
of DNA. N-bromoacetyloligonucleotide localizes the electrophilic moiety at 
the ON A double helix. Reaction results in cross-linking of the 
oligonucleotide to the duplex. Depurination and loss of the intact modified 
guanine base from the double helix can be effected by warming. Piperidine 
treatment effects strand scission. The production of 5' and 3' phosphate ends 
is expected. 
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Results and Discussion 
Syn thesis, derivatization, and purification of N-
bromoacety f of igodeoxyri bon uc f eo ti des. The synthesis of the 5'-O-DMT-3'-
phosphoramidite of TE follows in two steps from the previously described 
aminonucleoside 1 (Figure 4.3).64 Protection of the primary amine 1 with 
fluorenylmethyl chloroformate,65,66 followed by activation of the 3' alcohol 
with (3-cyanoethyl-N,N-diisopropylchlorophosphoramidite,67 affords a 
thymidine derivative containing an appropriately protected linker-amine 
suitable for use in standard automated oligodeoxyribonucleotide synthesis. 
The modified 5-amino-thymidine was incorporated into the oligonucleotide, 
5'_ETT3(Me5C)T4(Me5C)2T3(Me5C)T4-3', as the 5' terminal residue by coupling 
of phosphoramidite 3. Deprotection of the amine occurs quantitatively 
under standard deprotection conditions (concentrated NH40H, 55°C, 20 
hrs.),65,66 as judged by reverse-phase and anion-exchange HPLC and 
pol yacrylamide electrophoresis. The deprotected oligonucleotide 4 was 
purified by polyacrylamide gel electrophoresis. Alternate amine protecting 
groups compatible with automated oligonucleotide synthesis 
(monomethoxytrityl (MMT) and N-trifluoroacetyl) can also used to protect 
the amine in nucleosides 2 and 3. 
Derivatization of the oligonucleotide was effected via reaction with the 
N-hydroxysuccinimidyl bromoacetate.68-7o Purification of the derivatized 
oligonucleotide was initially accomplished using reverse-phase HPLC .11-73 
The buffers used for such purification consist of a water/acetonitrile gradient 
buffered with small concentrations of triethylammonium or ammonium 
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Fig. 4.3. (Top) Synthetic scheme for construction of Fmoc-protected 
thymidine 2-cyanoethyl-N,N-diisopropylphosphoramidite 3 used for the 
automated synthesis of oligonucleotides with a primary amine attached to the 
5-position of a single thymidine position from the known amine 1 in two 
steps. (Bottom) Oligonucleotides 4 through 7 containing T, Me5C, and a 
unique thymidine at the 5'-end modified at the 5..,position with a spacer-
primary amine (4), spacer-N-bromoacetamide (5), spacer-N-chloroacetamide 
(6), and spacer-N-iodoacetamide (7). 
possibility of reaction between the bromoacetyl moiety and ammonia, the 
buffer was acidified to pH 4.7. Initial studies were conducted with N-
bromoacetyloligonucleotides purified in this manner. In separate studies, it 
was observed that the bromoacetyl moiety purified by reverse phase HPLC 
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undergoes degradation to an unidentified product (vide infra). In later 
studies, N -bromoacetyloligonucleotides were purified by anion exchange 
chromatography. This requires additional treatment after HPLC purification 
to obtain salt-free DNA; however, after the implementation of this 
purification procedure, the yields of alkylation increased slightly. , 
GATCT A A GG ~h'. """::A~A~A:-:G:=;-A7". ·-:-A-:-A"""::A-::G~G:::;';.· A-:-A7" .... -:-f>.-:;:G:-:A~A:-O-A-;-..•••  71A G CT T T CT T CT T C C CT A -3' 




Fig. 4.4. Construction of the plasmid pUCALK from pUC19 via ligation of the 
oligonucleotides indicated into the BamH I / Sal I sites within the polylinker 
region. Binding site for the N-bromoacetyloligonucleotide 5 is boxed, and the 
targeted guanine base is in indicated. Restriction endonuclease sites used for 
the isolation of desired restriction fragments are indicated. 
Specificity and yield of reaction. To test both the specificity and yield of 
the alkylation reaction, three consecutive G -C base pairs were incorporated 
immediately 5' to the 19 base pair purine target site, 5'-A4GA4GGA3GA4-3', 
within a plasmid 2.3 kbp in size (pUCALK) (Fig. 4.4) . 
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Fig. 4.5. Autoradiogram of a high-resolution 8% denaturing polyacrylamide 
gel of cleavage products from the reaction of oligonucleotide 5 and a 32p 3'-
end-labeled 659-bp restriction fragment (Pst II Ssp I). Reaction conditions 
were 1 J.l.M concentration of oligonucleotide 5,20 mM Hepes, pH 7.4, 0.8 mM 
Co(NH3)6+3, and 10,000 cpm end-labeled DNA in a total volume of 15 J.l.l. 
Reactions were incubated at 37 °C, precipitated with NaOAc/EtOH, washed 
with 70% EtOH, and treated with 0.4 M piperidine (90 °C, 30 min.). Cleavage 
products were analyzed on an 8% 1:20 cross-linked, 48% urea polyacrylamide 
gel, 0.4 mm thick. Lanes 1 and 2 are A]4 and G_62,63 specific chemical 
sequencing reactions, respectively. Lane 3 contains DNA incubated for 48 
hours in the absence of N-bromoacetyloligonucleotide 5. Lanes 4-10: DNA 
incubated in the presence of N-bromoacetyloligonucleotide for 3, 5, 8, 12, 21, 
34 and 48 hours. Center: Sequence of the oligonucleotide-DNA triplex within 
plasmid pUCALK. The major site of modification is indicated. Right: ribbon 
model of triple-helical complex with the oligonucleotide bound parallel to 
the purine strand in the major groove of the duplex DNA. The positions of 
the electrophile and the three guanine bases proximal to the binding site are 
indicated. Arrow indicates base position of predominant cleavage. 
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N-Bromoacetyloligonucleotide 5 (1 f.lM) was allowed to react with a 659 
base pair Pst I/Ssp I 32p end-labeled restriction fragment at 37°C in the 
presence of 0.8 mM Co(NH3)6+3 and 20 mM Hepes buffer (pH 7.4). The 
reaction is allowed to proceed for the desired period at which time piperidine 
treatment is used to effect strand scission at modified bases. The extent of 
cleavage of the labeled restriction fragment by the N-
bromoacetyloligonucleotide 5 was followed for 48 hours at 37°C (Figure 4.5). 
Yields and specificity were determined by phosphorimaging of high 
resolution polyacrylamide gels. 
Analysis by high resolution gel electrophoresis reveals that reaction 
occurs predominantly at the guanine base located two base pairs to the 5'-end 
of the target site in 87% yield. No modification occurs on the pyrimidine 
strand. Modification occurs at the flanking guanines with relative rates of 
0.03 and 0.06 that of the major site of reaction. Apparently, there exists 
sufficient flexibility in the linker arm and/or the junction of the local triple-
helical complex to access all three guanine bases for modification to some 
extent. 
Maximal cleavage conditions. Not unexpectedly, maximal 
modification/ cleavage is observed when the presence and activity of 
nucleophiles capable of reaction with the bromoacetyl moiety is limited. The 
presence of spermine and Tris buffers results in a slight decrease in the yield 
of DNA cleavage; therefore, the poly cation Co(NH3)6+3 and Hepes buffers 
have been substituted. To study the reactivity of the bromoacetyl group in 
solution, the dinucleoside compound T-TE (8) was synthesized (Fig. 4.6). 
After derivatization of 8, 9 was incubated with Co(NH3)6+3 and Hepes at 37°C 
and 55 dc. HPLC analysis indicates that no degradation of 9 occurs in an 
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aqueous 1 mM Co(NH3)+3 solution; however, degradation of 9 does occur 
upon incubation in Hepes buffer at 55°C. The high yield of DNA 
modification indicates that this reaction is a minor one at 37 °C, at least with 
oligonucleotide bound to the double helix. 
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Fig. 4.6. T-TE 8-10 synthesized to study the reactivity of the bromoacetamide 
functionality under DNA alkylation conditions. 
Independent synthesis of the expected hydrolysis product 10 indicates 
that resolution of 9 and 10 is achieved under the HPLC conditions used. No 
hydrolysis of 9 to form 10 is observed upon incubation in aqueous solutions 
at 37°C or 55 dc. 
One explanation for the decreased yields observed in the presence of 
spermine is reaction between the tetraamine and the bromoacetyl moiety. 
Interestingly, spermine inhibits the methylation of DNA by N-methyl-N-
nitrosourea.75 An alternative explanation, as proposed by Zakrzewska and 
Pullman, for the decrease in yield of alkylation observed in the presence of 
spermine, involves binding of spermine to DNA, resulting in either a change 
in the electrostatic potential of the major groove or steric blockade of 
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electrophilic sites in the major groove. A similar mechanism could inhibit 
reaction of N-bromoacetyloligonucleotides with DNA. 
The T-TE dinucleoside 9 was also used to study various HPLC 
purification conditions . Isolation of the purified dinucleoside by reverse 
phase HPLC, lyophilization of the compound, and re-injection indicates the 
presence of an impurity. The impurity represents about 10% of the total 
material. This impurity is postulated to result from attack of ammonia or 
acetate on the bromoacetyl moiety during the lyophilization period. 
Determination of Rate of Reaction of N-haloacetyloligonucleotides with 
DNA. Reaction of the N-bromoace tyloligonucleotide 5 within a triple helical 
complex follows a first order rate equation given by : 
[DNAlintact = [DNAlinitiale-kt 
where k is the unimolecular rate constant, and t is time. 
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Fig. 4.7. Plot of decrease of intact DNA in the presence of N-
bromoacetyloligonucleotide 5 as a function of time. 
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A plot of In ([DNA)intact/[DN A) total) vs . time (pseudo-first order 
conditions, where micromolar concentrations of oligonucleotide and 
nanomolar concentrations of duplex insures formation of the triple helical 
complex) indicates that the reaction between N-bromoacetyloligonucleotide 5 
and the double-helical DNA is first order in target DNA concentration with a 
first order rate constant of 3.1 x 10-5 s-l at 37 ec, corresponding to a half-life 
for alkylation within the triple helical complex of 6.2 hours (37°C) (Fig. 4.7). 
Identical rates are obtained over the range of N-bromoacetyloligonucleotide 
concentrations 50 nM - 2 J.l.M. 
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Fig. 4.8. Plots of decrease in amount of intact DNA in the presence of 
haloacetyloligonucleotides 5, 6, and 7. 
N-Chloroacetyl- and N-iodoacetyloligonuc1eotides 6 and 7 were 
synthesized by derivatization of amino-oligonucleotide 4 with N-
hydroxysuccinimidyl chloro- and iodo- acetates. Determination of the first-
order rate constants for the reaction of these oligonucleotides with the double 
helical target site indicates that these moieties react with relative rates of 
kiodo/kbromo= 0.2 and kchloro/kbromo = 0.06 (Fig. 4.8) . The slower rates of 
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reaction for both the chloroacetyl and iodoacetyl derivatives parallel the 
relative rates observed at N-3 of adenine with the reactions of N-bromo-, 
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Fig. 4.9. Synthesis of N -bromo acetyl oligonucleotides 13 and 14 was 
accomplished via incorporation of phosphoramidites 11 and 12 using 
automated oligonucleotide synthesis. Phosphoramidites 11b and 12b were 
synthesized by: a) 5-(2-carbomethoxyethyl)-5'-ODMT-2'-deoxyuridine64 was 
stirred in 1,3 diaminopropane or 1,4 diaminobutane for 2 days; b) the primary 
amine was protected with p-anisy1chlorodiphenylmethane; and c) the 3' 
hydroxyl was activated as the phosphoramidite using standard procedures.67 
Synthesis of the· oligonucleotides was accomplished using standard 
automated synthesis. Derivatization was accomplished as previously 
described with N-hydroxysuccinimidyl bromoacetate, and purification with 
reverse-phase HPLC to yield oligonucleotides 13 and 14. 
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Optimization of linker arm. Design of the linker arm in 5 was based on 
model building studies with the DNA double helical target in an A' 
configuration. Since the exact structure of the DNA triplex as well as the 
triplex to duplex junction remains to be elucidated, two additional linker 
arms, containing one and two additional methylene groups, were studied 
(Fig. 4 .9) . Oligonucleotides 13 and 14 were synthesized from the 
phosphoramidites 11 and 12 and derivatized as before by reaction with N-
hydroxysuccinimidyl bromoacetate followed by reverse phase HPLC 
purification. 
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Fig. 4.10. Cleavage efficiencies of the N-bromoacetyloligonucleotides 5, 13 and 
14 at each of the three guanines 5' to the triplex target site. The 3' guanine is 
the base abutting the triplex site; the 5' guanine is 3 bases removed from the 
triplex binding site. 
The total cleavage efficiencies and specificities of the N-
bromoacetyloligonucleotides 5, 13 and 14 are plotted in Figure 4.10. 
Incubation of the DNA with N-bromoacetyloligonucleotide 13 results in the 
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largest overall cleavage efficiency; however, oligonucleotide 5 affords the 
highest cleavage efficiency at the central guanine and is the most specific in 
terms of reactivity at the central guanine vs. reaction at the flanking bases. 
These data are drawn from a single gel, and slight differences in 
oligonucleotide purity might affect the results obtained. The error in these 
measurements must be considered to be large relative to the deviation in the 
results; therefore, these experiments simply indicate that single methylene 
changes in the 9 atom long linker arm do not result in large changes in 
reactivity or specificity. 
Modelling of linker arm. A computer illustration depicting a 6 base pair 
triple helix with a terminal thymidine-bromoacetyl is shown in Figure 4.11. 
Since the exact structure of a triple helix or a triplex-duplex juncture is 
unknown, this model is intended to impart descriptive, not quantitative, 
information. Indeed, footprinting data suggest that triplex-duplex junctions 
result in some DNA distortion (see chapter II). The figure allows a pictorial 
understanding of the design of the linker arm and its relationship in space 
with the three strands present in the complex. 
The triple helix was constructed from coordinates obtained from fiber 
diffraction data.76 Three guanine bases were incorporated 5' to the triplex site; 
thus, this sequence represents that found in the plasmid pUCALK. The 
linker arm was constructed such that it extends in the direction of the targeted 
guanine bases, and was subsequently energy minimized with the N-7 of the 
targeted guanine, the electrophilic carbon, and the bromine atom defining an 
angle of 180°. 
Analysis of the structure indicates that the torsional angle around the Br-
C-C-O bond is 88°, close to the ideal value of 90° required to insure maximum 
orbital overlap during the displacement reaction. Likewise torsional angles 
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along the linker arm chain are within 10° of ideal values, indicating that the 
arm does not have to assume a strained conformation to allow alkylation of 
the DNA. The extended linker arm is ideally positioned to access the targeted 
guanine base two base pairs removed from the binding site, although the 
exact structure of the triplex-duplex junction is not known and it could differ 
substantially from the depicted model. 
The model suggests that geometrical considerations make the guanine 
two bases removed from the triplex target an ideal base for intracomplex 
reaction. The positioning of this base makes it the dominant site of reaction 
with all of the N-bromoacetyloligonucleotides constructed (oligonucleotides 
5,13, and 14. The curvature of the helix makes access of guanine bases farther 
removed from the triple helix site difficult, since the base is both 3.4 A farther 
away in a vertical direction and rotated another 30° around the helical axis. 
Reaction with the distal guanine base requires tilting of the base in the 
direction of the bromoacetyl moiety, and extension of the linker arm. 
The guanine base immediately adjacent to the triple helix site has 
actually not rotated sufficiently to be accessible for reaction. Accessto this base 
would require major alterations in the geometry of the linker arm and in the 
DNA target. The alkylation data suggest that this is highly unfavorable. 
A guanine base two bases removed from the target site is almost directly 
"below" the modified thymidine, due to the placement of the third strand 
directly above the purine strand of the duplex. 
The linker arm is not able to alkylate the other strand of the target 
duplex, due to the location of this second strand across the groove of the 
DNA. 
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Fig.4.11a. Model of a 6 base triple helix containing a 5' terminal bromoacetyl-
thymidine which is positioned for alkylation of a guanine base 2 base pairs to 
the 5' side of the triple helical target site. The triple helix was constructed 
using published coordinates . The linker arm was constructed, a constraint 
was placed on the geometry of the N7-C-Br angle (180°), and the linker arm 
was energy minimized. The Watson-Crick double helix is in blue, The third 
strand is green, and the linker arm is red . The N-7 of guanine, the 
electrophilic carbon, and the bromine leaving group are highlighted in green. 
Fig. 4.11h. Close-up view of the final base triplet and the linker arm. The 
view has been tilted to afford a view of the guanine base. The highlighted N7 





This work demonstrates that a non-diffusible electrophilic moiety 
judiciously attached to the 5'-end of an oligonucleotide is capable of 
alkylation of intact double-helical DNA at a single base position in high yield. 
The half-life for the triple helical complex is 6.2 hours. Predominant 
modification occurs at a guanine two bases 5' to the triplex target site, with 
modification of guanines flanking this position with rates 0.03 and 0.06 that of 
the central guanine . Modification by N -chi oro- and N-
iodoacetyloligonucleotides occurs with rates 0.06 and 0.20 that of N-
bromoacetyloligonucleotides. Changes in the linker arm do not result in 
large changes in the yield or specificity of the alkylation reaction. 
Since oligonucleotide-directed triple-helix formation is sufficiently 
generalizable and specific to allow the recognition of single sites in genomic 
DNA,25-27,77 modification of a single base within megabase-size chromosomes 
using strictly chemical methods might be possible. 
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Part II 
Double Strand Alkylation and Cleavage of DNA 
Using N-Bromoacetyloligonuc1eotides 
The manipulation of DNA is made possible by the high selectivity and 
cleavage efficiency afforded by restriction endonucleases, which allow the 
cleavage of DNA at predetermined sequences to be accomplished in 
quantitative yield in a manner which allows religation of the products. The 
use of naturally occurring endonucleases is largely limited to plasmid or 
cosmid size DNA (103 - 105 base pairs), due to the limited sequence specificity 
(4-8 base pairs) of these entities. 
The high efficiency and specificity of the alkylation cleavage chemistry 
developed would offer a number of advantages to DNA manipulations if 
double strand modification could be achieved. The high efficiency and base 
specificity of cleavage mimic those of restriction enzymes. The> 15 base pair 
specificity possible using the triple helix motif makes the cleavage at single 
sites within large chromosomal DNA realizable. 
Two motifs for the double strand cleavage of DNA using N-
bromoacetyloligonucleotides were considered. 
Double Strand Alkylation/Cleavage using Cross-over N-
Bromoacetyloligonucleotides. 
The synthesis and DNA cleavage of a 5'-purine-pyrimidine-3' sequence 
was accomplished by Horne and Dervan using an oligonucleotide containing 
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an internal 3'-3' phosphate linkage.21 This oligonucleotide recognizes purine 
stretches on each of the two strands of the DNA by crossing-over the major 
groove at the purine-pyrimidine junction. Oligonucleotides of this type 
contain two 5' ends. 21 Incorporation of N-bromoacetyl-thymidines at each 
end results in an N-bromoacetyloligonucleotide able to bind 18 base pairs of 
double helical DNA and alkylate each strand 22 base pairs apart. 






Fig. 4. 12. Motif for the cleavage of double helical DNA via an 
alkylation/ strand scission mechanism using cross-over oligonucleotides of 
the type described by Horne and Dervan.21 Cross-over oligonucleotides 
recognize sequences of the type S'-purine-pyrimidine-3'. Oligonucleotides 
containing amino-thymidines at each 5' end are derivatized to afford an 
oligonucleotide containing 2 S'-N-bromoacetyl moieties. The cleavage sites 
on the individual strands are separated by 22 base pairs. 
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Fig. 4. 13. Synthetic scheme for the synthesis of CPG-Alk-2 solid support for 
the synthesis of cross-over N-bromoacetyloligonuc1eotides of the type 
described by Horne and Dervan for the cleavage of double helical DNA via 
alkylation/ strand scission mechanism. 
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The construction of bis-alkylating cross-over oligonucleotides requires 
the synthesis of nucleoside 3 attached to a solid support via its 5' hydroxyl 
(Fig. 4.13). This was accomplished using standard procedures21,,67 and 
involves protection of the 3' hydroxyl with a dimethoxytrityl protecting 
group, attachment of a succinate linker to the 5' hydroxyl, and derivatization 
of solid CPG-NH2 support using an activated 5'-p-nitro-phenolate ester (Fig. 
4 .13). Synthesis of the first half of the oligonucleotide in the reverse 5'-3' 
direction, coupling of an abasic linker78,79 as described by Horne and Dervan,21 
and coupling of the remainder of the nucleosides in the conventional 3' to 5' 
direction affords oligonucleotide 23 (Fig. 4.14). 
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Fig. 4. 14. Oligonucleotides 22 and 23 for the study of double stranded DNA 
cleavage via alkylation/ strand scission mechanism using cross-over 
oligonucleotides of the type described by Horne and Dervan. 21 
Oligonucleotide 22 is converted to the N-bromoacetyloligonucleotide 23 as 
previously described. Purification was effected by HPLC using a Vydac anion 
exchange column. 
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The plasmids pUCALK and pUCLEU2D each contain binding sites for 
cross-over oligonucleotide 23 with guanines positioned on each strand two 
bases 5' to the end of each purine run (Fig. 4.15) . The cross-over 
oligonucleotide binds the underlined bases, using a 3' - 3' internal phosphate 
linkage to change polarity and cross-over the major groove at the purine-
pyrimidine junction. 
t 
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Fig. 4.15. Construction of the plasmid pUCLEU2D from pUCLEU2 via ligation 
of the oligonucleotides indicated into the Xho I site. Binding site for the N-
bromoacetyloligonucleotide 23 is boxed, and the targeted guanine bases are 
indicated. Restriction endonuclease sites used for the isolation of desired 
restriction fragments are indicated. 
Incubation of oligonucleotide 23 with Hind III linearized 32P-labeled 
plasmid pUCLEU2D indicates that alkylation of each of the guanines can be 
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accomplished in high yield (>80%). The yield of double strand cleavage was 
low. Plasmid pUCLEU2D was constructed to allow the insertion of this 
sequence into yeast chromosome III. Cleavage of yeast chromosome III by 
oligonucleotide 23 affords yields of 10%. Due to difficulties involved with the 
handling of chromosomes, it is not possible to manipulate large DNA at 
temperatures above 55°C. It is possible that higher cleavage efficiencies are 
achieved, but that due to the large overhang (22 bases) produced, 
denaturation and strand separation at this site does not occur. Due to the low 
cleavage yields, no further studies with this motif were undertaken. 
Double Strand Alkyl a tion/Cleav age Using Two N-
Bromoacetyloligonucleotide Binding Sites. 
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Fig. 4. 16. Strategy for the cleavage of double helical DNA via an 
alkylation/strand scission mechanism. Two oligonucleotides bind to separate 
sites on each of the two duplex strands, targeting guanines to the 5' end of the 
purine strand bound by each oligonucleotide. 
Sequence design. The efficient modification (>85%) of one strand of a 
double helical DNA target sequence can be realized using the N-
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bromoacetyloligonucleotide 5.61 Incorporation of triplex/ alkylation sites on 
each of the strands of the double helix affords a second motif for double 
helical modification of DNA (Figure 4.16). 
Using this strategy, double strand cleavage could be obtained at 5'-G-N-
purine-(N)n_pyrimidine-N-C-3' sequences (Fig. 4.16). Sequences of this type 
are recognized by the cross-over molecules pioneered by Horne and Dervan.21 
The cleavage sites on the two strands, however, would be 2x + 2 base pairs 
apart (x = triple helix binding site size). Difficulties in denaturation at the 
cleavage sights might be encountered. 
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Fig. 4. 17. Strategy for the cleavage of double helical DNA via an 
alkylation/strand scission mechanism. Two oligonucleotides bind to separate 
sites on each of the two duplex strands, targeting guanines on the purine 
strand two base pairs to the 5' end of the triplex site. Recognition of 5'-
pyrimidine-N-C-N-N-G-N-purine-3' sites places the sites of cleavage within a 
few base pairs of each other. Since cleavage is limited to a single nucleotide 
position, a properly designed overhang might be clonable to a complementary 
overhang produced by enzymatic cleavage of DNA. 
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A sequence of the type 5'-pyrimidine-N-G-(N)n-C-N-purine-3' places the 
cleavage sites on each of the two strands a few bases apart (Fig. 4.17). The 
designed sequence must contain a guanine two base pairs to the 5' side of each 
triplex binding site, the position most efficiently alkylated by the bound N-
bromoacetyloligonucleotide 5. Incorporation of a single guanine 5' to the 
binding site insures that specific cleavage at a single nucleotide position on 
each strand occurs. 
Model building indicates that juxtaposition of the two binding sites 
results in the formation of a four-stranded structure at the junction of the 
binding sites (Fig. 4.19). To avoid electrostatic repulsions which may make 
such a structure difficult to form, the binding sites are separated by a half turn 
of the DNA helix (six base pairs). 
Because cleavage is limited to a single nucleotide position, the resulting 
ends might be compatible with and clonable to those produced by cleavage of 
DNA with a restriction endonuclease. Due to the nature of the triplex 
binding sites, the endonuclease must produce 3' overhangs. The base pairs 
between the two oligonucleotide binding sites were chosen such that ends 
produced after alkylation/cleavage by N-bromoacetyloligonucleotide 5 are 
complementary to DNA cut with the restriction endonuclease Sfi 1. 
The plasmid pUCLEU2C was constructed based on the above considerations 
by ligation of oligonucleotides containing the sequence 
5'-TTTTCTTTCCTTTTCTTTT ACT AGTAAAAGAAAAGGAAAGAAAA-3' 
into the pUCLEU2 plasmid (Fig. 4.18).26,31 This sequence contains binding 
sites (underlined) on each strand for the N-bromoacetyloligonucleotide 5 (5'-
T4(Me5C)T4(Me5ChT3(Me5C)T4-3'), previously shown to efficiently modify 
plasmid pUCALK. Incorporation of a single guanine 5' to the target site 




Fig. 4.18. Construction of the plasmid pUCLEU2C from pUCLEU2 via ligation 
of the oligonucleotides indicated into the Xho I site. Binding sites for the N-
bromoacetyloligonucleotide 5 are boxed, and the targeted guanine bases are 
indicated by the arrows. Restriction endonuclease sites used for the isolation 
of desired restriction fragments are indicated. 
the targeted guanine by the N-bromoacetyloligonucleotide, base treatment, 
loss of the guanine base, and strand scission, the resulting overhang (S'-CTA-
3') is compatible with the ends generated by cleavage with Sfi I, which 
produces 5'-CTA-3' and 5'-TAG-3' overhangs. The presence of 6 base pairs 
between the oligonucleotide binding sites insures that electrostatic 
interactions do not prevent simultaneous binding of oligonucleotides to both 
DNA binding sites. For ease of analysis and oligonucleotide synthesis, a 
sequence containing identical binding sites on each strand of the duplex was 
designed for this study; however, using two different N-
bromoacetyloligonucleotides, cleavage at different binding sites could be 
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accomplished. The use of the plasmid pUCLEU2 as a vector, which contains a 
gene needed by the LEU2 deficient yeast strain SEY6210,80 allows the 
introduction of the triplex target site into chromosome III of the yeast 
genome. Analysis of plasmid DNA cleavage products using high resolution 
polyacrylamide gel electrophoresis and of chromosomal DNA using pulsed 
field gel electrophoresis allows the study of the cleavage specificity afforded by 
N-bromoacetyloligonucleotides from the single base to the megabase pair 
level. 
Nucleotide resolution of cleavage specificity. To determine the efficiency 
and specificity of modification of double helical DNA afforded by 
N-bromoacetyloligonucleotide 5 at the targeted guanine bases, a 0.9 kilobase 
pair Nar I/EcoR I restriction fragment containing the triple helix site was 
labeled approximately 210 base pairs from the target. DNA 32P-Iabeled at the 
Nar I site on either strand (3' or 5' end-labeled) was incubated with 
N-bromoacetyloligonucleotide 5 under conditions previously shown to result 
in high yields of modification (0.8 mM Co(NH3)+3, 10 mM Hepes pH 7.4). 
Modification occurs solely at the guanine nucleotide located two bases to the 
5' side of each oligonucleotide binding site (Fig. 4.19). The yield of alkylation 
is >96% on each strand. The higher yield (as compared to that previously 
reported on plasmid pUCALK)61 is most probably a result of improvements 
in the purification (i. e. implementation of anion exchange HPLC as a means 
of purification) of the derivatized N-bromoacetyloligonucleotide 5. 
The rate constants for reaction of N-bromoacetyloligonucleotide 5 with 
each of the two strands were determined using phosphorimaging as 
previously described. Half lives for reaction of the N-
bromoacetyloligonuc1eotide 5 with the 3' and 5' end-labeled strands are 5.5 
and 6.5 hours respectively. These values are averages from three separate 
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Figure 4.19. Left: Autoradiogram of a high-resolution 6% denaturing 
polyacrylamide gel of cleavage products from reaction of N-
bromoacetyloligonucleotide 5 with a 32p 3'- and S'-end-labeled 0.9 kbp 
restriction fragment (Nar II Ssp I) from plasmid pUCLEU2C. Reaction 
conditions were 1 J.lM concentration of oligonucleotide 5, 20 mM Hepes, pH 
7.4,0.8 mM Co(NH3)+3, and 10,000 cpm end-labeled DNA in a total volume of 
15 J.ll. Reactions were incubated at 37 °C for 36 hours, precipitated with 
NaOAc/EtOH, washed with 70% EtOH, and treated with 0.1 M piperidine (90 
DC, 30 min.). After lyophilization, cleavage products were analyzed on a 6% 
1:20 cross-linked, 48% urea polyacrylamide gel, 0.4 mm thick. Lanes 1-4 are 5'-
end-labeled DNA. Lanes 5-8 contain 3' end-labeled DNA. Lanes 1 and 8 are 
A-specific chemical sequencing reactions for the 5' and 3' end-labeled 
fragments . Lanes 2 and 7 are G-specific chemical sequencing reactions for the 
5' and 3' end-labeled fragments. Lanes 3 and 6 contain DNA incubated for 36 
hours in the absence of S'-N -bromoacetyloligonucleotide 5, followed by 
piperidine treatment. Lanes 4 and 5 contain DNA incubated for 36 hours 
with S'-N-bromoacetyloligonucleotide 5, followed by piperidine treatment. 
Right: Sequence of the oligonucleotide-DNA triplex within plasmid 
pUCLEU2C. The major sites of modification are indicated. 
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determinations. It is not clear why the two rates differ, since the 19 base pair 
binding sites, as well as the four base pairs flanking each side of each binding 
site, are identical on the two strands. It is possible that small differences in 
salt concentration or purity of the DNA isolated from the different labelling 
reactions, or differences in the extended DNA conformations of the two 
strands, lead to the observed differences in alkylation rate. The rates on each 
strand are not considerably different from the rate reported for reaction of the 
N-bromoacetyloligonucleotide 5 with the plasmid pUCALK (half life = 6.2 
hours) .61 The bases 5' to the purine site in the plasmid pUCALK are 5'-GGG-
3'; the corresponding bases in the plasmid pUCLEU2C are 5'-TGA-3'. This 
suggests that the base pairs flanking the targeted guanine have little effect on 
the efficiency or rate of the reaction. Model building studies indicate that no 
combinations of flanking base pairs present significant steric barriers to 
reaction, although it is difficult to predict the effect of such changes on DNA 
conformation. 
Double Strand DNA Cleavage. To determine if N-
bromoacetyloligonucleotides can be used to effect efficient double strand 
cleavage of DNA, the plasmid pUCLEU2C was Hind III linearized and 32p 3' 
end-labeled. Modification and cleavage at the triple helix target site is 
expected to result in the production of bands 3.3 and 3.4 kilobase pairs in size. 
Standard treatment with piperidine at elevated temperatures (1 % 
aqueous piperidine, 90 °C, 30 min.) results in denaturation of the duplex. 
Attempts to anneal the two strands together in a series of buffers after 
piperidine treatment and lyophilization were unsuccessful. 
Incubation of 32p end-labeled Hind III linearized pUCLEU2C DNA with 




Figure 4.20. Left: Diagram of linearized plasmid pUCLEU2C indicating 
location and sequence of triple helical oligonucleotide binding sites. The sites 
of alkylation and subsequent DNA cleavage are indicated. 
Right: Autoradiogram of a 1.0 % agarose gel of cleavage products from the 
reaction of oligonucleotide 5 with a 32p 3'-doubly end-labeled linearized 
plasmid pUCLEU2C (6.7 kbp in length). Reaction conditions were 1 ).I.M 
concentration of oligonucleotide 5,20 mM Hepes, pH 7.4, 0.8 mM Co(NH3)+3, 
and 10,000 cpm end-labeled DNA in a total volume of 15).1.1. Reactions were 
incubated at 37°C for 36 hours, precipitated with NaOAc/EtOH, washed with 
70% EtOH, and treated with 0.1 % aqueous piperidine in 100 mM NaCl, 10 mM 
EDTA, 10 mM Tris pH 8.0 (55 °C, > 12 hrs.). Cleavage products were analyzed 
on a 1 % agarose gel. Lane 1: DNA size markers obtained by digestion with 
restriction endonucleases. Sizes are indicated to left of band. Lane 2: DNA 
incubated in the absence of oligonucleotide 5, precipitated, and piperidine 
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guanine bases. After precipitation from the alkylation reaction, incubation of 
the DNA in 0.1 % piperidine at 55°C for 12 hrs. in a buffer containing 10 mM 
EDTA, 10 mM Tris pH 8.0 and 100 mM NaCl results in the production of a 
single double strand break in high yield with no detectable cleavage at non-
modified sights or denaturation of the duplex. The high yields observed 
indicate that these work-up conditions are sufficient to result in quantitative 
or near quantitative strand scission at modified sites. 
Phosphorimaging of the agarose gel separated products indicates that 
double strand cleavage efficiencies of greater than 85% were achieved after 36 
hours, suggesting single strand cleavage efficiencies of >92% on each strand. 
Double strand alkylation and cleavage by N-bromoacetyloligonucleotide 
5 was studied at both 37°C and 50 0c. Although the reaction rate is 
substantially increased at 50°C, a large increase in background degradation 
results. Apparently, at these elevated temperatures, the DNA is susceptible to 
modification by adventitious metals or other trace contaminants. Any 
depurination or other modification is converted to a cleavage site upon 
piperidine treatment. The optimal temperature for DNA alkylation/cleavage, 
representing a compromise between the rates of the specific vs. non-specific 
reactions, is approximately physiological temperature, 37°C. 
Cloning of N-bromoacetyloligonucleotide cleavage products. Cleavage 
of pUCLEU2C DNA with the N-bromoacetyloligonucleotide produces ends 
with the 3' overhanging sequence 5'-CTA-3'. The alkylation/piperidine 
treatment mechanism of DNA cleavage is expected to result in the 
production of 3' and recessed 5' phosphate ends. Ligation of standard 
restriction enzyme digested DNA products involves reaction of a 5' 
phosphate end with a 3' hydroxyl group. Digestion of the plasmid pUCSfiI 
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Figure 4.21. Cleavage of plasmid pUCSfiI with Sfi I and EcoR I produces as the 
longer piece of DNA a fragment containing a 5' overhang on one end (5'-
AATT) and a 3' overhang on the other (3'-TAG). Incubation of plasmid 
pUCLEU2C with N-bromoacetyloligonucleotide 3, followed by strand scission 
effected by piperidine treatment results in double strand cleavage. Cleavage 
with the restriction endonuclease EcoR I produces two fragments containing 
5'-AATT and 3'-ATC overhangs. Both of these products are ligatable with the 
larger of the two fragments isolated after Sfi II EcoR I digestion of pUCSfiI. 
After circularization and transformation of bacterial cells with the new 
plasmid, DNA was isolated and sequenced to verify the production of 
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with SfiI produces the 3' overhanging sequence, 5'-TAG-3', which is 
complementary to the end of the oligonucleotide digested product (Fig. 4.21). 
Because the 3' end of the SfiI product contains a free hydroxyl group, it 
could be ligated to the expected 5' phosphate end of the N-
bromoacetyloligonucleotide digested DNA. It is unlikely that the 3' 
phosphate end of the oligonucleotide digested product is ligatable to the 5' 
phosphate of the restriction enzyme cut DNA; however, the remaining single 
strand nick could readily be repaired in vivo following transformation. 
The two cleavage products obtained by digestion of pUCLEU2C with 
EcoR I and N-bromoacetyloligonucleotide 5 were each ligated into the Sfi 
I/EcoR I fragment of pUCSfiI using T4 DNA ligase by Scott Strobel. The 
colonies were screened by a-complementation and five plasmids for each of 
the two fragments were sequenced. All products were consistent with 
cleavage by N-bromoacetyloligonucleotide 5 at the targeted positions, loss of 
the guanine base, and simple ligation of the resulting fragments into the 
SfiI/EcoR I sites of pUCSfiI. Thus, this synthetic cleaving agent results in the 
chemical modification of DNA in a manner which produces end products 
that can be readily ligated to restriction enzyme digested DNA. 
Alkylation/Cleavage of agarose embedded DNA by N-
bromoacetyloligonucleotides. To determine the effect of base specific 
modification on the specificity of oligonucleotide-directed triple helical 
cleavage, it is desirable to study the modification and subsequent cleavage at a 
triple helix site within a large piece of DNA (the 340 kilobase pair yeast 
chromosome III). To avoid degradation due to shearing, large DNA is 
routinely manipulated by embedding it within agarose plugs, followed by 
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diffusion of reagents in and out of the agarose matrix. Oligonucleotides 
equipped with EDTAFe(II) are capable of binding to and cleaving agarose 
embedded DNA .26.32 To determine whether alkylation by N-
bromoacetyloligonucleotides is compatible with such manipulations, Hind III 
linearized plasmid pUCLEU2C was embedded in 1% low-melting agarose. 
Incubation of the plug in 0.8 mM Co(NH3)6+3, 10 mM Hepes pH 7.0, diffusion 
of the N-bromoacetyloligonuc1eotide 5 into the plug, incubation at 37°C and 
piperidine treatment (0.1 % piperidine in 100 mM NaCl, 10 mM EDTA, 10 mM 
Tris pH 8.0, 55 ec, 12 hours) results in double strand cleavage of the DNA at 
the triple helix site with slightly lower yields than those observed in solution. 
This slight loss in yield could be due to reaction between the bromoacetyl 
moiety and the agarose saccharides. 
To circumvent this problem, DNA was embedded in agarose which had 
been pre-treated by incubation in 2-bromoacetamide. It was hoped that such 
incubation would "cap" nucleophilic sites capable of reaction with the N-
bromo acetyl moiety. Agarose solidified in molds to afford a high 
surface:volume ratio was incubated in a buffer solution containing 10 mM 2-
bromoacetamide at 37°C for 36 hours, then extensively washed in buffer. The 
agarose was melted and used to cast plugs containing either plasmid DNA or 
yeast chromosomal DNA. While agarose treated in this manner retains its 
gelling characteristics and DNA can easily be embedded within it, its melting 
temperature and resistance to shearing are reduced. The resulting plugs are 
susceptible to mechanical destruction during the several pipetting steps 
required to equilibrate the plug in buffer. Incubation of the plug at 55°C in 
0.1% piperidine (100 mM NaCl, 10 mM EDTA, 10 mM Tris pH 8.0) results in 
partial melting and destruction of the plug. These observations indicate that 
182 
reaction between bromoacetamide and agarose results in a loss of gel strength. 
Such reaction may be responsible for the decreased efficiency of DNA 
modification by N-bromoacetyloligonucleotides observed on DNA embedded 
in agarose plugs. 
Site specific cleavage of yeast chromosomal DNA using N-
bromoacetyloligonucleotides. Oligonucleotides equipped with the DNA 
cleaving moiety EDTAFe(II) are capable of binding to and cleaving DNA at a 
single engineered triple helix site within a yeast chromosome.26 These 
molecules, however, are both inefficient (maximum cleavage yield observed 
was 6%) and, unless conditions are carefully chosen, result in double strand 
cleavage at partially homologous secondary sites.26 Coupling of a base specific 
cleaving moiety with the >15 base pair specificity attainable using the triple 
helix motif may result in the construction of molecules which, although 
bound at secondary sites, effect DNA modification and cleavage at a single 
site. In this study, additional specificity is obtained due to the requirement 
that potential triple helix sites (i. e . polyp urine runs) be present on both 
strands of the DNA within a reasonable number «20) of base pairs for double 
strand modification and cleavage to be observed. 
A yeast strain containing the target site found in pUCLEU2C was 
constructed using homologous recombination between the pUCLEU2C 
plasmid and Saccharomyces cerevisiae yeast strain SEY6210. The strain is 
leu2-, inhibiting growth on leucine deficient media. 80 The plasmid 
pUCLEU2C contains the desired target site adjacent to the LE U2 gene. 
Incorporation of this fragment with the LE U2 gene into the yeast genome 
allows selection on leucine deficient media. Transformed yeast strains were 
selected, and the presence of the target site was verified by PCR amplification 
of segments of the third chromosome, followed by restriction enzyme 
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digestion and sequencing.26,31 Pulsed field gel electrophoresis of the yeast 
genome to separate the chromosomes, followed by southern blotting with 
probes specific for the LEU2 gene, verified that the LEU2 gene and the triplex 
sites were incorporated exclusively into chromosome III of the Saccharomyces 
cerevisiae genome. 
DNA from a transformed strain was isolated and embedded in agarose to 
protect against mechanical shearing during DNA manipulations. After 
equilibration with Co(NH3)6+3 (1 mM) and buffer (Hepes, pH 7.4, 10 mM 
EDTA) (triplex/alkylation buffer), the plug was incubated with N-
bromoacetyloligonuc1eotide 5 at 37°C for 24 hours. The unreacted N-
bromoacetyloligonucleotide was successively diluted from the duplex in a 
series of washes using low salt, high pH (10 mM Tris, pH 9.5, 10 mM EDTA) 
buffer, the plugs were reequilibrated in triplex/alkylation buffer, and a second 
aliquot of N-bromoacetyloligonucleotide 5 was added. After this second 
incubation, plugs were washed and incubated with piperidine (0.1 % aqueous 
piperidine, 100 mM NaCl, 10 mM EDTA, 10 mM Tris, pH 8.0, 55°C, 12 hours) 
to effect strand scission. Pulsed field gel electrophoresis results in complete 
resolution of the smallest four chromosomes, with partial separation of the 
larger chromosomes (Fig. 4.22). 
Incubation of yeast chromosomes with N-bromoacetyloligonucleotide 5 
produces the expected 110 kbp product (Fig. 4.22). The larger of the expected 
products (230 ,kbp in size) co-migrates with chromosome I and is not 
visualized by ethidium staining. The smaller of the products can be faintly 
observed as a fast running band on the gel at the position indicated. Size 
determination is based on the migration of 39 kbp size ladders. Ethidium 
staining indicates that the chromosomes are intact and that no unexpected 
new bands are produced. These results indicate that: (i) the piperidine 
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Figure 4.22: Cleavage of yeast chromosome III by N -
bromoacetyloligonucleotide 5. Agarose plugs containing DNA from yeast 
strains SEY6210 (no triplex site) and SEY6210C (triplex site present) were 
equilibrated in 1.0 mM Co(NH3)+3 , 20 mM Hepes pH 7.4,10 mM EDTA, and 2 
11M N-bromoacetyloligonucleotide 5. After 24 hours, the plugs were washed 
with a Tris pH 9.5 (10 mM), EDTA (10 mM) solution three times (10 min. each 
wash). Plugs were re-equilibrated with 1.0 mM Co(NH3)+3, 20 mM Hepes pH 
7.4, 10 mM EDTA, and 2 11M N-bromoacetyloligonucleotide 5. After a second 
24 hour incubation (37°C), the plugs were washed in 0.1 % piperidine, 100 
mM NaCl, 10 mM EDTA, 10 mM Tris pH 8.0, (3 washes 10 min. each) and 
incubated in 900 III of this solution for 12 hours at 55 °C. The plugs were 
equilibrated with 0.5x TBE buffer, and loaded into a 1.0% agarose gel for 
pulsed field gel electrophoresis. The gel was run for 24 hours at 200 V. Pulsed 
times were ramped from 10 - 60 seconds for the first 18 hours, and from 60 - 90 
sec. over the last 6 hours. 
Left. Diagram of yeast chromosome III indicating location and sequence of 
triple helical oligonucleotide binding sites and site of binding of HIS 4 probe 
used for cleavage analysis by hybridization. The binding site sequence and 
sites of alkylation and subsequent DNA cleavage are indicated. 
A. Ethidium Bromide stained pulsed field agarose gel. Chromosomes IX, III, 
II and I are clearly resolved and indicated. Resolution of the remaining 
chromosomes is incomplete. Lane 1: DNA from yeast strain SEY6210 lacking 
triple helical target site incubated with N-bromoacetyloligonucleotide 5 and 
piperidine treated. Lane 2: DNA from yeast strain SEY6210C incubated and 
piperidine treated in the absence of N-bromoacetyloligonucleotide 5. Lane 3: 
DN A from yeast strain SEY6210C incubated with N -
bromoacetyloligonucleotide 5 and piperidine treated. 
B. Autoradiogram of a DNA blot hybridization experiment of gel in A with a 
250 bp HIS 4 fragment radio-labeled with 32p by random-probe 
hybridization.77 Locations of the intact chromosome III (340 kbp) and the 110 
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incubation is gentle enough to be used on chromosomal DNA without 
general destruction of the DNA and (ii) non-specific modification of DNA by 
the N-bromoacetyloligonucleotide 5 occurs infrequently, resulting in no 
chromosomal degradation. It is interesting to note that non-specific binding 
by oligonucleotides is greatly disfavored, due to charge repulsion between the 
oligonucleotide and the target DNA. The ratio of specific to non-specific 
DNA modification by derivatized oligonucleotides is most likely very high. 
Most DNA binding molecules and proteins are positively charged, increasing 
their non-specific as well as specific binding affinities for DNA. Cleavage of 
large DNA using molecules of net positive charge might result in a large 
amount of random cleavage and degradation, unless the specificity of the 
cleaving moiety is very high.35 
To accurately determine the cleavage effiCiency of chromosomal 
cleavage, as well as to determine if low efficiency cleavage is occurring at 
secondary sites on chromosome III, the DNA was transferred to a membrane 
and hybridized with a marker specific for HIS 4, a gene found on the short 
arm of yeast chromosome III (Fig. 4.22). The cleavage efficiency, as 
determined by blot hybridization with a HIS 4 probe and analysis of the data 
by phosphorimaging, is 90%. Furthermore, no cleavage at secondary sites is 
observed (~ - 2%), indicating that double strand modification occurs at a 
single site within the 340 kbp of chromosome III. 
Effect of oligonucleotide cycling, pH, and concentration. The effect of 
cycling of the oligonucleotide was studied by incubation of yeast DNA with 
one, two or three separate aliquots of oligonucleotide 5 (Fig. 4.23, A). In each 
of the reactions, yeast DNA was incubated for a total of - 72 hours with N-
bromoacetyloligonucleotide 5. DNA in lane 1 was incubated with a single 
aliquot of N-bromoacetyloligonucleotide 5, DNA in lane 2 was incubated with 
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Figure 4.23: Cleavage of yeast chromosome III assayed by pulsed field agarose 
gel electrophoresis and 32p-HIS 4 probe hybridization. Unless indicated 
otherwise, all reactions were conducted as follows: agarose plugs containing 
DNA from yeast strains SEY6210 and SEY6210C were equilibrated in 1.0 mM 
Co(NH3)6+3 , 20 mM Hepes pH 7.4, 10 mM EDTA (alkylation/triplex buffer), 
and N-bromoacetyloligonuc1eotide 5 was added to a final concentration of 2 
11M. After 24 hours, the plugs were washed with Tris pH 9.5 (10 mM) and 
EDTA (10 mM) three times (10 min. each wash). The plugs were re-
equilibrated with 1.0 mM Co(NH3)6+3, 20 mM Hepes pH 7.4, 10 mM EDTA, 
and N-bromoacetyloligonuc1eotide 5 was added to a final concentration of 2 
11M. After a second 24 hour incubation, the plugs were washed in 0.1% 
piperidine, 100 mM NaCl, 10 mM EDTA, 10mM Tris pH 8.0, (3 washes, 10 
min. each) and incubated for 12 hours at 55°C in 900 III of the piperidine 
solution. The plugs were chilled, washed twice with 0.5x TBE buffer, and 
loaded into a 1.0% agarose gel for pulsed field gel electrophoresis. The gel was 
run for 24 hours at 200V. Pulsed times were ramped from 10 - 60 seconds for 
the first 18 hours, and from 60 - 90 sec. over the last 6 hours. The DNA was 
transferred to a membrane, and hybridized with a 250 bp HIS4 probe specific 
for the short arm of chromosome III and 32P-radio-labeled by random 
priming. 
A. Cleavage of yeast chromosomal DNA as a function of number of 
equilibrations with N-bromoacetyloligonucleotide 5. Autoradiogram of a 
DNA blotting experiment with a random primer 32p radio-labeled HIS 4 
probe specific for the short arm of chromosome III after pulsed field agarose 
gel electrophoresis. Lane 1: Yeast chromosomal DNA incubated for 24 hours 
in the absence of N-bromoacetyloligonuc1eotide 5 in alkylation/triplex buffer, 
washed in high pH, low salt buffer, equilibrated for 20 hours in the absence of 
N-bromoacetyloligonuc1eotide 5 in alkylation/triplex buffer, washed a second 
time, equilibrated for 20 hours in the absence of N-
bromoacetyloligonucleotide 5 in alkylation/ triplex buffer, washed and treated 
with piperidine as stated above. Lane 2: Yeast chromosomal DNA incubated 
with N-bromoacetyloligonucleotide 5 for 72 hours, followed by piperidine 
treatment. Lane 3: Yeast chromosomal DNA incubated with N-
bromoacetyloligonuc1eotide 5 for 44 hours, washed in high pH low salt buffer, 
incubated with N-bromoacetyloligonucleotide 5 for 24 hours, and piperidine 
treated. Lane 4: Yeast chromosomal DNA incubated for 24 hours with N-
bromoacetyloligonuc1eotide 5, washed in high pH low salt buffer, equilibrated 
for 20 hours with N-bromoacetyloligonuc1eotide 5, washed again, equilibrated 
for 20 hours with N-bromoacetyloligonucleotide 5, washed and treated with 
piperidine as stated above. 
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B. Cleavage of yeast chromosomal DNA as a function of pH, EDTA, and N-
bromoacetyloligonudeotide concentration. Autoradiogram of a DNA 
blotting experiment with a random primer 32p radio-labeled HIS 4 probe after 
pulsed field gel electrophoresis. Yeast chromosomal DNA incubated for 24 
hours with N-bromoacetyloligonuc1eotide 5 (2 IlM) in alkylation/triplex 
buffer, washed in high pH, low salt buffer, equilibrated for 20 hours with N-
bromoacetyloligonuc1eotide 5, and piperidine treated as stated above. Lane 1: 
Yeast chromosomal DNA incubated with N-bromoacetyloligonuc1eotide 5 at 
pH 7.0. Lane 2: Yeast chromosomal DNA incubated with N-
bromoacetyloligonuc1eotide 5 at pH 7.4. Lane 3: Yeast chromosomal DNA 
incubated with N-bromoacetyloligonuc1eotide 5 at pH 7.8. Lane 4: Yeast 
chromosomal DNA incubated with N-bromoacetyloligonuc1eotide 5 at pH 
8.2. Lane 5: Yeast chromosomal DNA incubated with N-
bromoacetyloligonuc1eotide 5 at pH 7.4, in the presence of 1 mM EDTA. Lane 
6: Yeast chromosomal DNA incubated in the absence of N-
bromoacetyloligonuc1eotide 5. Lane 7: Yeast chromosomal DNA incubated 
with 0.1 IlM N-bromoacetyloligonuc1eotide 5. Lane 8: Yeast chromosomal 
DNA incubated with 0.2 IlM N-bromoacetyloligonuc1eotide 5. Lane 9: Yeast 
chromosomal DNA incubated with 0.5 IlM N-bromoacetyloligonuc1eotide 5. 
Lane 10: Yeast chromosomal DNA incubated with 1 IlM N-
bromoacetyloligonuc1eotide 5. Lane 11: Yeast chromosomal DNA incubated 
with 2 IlM N-bromoacetyloligonuc1eotide 5 . 
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two separate aliquots of N-bromoacetyloligonucleotide 5, and DNA in lane 3 
was incubated with three separate aliquots of N-bromoacetyloligonucleotide 
5. 
The cleavage efficiencies for lanes 1-3 are 83, 80 and 83%, indicating that 
disruption of the triplex followed by incubation with fresh oligonucleotide 
results in no detectable increase in cleavage efficiency, and that efficient 
cleavage can be realized using a single lengthy incubation. 
The effect of pH, EDTA, and oligonucleotide concentration on the 
efficiency of chromosomal cleavage by N-bromoacetyloligonucleotides was 
studied (Fig. 4.23, B). Cleavage at pH 7.0 and 7.4 remained high, in agreement 
with studies on plasmid DNA. No cleavage was observed at pH ~ 7.8 (B, lanes 
3 and 4), in accordance with the known pH dependence of pyrimidine 
oligonucleotide-directed triple helix formation. IS, 19,26,27 The presence of 
EDTA in yeast cleavage reactions prevents the degradation of the DNA by 
trace nucleases or metals. The concentration of EDTA has no effect on 
alkylation/ cleavage efficiency (B, lane 5). 
Oligonucleotide concentration markedly effects cleavage efficiency. 
Although efficient cleavage of plasmid DNA in solution is observed at very 
low (16 nM) N-bromoacetyloligonucleotide concentrations, the cleavage of 
large DNA in agarose requires micromolar N-bromoacetyloligonucleotide 
concentrations (B, lanes 6-11). 
Statistically and empirically expected specificity of N-
bromoacetyloligonucleotides. Statistically, a 19 base pair purine site flanked 
by a guanine base two base pairs to the 5' side of the binding site is expected to 
occur once every 2.1 million base pairs (219 x 4). Statistically, two such sites 
occur within 20 base pairs of each other once in 1 x 1011 base pairs ([2 x 106]2 x 
0.05). Previous data indicate that a pyrimidine oligonucleotide of similar 
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composition equipped with EDTAePe(II) binds to and cleaves the target DNA 
at a limited number (4) of secondary sites within the 340 kilobase pairs of 
chromosome III under conditions similar to those used in the present study.26 
Assuming that this represents a random distribution of partially homologous 
pyrimidine oligonucleotide binding sites within genomic DNA, this suggests 
that N -bromoacetyloligonucleotides may bind approximately once every 
100,000 base pairs of DNA. DNA modification is expected to occur at a subset 
of these sites (statistically lout of every four), due to the requirement for an 
appropriately positioned guanine base, making the specificity of single strand 
modification one site per 4 x 105 base pairs. Two such binding sites within 20 
base pairs of each other are statistically expected to occur once every 8 x 109 
base pairs ([4 x 105]2 / 20). 
The empirically observed specificity of pyrimidine oligonucleotides is 
considerably less than what is statistically expected. This may be due to the 
known overrepresentation of polypurine sequences in eukaryotic DNA.33,34 
The specificity of double strand cleavage by N-bromoacetyloligonucleotides 
arises in great measure from the requirement for two oligonucleotide binding 
sites on separate DNA strands. The specificity expected for this motif based on 
the observations of oligonucleotide-EDTAePe(II) specificity made by Strobel26 
is still sufficient to allow for single site cleavage within DNA roughly the size 
of 2 human genomes. No double strand secondary cleavage sites (> 3% 
cleavage efficiency) are detected within the 340 kbp of chromosome III, 
indicating that within the limits of this experiment, the coupling of cleavage 
and binding specificities results in reagents capable of site specific cleavage 
within megabase size DNA. 
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Conclusion . 
Two strategies for the double strand modification and cleavage of double 
helical DNA are presented. Cross-over N-bromoacetyloligonucleotides 
containing two 5' ends recognize and modify both strands of the double helix, 
but double helical cleavage yields are low. Incorporation of triple helix sites 
on both strands allows DNA modification by two N -
bromoacetyloligonucleotides at either 5'-purine-N-G-N-C-N-pyrimidine-3' or 
5'-pyrimidine-N-C-N-G-N-purine-3' sequences. 
Using this motif, N-bromoacetyloligonucleotides have be used to effect 
the base specific, near quantitative modification of double helical DNA in a 
manner which produces ends which are clonable with compatible ends 
produced by conventional restriction enzyme digestion. The specificity of this 
motif is sufficient to produce efficient double strand chemical cleavage at a 
single nucleotide position within a 340 kbp yeast chromosome. 
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Part III 
Determination of the Effective Molarity of a DNA Modification 
Moiety Tethered to a DNA Binding Molecule 
Life is made possible by the presence of natural catalysts which are 
capable of effecting, under mild conditions (37°C, neutral pH), reactions 
which would otherwise simply not occur on any appreciable time scale.81 A 
large body of work indicates that significant rate enhancement can be obtained 
upon incorporation or binding of two reactants within a single molecule or 
. macromolecular complex.82-91 Since this is one mechanism which can be and 
is used by natural systems to accelerate reactions under mild conditions, it is 
not surprising that this phenomenon has been thoroughly studied. This rate 
enhancement is most often reported as an effective molarity, and values as 
high as 1013 M have appeared in the literature.88 This value represents the 
concentration of one of the starting materials required to achieve a rate of 
bimolecular reaction equal to that observed in the intramolecular case. 
Affinity cleaving, a technique developed to elucidate the structural 
principles for DNA recognition,1,3-S,7-13,lS,16,18,21,32,92,93 is indirectly based on 
this concept. This technique relies on the use of chemical synthesis to attach 
an indiscriminate and highly reactive cleaving reagent to a DNA binding 
molecule. In so doing, an inefficient bimolecular reaction is transformed into 
a reaction occurring within a complex containing the double helical target 
DNA, the binding molecule, and the attached reactive moiety (Figure 4.24).1,2 
The covalent tether is designed both to localize the reactive moiety and to 
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Figure 4.24. (top) Reaction of bromoacetamide (E = electrophile) with DNA is 
a bimolecular reaction, which results in cleavage at each guanine in the 
sequence. (bottom) Covalent attachment of the bromoacetamide moiety to an 
oligonucleotide results in reaction solely within the triple helical complex, 
and exclusive modification of a single guanine. Shaded areas in the gel 
indicate bands which were quantitated for the determination of the 
bimolecular and unimolecular rate constants. The sequence indicated is that 
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incorporate the flexibility required to avoid modifying the binding properties 
of the molecule recognizing the DNA.1,2 It is of interest to understand the 
rate acceleration obtained upon formation of the DNA-affinity cleaving 
molecule complex as compared to the rate of the bimolecular solution 
reaction between the DNA and the reactive moiety. This rate enhancement 
might help design function ali ties which can effect DNA 
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Fig. 4.25. Chemical structure and sequence of the modified terminal 
thymidine within N-bromoacetyloligonucleotide 5. 
The N-bromoacetyloligonucleotide 5 contains a bromo acetamide moiety 
attached to the 5' terminal thymidine residue of a 19 base oligonucleotide 
(Figure 4.25),61 which binds double helical DNA at a 19 base pair purine target 
site via triple helix formation (Fig. 4.24). N-Bromoacetyloligonucleotide 5 is 
capable of nearly quantitative modification of an appropriately positioned 
guanine base two base pairs to the 5' side of the purine target site within a 659 
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base pair fragment of duplex DNA.61 To determine the rate enhancement 
obtained upon incorporation of the bromoacetamide functionality within a 
triple helical complex, the bimolecular and unimolecular rate constants for 
reaction of 2-bromoacetamide and N-bromoacetyloligonucleotide 5 with a 
single guanine within a DNA restriction fragment have been determined. 
A 32P-labeled 0.9 kbp restriction fragment (Nar I/EcoR I fragment from 
plasmid pUCLEU2C, labeled at the Nar I site) was incubated with various 
concentrations of 2-bromoacetamide (4-500 mM) in 25 mM NaCl, 20 mM 
Hepes, pH 7.2. Reactions were quenched at appropriate times by addition of 
OMS stop solution and ethanol precipitation.62,63 After piperidine treatment 
(1.0% aqueous piperidine, 90°C, 30 min) and lyophilization, the products 
were separated by gel electrophoresis, and quantitation was accomplished 
using phosphorimaging (Fig. 4.26). 
The reactivity of the targeted guanine was determined by quantitating 
the amount of DNA which corresponds to reaction at the desired guanine 
relative to DNA which had not reacted at that guanine (Figure 4.24). 
Fragments smaller than the desired band are not quantitated, since it is not 
possible to determine if reaction at the designated guanine has occurred. All 
fragments larger than those cleaved at the desired band are considered 
"intact" DNA, as reaction at the targeted base has not occurred. The natural 
log of "intact" DNA/"total" DNA was plotted versus time to determine a 
pseudo-first order rate constant (Figure 4.27). The first order rate constant for 
reaction of this guanine within the N-bromoacetyloligonuc1eotide-DNA 
complex has been determined to be 3.6 x 10-5 sec1, corresponding to a half-life 
of 5.5 hours within the triple helical complex. This value has been measured 
and does not change over a N-bromoacetyloligonucleotide concentration 
range of 50 nM - 2 I..IM. 
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Fig. 4.26. Autoradiogram of a high resolution 6% denaturing polyacrylamide gel 
of cleavage products obtained after incubation of pUCLEU2C 32p 3'-end-labeled 
DNA with various concentration of bromoacetamide as a function of time. 
DNA was dissolved in an aqueous solution of 50 mM NaCl, 40 mM pH 7.4 
Hepes. An equal volume of bromoacetamide (2x solution) was added to the 
appropriate final concentration (in 25 mM NaCl, 20 mM Hepes, pH 7.4), and the 
reactions incubated at 37°C. After the indicated time, the DNA was precipitated 
by addition of ethanol, washed, and treated with piperidine (1 % piperidine, 90°C, 
30 min.). After lyophilization, the DNA was dissolved in formarnide buffer and 
loaded onto a 6% polyacrylamide gel. 
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Figure 4.27: Determination of the bimolecular rate constant for reaction 
of bromoacetamide with double helical DNA. Each line represents a single 
time course at a different bromoacetamide concentration. Best fit lines give 
slopes with the following values: 500 mM bromoacetamide: 0.020; 100 mM 
bromoacetamide: 0.0048; 20 mM bromoacetamide: 0.0010; 4 mM 
bromoacetamide: 0.00028. 
Table 4.1 contains the slopes, bimolecular rate constants, half-lives of the 
targeted guanine base, effective molarity, and nominal rate acceleration 
obtained for each time course. Bimolecular rate .constants are obtained by 
division of the slope by the bromoacetamide concentration used for that time 
course. The determined bimolecular rate constant, the mean of seven 
separate time course experiments, is 1.5 ± 0.4 x 10-5, M-I sec-I. The plots in 
Figure 4.27 represent actual data from four of these sets of reactions derived 
from a single gel. 
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Bromo- slope of bimo!. rate 1/2 life effective M rate 
acetamide plot constant ofBRAA acceleration 
cone. (M-i secI ) 
500 mM 0.0195 1.1 x 10-5 36 hours 3.2M 64 x 106 
100 mM 0.0062 1.7 x 10-5 116 hours 2.0M 40 x 106 
0.0076 2.1 x 10-5 92 hours 1.7M 34 x 106 
20mM 0.0010 1.4 x 10-5 690 hours 2.5 M 50 x 106 
0.0010 1.4 x 10-5 690 hours 2.5 M 50 x 106 
4mM 0.00028 1.9 x 10-5 2500 hours 1.8 M 36 x 106 
0.00015 1.0 x 10-5 4600 hours 3.3M 67x 106 
Table 4.1. Determination of bimolecular rate constant and effective molarity 
of N-bromoacetyloligonucleotides for the modification of double helical 
DNA. Slopes of plots (Fig. 4.27) are used to determine bimolecular rate 
constant, half-life for the targeted guanine base, effective molarity obtained 
upon tethering a bromoacetamide moiety to an triple-helix forming 
oligonucleotide. 
The half-life of the targeted guanine represents the length of time 
required at the particular bromoacetamide concentration for one half of the 
guanines at that position to be alkylated. For comparison, the half-life of the 
targeted guanine within the triple helical complex is 5.5 hours. The effective 
molarity of bromoacetamide for each time course was determined by 
calculating the concentration of bromo acetamide required to obtain equal 
reaction rates in the bimolecular and intracomplex reactions. An effective 
molarity of 2.5 ± 0.5 M is obtained by averaging the values obtained from each 
time course. The reported rate acceleration is the ratio of the rates of reaction 
of the targeted guanine base with 50 nM N-bromoacetyloligonucleotide 5 vs. 
50 nM bromoacetamide. This represents the lowest concentration of N-
bromoacetyloligonucleotide 5 for which a rate of reaction was measured. 
Undoubtedly, the rate of the intra-complex reaction does not change 
drastically until oligonucleotide concentrations below the dissociation 
constant « 16 nM) are reached. Since the determined rate acceleration is 
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dependent on the oligonucleotide concentration used to drive triplex 
formation, the effective molarity is a more accurate measure of the effect of 
tethering the reactive moiety to a DNA binding molecule. 
There has been extensive discussion on the source of the rate 
enhancement observed in intramolecular reactions. 82- 91 A simple 
calculation indicates that the rate enhancement observed in this study can be 
ascribed predominantly to localization of the reactive moiety close to the 
DNA. Assuming the linker arm to be quite flexible, it is possible to calculate 
the space accessible to the electrophilic carbon. This space is a hemisphere 
defined by a radius based on a fully extended all-trans tether (11.2 A)94 and by 
the DNA double helix, which sterically prevents the linker arm from the 
other half of the sphere. The volume of this hemisphere is approximately 5.9 
x 10-21 cm3 . Confining a single molecule within this space results in an 
effective molarity of 0.5 M. The observed effective molarity is five times 
greater. A higher effective molarity is expected, as the entire volume of the 
hemisphere is not energetically equally accessible and the tether was designed 
to access the N-7 of the targeted guanine easily. Thus, the observed rate can be 
largely accounted for by confinement of the reactive moiety close to the DNA 
within the space accessible to the tether. 
Theoretical concentration of tethered bromoacetyl based on volume 
calculation: 
length of linker arm (radius): 




5.8 x 10-24 dm3 
3.4 x 1023 molecules/liter 
=0.5 M 
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The observed value also closely approximates that predicted based on 
entropic arguments proposed by Jencks and others.82,83 These calculations 
indicate an intramolecular reaction to be favored over its bimolecular 
counterpart by approximately 35 e.u. under ideal circumstances. To account 
for loss of rotational entropy in the product, 3.3 and 6.2 entropy units are 
subtracted for each sp3-sp3 and sp3-sp2 bond whose rotation is restricted in the 
product. Using a crude calculation of this type to predict the effective 
molarity expected for N-bromoacetyloligonucleotide-directed alkylation of 
DNA, a calculated value of 5 M is obtained.82,83 
Conclusions 
The bimolecular rate constant for reaction of bromo acetamide with a 
specific guanine base in double helical DNA has been measured and is 
reported to be 1.5 ± 0.4 x 10-5, M-l sec l . Delivery of a reactive moiety to a 
DNA target by covalent attachment with a flexible tether to a DNA binding 
domain therefore results in an effective molarity at the DNA target site of 2-3 
M. The rate of the intra-complex reaction shows no change over the N-
bromoacetyloligonucleotide concentration range of 50 nM to 2 ~M. At a 
concentration of 50 nM, the ratio of the rates of the bimolecular and 
oligonucleotide-directed alkylation reactions is 5 x 107. 
This work has implications for the design of sequence specific DNA 
modification reagents, since it defines the inherent reactivity necessary to 
afford a sequence specific cleaver which is capable of efficient cleavage on a 
desired time scale. 
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Part IV 
Use of N-Bromoacetyloligonucleotides to Measure 
Binding Affinities and Cooperative Interactions 
The high cleavage yield observed using the alkylation/base treatment 
method of modifying and cleaving DNA makes analysis of alkylation 
efficiency an ideal method of studying DNA binding by molecules with weak 
affinities, or in studies where it is desirable to measure small changes in 
binding affinities. N-bromoacetyloligonucleotides have been used to study 
the binding of short oligonucleotides and to quantitate changes in binding 
affinity due to external forces such as cooperative interactions. 
Effect of oligonucleotide length on alkylation/cleavage efficiency. 
Specific double strand cleavage at a single binding site was observed 
when the N-bromoacetyloligonucleotide Alk-19 was used to cleave yeast 
chromosome III (340 kilobase pairs of DNA). N-bromoacetyloligonucleotide 
Alk-19 is identical to N-bromoacetyloligonucleotide 5. Oligonucleotides in 
this section are named Alk-N, where N = length of oligonucleotide for ease of 
discussion. The specificity observed is a function of both the increased 
specificity of the cleaving function used and the requirement for 
oligonucleotide binding sites on opposite strands within a limited distance « 
20 bp) for double strand cleavage to be observed. Double strand cleavage at the 
target site involves recognition of 40 base pairs of DNA (two 19 base pair 
target sequences and two guanine bases). Statistically, two purine sites 
amenable to cleavage by alkylation are expected to occur once every 4 x 1012 
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base pairs. Due to the overrepresentation of polyp urine sequences in 
genomic DNA33,34 and the ability of triple helix forming oligonucleotides to 
bind to sequences of imperfect homology,26,27 it is to be expected that the 
frequency of cleavage will be greater than statistics would indicate. However, 
if this motif is to be used as a tool for genomic mapping and cleaving at sites 
of interest, it will be necessary to recognize and cleave sequences with greater 
frequency. In addition, shorter oligonucleotides are thought to traverse 
biological membranes with greater efficiencies.95 These considerations make 
it desirable to understand the affinities and alkylation efficiencies of short 
oligonucleotides. 
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Fig. 4.28. N-Bromoacetyloligonucleotides synthesized for the study of 
oligonucleotide length on DNA alkylation/cleavage efficiency. N-
Bromoacetyloligonucleotides bind to sites (boxed) on each of the two strands 
of the DNA target helix, alkylating a single guanine (indicated by the arrow) 
on each strand. Upon piperidine treatment, cleavage at the site of alkylation 
is expected. 
Binding affinity as a function of oligonucleotide length. 
Oligonucleotides Alk-19 through Alk-7 were synthesized from T, Me5C, and 
TE (3) phosphoramidites to study the effect of oligonucleotide length on 
alkylation efficiency, and to determine if DNA modification can be 
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Fig. 4.29. Alkylation of plasmid DNA as a function of N-
bromoacetyloligonucleotide length and concentration. Autoradiogram of a 
high-resolution 6% denaturing polyacrylamide gel of cleavage products from 
the reaction of oligonucleotides CT-07 through CT-19 with a 32p 3'-end-
labeled 0.9 kbp restriction fragment (Nar II EeaR 1) from plasmid pUCLEU2C. 
Reaction conditions were N -bromoacetyloligonuc1eotide at stated 
concentration, 20 mM Hepes, pH 7.0, 1.0 mM Co(NH3)+3, 10 mM EDTA, and 
10,000 cpm end-labeled DNA in a total volume of 15 j..tl. Reactions were 
incubated at 37 ec for 36 hours, precipitated with NaOAc/EtOH, washed with 
70% EtOH, and treated with 0.1 M piperidine (90 ec, 30 min.). After 
lyophilization, cleavage products were analyzed on a 6% 1:20 cross-linked, 
48% urea polyacrylamide gel, 0.4 mm thick. Lane 1: untreated DNA. Lane 2: 
piperidine treated DNA. Lane 3: A sequencing reaction. Lane 4: G sequencing 
reaction. Lanes 5-9: DNA incubated with N-bromoacetyloligonuc1eotide Alk-
19 at 2 j..tM (lane 5), 400 nM (lane 6), 80 nM (lane 7), and 16 nM (lane 8). Lanes 
10-13: DNA incubated with N-bromoacetyloligonuc1eotide Alk-14 at 2 j..tM 
(lane 10), 400 nM (lane II), 80 nM (lane 12), and 16 nM (lane 13). Lanes 14-17: 
DNA incubated with N-bromoacetyloligonuc1eotide Alk-12 at 2 j..tM (lane 14), 
400 nM (lane 15), 80 nM (lane 16), and 16 nM (lane 17). Lanes 18-21: DNA 
incubated with N-bromoacetyloligonucleotide Alk-09 at 2 j..tM (lane 18), 400 
nM (lane 19), 80 nM (lane 20), and 16 nM (lane 21) . Lanes 22-25: DNA 
incubated with N-bromoacetyloligonuc1eotide Alk-07 at 2 j..tM (lane 22), 400 
nM (lane 23), 80 nM (lane 24), and 16 nM (lane 25). 
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achieved in high yield with shorter sequence requirements (Fig. 4.28). 
Derivatization of the oligonucleotides was accomplished using N-
hydroxysuccinimidyl bromoacetate. Each was purified by anion exchange 
HPLC, with small changes in the solvent gradient to account for the change in 
charge associated with differences in oligonucleotide length. Separation and 
ease of purification increased inversely with oligonucleotide length: shorter 
oligonucleotides eluted in sharper bands with larger differences in the 
retention times of the amino- and N-bromoacetyl-oligonucleotides. 
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Fig. 4.30. Single strand alkylation/cleavage efficiency by N-
bromoacetyloligonucleotides of various lengths as a function of 
oligonucleotide concentration. Data are obtained by phosphorimaging of gel 
in Figure 4.29. 
Figures 4.29 and 4.30 indicate the efficiencies of alkylation observed by 
oligonucleotides of various lengths as a function of concentration. 
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Approximate dissociation constants for the N-bromoacetyloligonucleotides 








< 10 nM 
<10nM 
-15 nM 
- 400 nM 
» 211M 
There is a sharp decrease in site saturation under the conditions used (37 
°C, neutral pH) with oligonucleotides < 12 nucleotides long. This is 
corroborated by results obtained using OMS footprinting (Chapter 11), which 
indicate that at an oligonucleotide concentration of 211M, detectable binding 
is observed for the 9 base oligonucleotide CT-09 at 0° and 12.5°, but not at 
room temperature. These studies agree that efficient binding at physiological 
temperature and pH requires oligonucleotides ~ 12 nucleotides in length. 
Specificity of N-bromoacetyloligonucleotides . Oligonucleotides Alk-12, 
Alk-14 and Alk-19 modify a single guanine within the 0.9 kilobase pair 
restriction fragment. Oligonucleotide Alk-9 modifies at least 2 guanines: the 
targeted guanine .5' to the 19 base purine site, and at least one of the two 
central guanines within the purine target sequence. This indicates that 
oligonucleotide Alk-9 binds at least two sites within the purine sequence. 
Binding to the second site requires the formation of at least one mismatch 
and occurs with lower affinity, since, at low oligonucleotide concentration, 
cleavage occurs only at the guanine 5' to the target site. No modification of 
any of the adenines within the target sequence is observed, indicating the base 
specificity of the cleavage reaction. 
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Statistical sign ifica nce of cleavage 





bromoacetyloligonucleotides requires the presence of two oligonucleotide 
binding sites on opposite strands with guanines properly positioned for 
attack. The two sites must be located within a reasonable distance ($; 20 base 
pairs) to allow the strands to denature and separate. Statistically, sites 
amenable to cleavage by N-bromoacetyloligonucleotides nine bases long are 
expected to occur once every 2 x 105 base pairs ([0.59 x 0.25]2 x 20). Sites for 
cleavage by two 12 or 14 base oligonucleotides are expected once every 1.3 x 107 
([0.512 x 0.25]2 x 20) and once every 2.2 x 108 ([0.514 x 0.25]2 x 20) base pairs. 
These calculations assume that only purine sites can be bound (i. e. 
mismatches are not tolerated), and that a statistical distribution of purine sites 
exists. Since the triple helix motif can be used to recognize sites which 
contain all four base pairs of DNA,20,96 and since purine sequences are 
overrepresented in genomic DNA,33,34 it is expected that potential cleavage 
sites will occur more frequently than statistically expected. 
To be used as tools for genetic mapping, rare cutting cleaving strategies 
must be able to cut DNA at genetic markers of interest. Markers are usually 
within cosmid size DNA (50,000-250,000 base pairs). These calculations 
indicate that 9-10 base N-bromoacetyloligonucleotides could be used to 
produce cleavage with the frequency required to find and cut sites within this 
size range of DNA. 
Cleavage of DNA using degenerate N-bromoacetyloligonucleotides. 
Techniques for the determination of triple helical target sites in un sequenced 
DNA based on the use of degenerate oligonucleotides have recently been 
developed. 31 Oligonucleotides are synthesized from a mixture of T and C 
nucleoside phosphoramidites. 5-Bromo-2'-deoxyuridine and 5-methyl-2'-
211 
deoxycytidine are often substituted for thymidine and 2'-deoxycytidine to 
increase the binding affinities of the resulting oligonucleotides. The 
synthesis of degenerate oligonucleotides results in the production of 2n 
different sequences, where n is the number of degenerate positions. While 
oligonucleotide binding affinity increases with oligonucleotide length, the 
concentration of the single perfectly matched oligonucleotide for a given 
target site decreases as the degeneracy increases. 
TNNNNNNNNNNNNNNNNTE 1 N = 60% T, 40% Me5C 
TNNNNNNNNNNNNTE N = 60% T, 40% Me5C 
TNNNNNNNNNNTE N = 60% T, 40% Me5C 
TNNNNNNNNNNNNTE N = 60% Br5U, 40% Me 5C 






Fig. 4.31. Oligonucleotides degenerate in T and MeSC or BrSU and MeSC for 
the determination of possible triple helix/alkylation sites within 
un sequenced DNA. The compositions of nucleotidesused to synthesize 
these oligonucleotides are listed. Oligonucleotides bind to target sites on both 
strands (boxed), alkylating a single G on each strand (arrow), effecting double 
strand cleavage. 
Since perfectly matched oligonucleotides < 12 bases in length display low 
binding affinities even at high concentrations, degenerate N-
bromoacetyloligonucleotides :2: 12 bases (12, 14 and 19 bases) in length 
containing la, 12, and 17 degenerate positions were synthesized (Fig. 4.31). 
Each of these oligonucleotides contains a 3' terminal thymidine and a 5' 
212 
terminal amino-thymidine residue. The oligonucleotides were synthesized 
using a 60:40 mixture of T:MeSC or BrSU:MesC to skew the distribution of 
oligonucleotides toward those with higher T content. Oligonucleotides with 
high C content are not expected to form stable pyrimidineepurine-pyrimidine 
triple helical complexes (see Chapters I and II). The synthesis of degenerate 
N-bromoacetyloligonuc1eotide 12-, 14-, and 19mers, degenerate at 10, 12 and 17 
positions results in the production of 1024, 4096, and 131072 different 
sequences. At a total oligonucleotide concentration of 2 JlM, a concomitant 
decrease in the concentration of the perfectly matched oligonucleotide from 2 
to 0.5 to 0.015 nM results. At high oligonucleotide concentrations and low 
pH, the binding of partially mismatched oligonucleotides is expected. 
After synthesis and deprotection, amino-oligonucleotides were purified 
by polyacrylamide gel electrophoresis as a single band of normal size. 
Derivatization of the oligonucleotides with N-hydroxysuccinimidyl 
bromoacetate was accomplished as previously described. Derivatized 
degenerate N-bromoacetyloligonucleotides could not be purified by HPLC, 
because these oligonucleotides eluted from the column in a peak several 
minutes wide. There was no detectable change in the HPLC profile upon 
derivatization. Purification was accomplished by removal of excess N-
hydroxysuccinimidyl bromoacetate using Sephadex chromatography (1 ml G-
25 spin column77) for the T /MeSC degenerate oligonucleotides. It was later 
observed that more efficient removal of salts could be accomplished using 
Sep-pak reverse phase cartridges. Degenerate BrSU /MeSC oligonucleotides 
were purified in this manner. Purification by Sep-pak cartridges was 
accomplished by washing the cartridge with 20 ml of water to effect complete 
removal of salts. 
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Derivatization of amino-oligonucleotides typically results in a high yield 
of bromoacetylation (> 90%) . Derivatization of the degenerate 
oligonucleotides used in this study is expected to result in a similar yield of 
conversion to the N-bromoacetyloligonucleotides. It is possible that the 
binding affinities of the amino-oligonucleotides exceed that of derivatized N-
bromoacetyloligonucleotides, due to the presence of the protonated amine. 
Since the amino-oligonucleotides are not separated from the derivatized 
product, competition for binding sites and a decrease in alkylation efficiency 
might result. 
Binding of degenerate N -bromoacetyloligonucleotides to potential 
oligonucleotide binding sites containing guanines appropriately positioned 
for double strand alkylation and cleavage is expected to result in the 
production, albeit in low yield, of cleavage bands on high resolution 
sequencing (polyacrylamide) gels and coarse resolution double strand 
(agarose) gels. Isolation and sequencing of the bands produced could be used 
to identify triple helix/ alkylation sites within cosmids or genetic markers of 
unknown sequence. 
To determine whether degenerate oligonucleotides can bind, alkylate 
and effect cleavage at a triple helix site, the plasmid pUCALK2C, containing 
the known triple helix/alkylation site previously studied, was incubated with 
degenerate N-bromoacetyloligonucleotides of various lengths. Analysis for 
single stranded modification and cleavage using polyacrylamide sequencing 
gels indicates that degenerate oligonucleotides cleave each strand of the 
duplex with an efficiency of 15 - 20% on each strand (Figs. 4.32 and 4.33). This 
efficiency is observed at an ideal pyrimidine oligonucleotide binding site. 
Binding and cleavage efficiency at less ideal sites 0. e. higher G content, 
presence of mismatches) is expected to be lower. These efficiencies are slightly 
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Figure 4.32. Alkylation by degenerate oligonucleotides. Autoradiogram of a 
high-resolution 6% denaturing polyacrylamide gel of cleavage products from 
the reaction of degenerate oligonucleotide CT-19, CT-14, CT-12, BrSUC-14, and 
BrSUC-12 with a 32p 3'-end-labeled 0.9 kbp restriction fragment (Nar II EeoR 
1) from plasmid pUCLEU2C. Reaction conditions were 2 or 10 11M total 
concentration of N-bromoacetyloligonucleotide, 20 mM Hepes, pH 6.8, 1.0 
mM Co(NH3)+3, and 10,000 cpm end-labeled DNA in a total volume of 15 Ill. 
Reactions were incubated at 37 °C for 36 hours, precipitated with 
NaOAc/EtOH, washed with 70% EtOH, and treated with 0.1 M piperidine (90 
°C, 30 min.). After lyophilization, cleavage products were analyzed on a 6% 
1:20 cross-linked, 48% urea polyacrylamide gel, 0.4 mm thick. Lane 1: A 
sequencing reaction. Lane 2: G sequencing reaction. Lanes 3-7: pUCLEU2C 
DNA incubated with 10 11M degenerate N-bromoacetyloligonucleotide. Lanes 
8-12: pUCLEU2C DNA incubated with 2 11M degenerate N-
bromoacetyloligonucleotide. Lanes 3 and 8: pUCLEU2C DNA incubated with 
degenerate oligonucleotide TC-19. Lanes 4 and 9: pUCLEU2C DNA incubated 
with degenerate oligonucleotide TC-14. Lanes 5 and 10: pUCLEU2C DNA 
incubated with degenerate oligonucleotide TC-12. Lanes 6 and 11: pUCLEU2C 
DNA incubated with degenerate oligonucleotide BrsU /MeSC-14. Lanes 7 and 
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lower than those observed by Strobel using degenerate oligonucleotides to 
block the action of a methylase at a methylase/triple helix site.31 Degenerate 
oligonucleotides afford approximately 25% protection from methylation at a 
similar ideal triple helix site. The T /MeSC were desalted using Sephadex 
columns, the BrsU / MesC oligonucleotides were purified using Sep-pak 
cartridges. The decreased cleavage efficiencies observed with the T /MeSC 
degenerate oligonucleotides at higher concentrations is due to the incomplete 
removal of salts from the oligonucleotide derivatization reaction, as judged 
by the UV spectrum of these oligonucleotides. 
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Fig. 4.33: Cleavage efficiencies observed at known triple helix/alkylation site 
upon incubation of degenerate N-bromoacetyloligonucleotides of various 
lengths and base composition with DNA from pUCLEU2C at total 
oligonucleotide concentrations of 10 IlM and 2 IlM. 
Effect of degenerate oligonucleotide length on cleavage efficiency. 
Degenerate N-bromoacetyloligonucleotides 14 bases in length alkylate DNA 
with greater efficiencies than 12 or 19 base long oligonucleotides. This 
suggests that the increase in binding affinity observed upon formation of 
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more than 14 base triplets does not compensate for the lower oligonucleotide 
concentration due to the increased degeneracy. Decreasing the number of 
base triplets also lowers binding affinity. The four fold increase in individual 
oligonucleotide concentration does not compensate for the loss of two base 
triplets. As was observed with perfectly matched oligonucleotides, 12-14 
bases represents the minimal oligonucleotide length required for binding at 
physiological pH and temperature. These data suggest that the rapid 
screening of unsequenced DNA by degenerate oligonucleotides can most 
efficiently be accomplished using oligonucleotides approximately 14 bases in 
length. 
The expected yield of double strand cleavage is the square of the single 
strand modification efficiency. Degenerate N-bromoacetyloligonucleotides 
are therefore expected to effect double strand cleavage with efficiencies of less 
than 5% (0.2)2. This has been verified using agarose gel analysis of pUCLEU2C 
cleavage and pulse field gel electrophoretic analysis of yeast chromosomal 
cleavage by N-bromoacetyloligonucleotides. 
Specificity of cleavage. Degenerate oligonucleotides can bind in a number 
of ways within the 19 base purine target sequence in plasmid pUCLEU2C. 
Alkylation occurs exclusively at the guanine bases, indicating the base 
specificity of the alkylation reaction. N-Bromoacetyloligonucleotides 19 bases 
in length bind the entire site and cleave only the single targeted guanine. N-
Bromoacetyloligonucleotides 14 and 12 bases in length bind within the target 
site in a manner which allows modification of guanines both internal and 5' 
to the target sequence. This indicates the ability of degenerate 
oligonucleotides to bind to varying sequences, and suggests that cleavage at 
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long purine runs frequently found in eukaryotic DNA33,34,97,98 will occur non-
specifically at guanines located throughout such sequences. 
Use of degenerate N-bromoacetyloligonucIeotides to determine 
triplex/alkylation sites in unsequenced DNA. The use of degenerate N-
bromoacetyloligonucleotides to find and sequence triplex/ alkylation sites in 
unsequenced DNA requires: (i) isolation of the fragments produced by site 
specific double helical cleavage; (ii) digestion of the products to produce blunt-
ended fragments; and (iii) cloning of the fragments into a vector to facilitate 
sequencing. Due to the low yield of double helical cleavage observed with N-
bromoacetyloligonucleotides, these manipulations are expected to be difficult 
to accomplish with the small amount of DNA produced. 
Furthermore, sites recognizable by the bis-alkylation motif are expected 
to arise much less frequently than triplex/restriction enzyme (Achilles heel) 
sites. For instance, efficient binding requires the use of oligonucleotides;::: 12 
bases in length. A 12 base pair purine site overlapping a 6 base pair restriction 
enzyme site is statistically expected to occur once every - 500,000 base pairs (a 
6-base pair restriction enzyme cuts one in 2048 sequences; one out of every 256 
of these sites (29/2) will be flanked by nine consecutive purines on either of 
the two sides). On the other hand, double strand cleavage by 12 base N-
bromoacetyloligonucleotides requires two 12 base pair binding sites within 20 
base pairs of each other, each with an appropriately positioned guanine. Such 
a sequence is statistically expected to occur once every 13.4 x 106 base pairs (a 12 
base purine site occurs once every 212 bases; one out of four of these contains 
an appropriately positioned guanine base, two such sites within 20 base pairs 
of each other occur once every [4 x 212]2 / 20, or 13.4 x 106 base pairs). These 
calculations are based on the requirements for perfect purine runs, and are 
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presented to compare the relative frequency of these types of sites. These 
considerations suggest that double strand cleavage sites for N-
bromoacetyloligonucleotides probably do not occur with a frequency which 
will allow this motif to playa useful role as a rare-cutting strategy to be used 
in genomic mapping. 
Cooperative Binding of N-Bromoacetyloligonuc1eotides to Abutting Sites 
Biological systems often use cooperative interactions to increase the 
sensitivity of DNA binding molecules both to base mismatches and to small 
concentration changes.99-103 Cooperative binding by oligonucleotides to DNA 
may offer several advantages: (i) shorter oligonucleotides may more readily 
penetrate membrane barriers around the cell and the nucleus;95 and (ii) the 
sensitivity of binding affinity to the presence of mismatches may in some 
cases be increased. 
Strobel and Dervan have reported that the binding affinity of a 
oligon ucleotide-EDT A • Fe(II) 9 bases in length increases by a factor of 3.4 in 
the presence of an oligonucleotide which binds an abutting site.25 Binding of 
oligonucleotides to adjacent sites on single stranded RNA has been shown to 
increase the effectiveness of short oligonucleotides as inhibitors of 
transcription.1°4,105 The enhanced binding is likely due to favorable stacking 
interactions and/or induced conformation changes propagated to adjacent 
binding sites.25 Oligonucleotides equipped with dimerization domains 
capable of forming Watson-Crick hydrogen bonds bind cooperatively to 
adjacent triple helix sites with a 15 fold increase in binding affinity.23 
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The cooperative binding of two oligonucleotides to abutting sites was 
studied using alkylation as a measure of site saturation. The high efficiency 
of alkylation allows accurate determination of any increase in binding affinity 
due to cooperative binding of the two oligonucleotides. 
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5'- TTTTCTTTCCTTTTCTTT 
3'- "' AAAGAMGG AAAAG AAA 
CT AGT AAAGAAAAGGAAAGAAA -3' 
GATC . TTTCTTTTCCTTTGTTTTC-5' 






Fig. 4.34. Oligonucleotides used to study cooperative end-to-end interactions 
in oligonucleotide-directed triple helix formation. Oligonucleotide binding 
sites are indicated by the boxes and guanine bases targeted for alkylation are 
indicated by the arrows. Oligonucleotides bind to sites on each of the two 
strands; thus, both single and double strand cleavage can be studied. 
Oligonucleotide Alk-9 binds a 9 base pair site, with a guanine positioned 
for efficient alkylation two base pairs to the 5' side of the binding site. 
Oligonucleotide Coop-l0 binds a 10 base pair site adjacent to the binding site 
for Alk-9 (Fig. 4.34). The efficiency of alkylation of the targeted guanine base 
by oligonucleotide Alk-9 was determined at four different Alk-9 
concentrations in the presence of several concentrations of Coop-l0 (Fig. 4.35). 
The binding affinity of the 19 base long oligonucleotide Alk-19 was also 
determined, to allow comparison of the effects of non-covalent (cooperative) 
vs. covalent linking of the oligonucleotides. 
Alk-9 alkylates guanines both 5' and internal to the 18 base purine site 
sequence, indicating that the oligonucleotide binds in at least two different 
locations. Addition of Coop-l0 inhibits binding at the secondary site, due to 
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Fig. 4.35. Cooperative Binding of Oligonucleotides Alk-9 and Coop-l0 as 
assayed by extent of alkylation. Autoradiogram of a high-resolution 6% 
denaturing polyacrylamide gel of cleavage products from the reaction of N-
bromoacetyloligonucleotide Alk-19 or N-bromoacetyloligonucleotide Alk-9 
with a 32p 3'-end-labeled 0.9 kbp restriction fragment (Nar II EcoR I) from 
plasmid pUCLEU2C. Reaction conditions were N -
bromoacetyloligonucleotide Alk-19, N -bromoacetyloligonucleotide Alk-9, 
and/or oligonucleotide Coop-l0 at stated concentrations, 20 mM Hepes, pH 
7.0, 1.0 mM Co(NH3)+3, and 10,000 cpm end-labeled DNA in a total volume of 
15 Ill. Reactions were incubated at 37 ec for 36 hours, precipitated with 
NaOAc/EtOH, washed with 70% EtOH, and treated with 0.1 M piperidine (90 
ec, 30 min.). After lyophilization, cleavage products were analyzed on a 6% 
1:20 cross-linked, 48% urea polyacrylamide gel, 0.4 mm thick. Lane 1: A 
sequencing reaction. Lane 2: G sequencing reaction. Lane 3: pUCLEU2C 
restriction fragment incubated without oligonucleotide and piperidine 
treated. Lane 4: 2 11M N-bromoacetyloligonucleotide Alk-19. Lane 9: 400 nM 
N -bromoacetyloligonucleotide Alk-19. Lane 14: 80 nM N-
bromoacetyloligonucleotide Alk-19. Lane 19: 16 nM N-
bromoacetyloligonucleotide Alk-19. Lanes 5-8: 2 11M N-
bromoacetyloligonucleotide Alk-9. Lanes 10-13: 400 nM N-
bromoacetyloligonucleotide Alk-9. Lanes 15-18: 80 nM N-
bromoacetyloligonucleotide Alk-9. Lanes 20-23: 16 nM N-
bromoacetyloligonucleotide Alk-9. Lanes 6, 11, 16, 21: 80 nM oligonucleotide 
Coop-l0. Lanes 6, 12, 17, 22: 400 nM oligonucleotide Coop-l0. Lanes 8, 13, 18, 
23: 2 11M oligonucleotide Coop-l0. 
,222 
1 2 3 4 5 6 7 8 9 1011 12 13 141516 17 18 192021 22 23 
2mMAlk-9 400 nMAlk-9 80 nMAlk-9 16 nM Alk-9 
A G C 19 0 .08 0.4 2 19 0 .08 0.4 2 19 0 .08 0.4 2 19 0 .08 0.4 2 -------- --~~- - --- -.... 
--... --._. --~-- - -- -
223 
16 80 400 2000 
Alk-9 concentration (nM) 
mi 0 nM Coop-lO 
[] 400 nN Coop-lO 
Fig. 4.36. Yield of alkylation observed upon incubation of the N-
bromoacetyloligonucleotide Alk-9 with pUCLEU2C DNA at four different 
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Fig. 4.37. Yield of alkylation observed upon incubation of N-
bromoacetyloligonucleotide Alk-9 with pUCLEU2C DNA as a function of the 
concentration of oligonucleotide Coop-lO, which binds an abutting site. 
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the higher affinity of Coop-10 for this site. The yield of alkylation by N-
bromoacetyloligonucleotide Alk-9 increases by a factor of 10 upon addition of 
400 nM Coop-10. At 16 nM Alk-9, the presence of 400 nM Coop-10 increases 
the binding affinity of Alk-9 by a factor of 10. 
The effect of Coop-10 concentration on the binding affinity of Alk-9 is 
depicted in Figure 4.37. Addition of small amounts of Coop-10 results in an 
increase in binding affinity. Higher concentrations of Coop-10 do not increase 
cleavage efficiency, and,at high Coop-10:Alk-9 ratios, eventually lead to 
decreases in binding of Alk-9, due to competition between the two 
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Fig. 4.38. Yield of alkylation observed upon incubation of N-
bromoacetyloligonucleotide Alk-9 with pUCLEU2C DNA as a function of the 
concentration of oligonucleotide Coop-10, which binds an abutting site. 
Approximate dissociation constants for the oligonucleotide Alk-9 at each 
concentration of Coop-10 can be inferred from this plot. 
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Cleavage efficiencies as a function of Alk-9 concentration are plotted in 
Figure 4.38. Approximate binding affinities for Alk-9 at each Coop-l0 
concentration can be determined. The dissociation constant for the 19 base 













The dissociation constant for Alk-9 in the absence of Coop-l0 is 
approximately 400 nM. In the presence of 400 nM Coop-l0, the binding 
affinity increases by about a factor of 10 (dissociation constant decreases to 40 
nM). Higher Coop-l0 concentrations do not result in increased binding 
affinities. In no case do these cooperatively binding systems approach the 
binding affinity of the 19 base oligonucleotide Alk-19, which has a 
dissociation constant of less than 10 nM. 
Effect of oligonucleotide length and cooperative interactions on cleavage 
of large chromosomal DNA. The effect of oligonucleotide length and the 
ability of oligonucleotides to cooperatively bind to large DNA was studied on 
yeast chromosomal DNA. Cleavage of yeast chromosome III by 
oligonucleotides Alk-7 through Alk-19 was accomplished (Figure 4.39). 
Oligonucleotides> 12 bases in length display high cleavage yields under these 
experimental conditions (micromolar in N-bromoacetyloligonucleotide). 
Rapid decreases in cleavage efficiency are observed with oligonucleotides less 
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Figure 4.39. Cleavage of yeast chromosomal DNA by N-
bromoacetyloligonucleotides Alk-7 through Alk-19. Autoradiogram of a 
DNA blotting experiment after pulse field gel electrophoresis. 
A. Alkylation efficiency as a function of oligonucleotide length. Agarose 
plugs containing DNA from the yeast strain SEY6210C were equilibrated in 
1.0 mM Co(NH3) 6 + 3, 20 mM Hepes pH 7.0 and 2 11M N-
bromoacetyloligonucleotide 5. After 60 hours, the plugs were washed in 0.1 % 
piperidine, 100 mM NaCl, 10 mM EDTA, 10 mM Tris pH 8.0 (3 washes 10 min. 
each) and incubated for 12 hours at 55°C. The plugs were then equilibrated 
with O.5x TBE buffer, and loaded into a 1.0% agarose gel for pulse field gel 
electrophoresis. Separation was accomplished by electrophoresis at 200 V for 
24 hours. Pulse times were ramped from 10 - 60 seconds for the first 18 hours, 
followed by 60 -90 sec. over the last 6 hours. Lane 1: yeast chromosomal DNA 
incubated in the absence of oligonucleotide and not treated with piperidine. 
Lane 2: yeast chromosomal DNA incubated in the absence of oligonucleotide 
and treated with piperidine. Lane 3: yeast chromosomal DNA incubated with 
N-bromoacetyloligonucleotide Alk-7. Lane 4: yeast chromosomal DNA 
incubated with N -bromoacetyloligonucleotide Alk-9. Lane 5: yeast 
chromosomal DNA incubated with N-bromoacetyloligonucleotide Alk-12. 
Lane 6: yeast chromosomal DNA incubated with N -
bromoacetyloligonucleotide Alk-14. Lane 7: yeast chromosomal DNA 
incubated with N-bromoacetyloligonucleotide Alk-19. 
B. Alkylation efficiency by oligonucleotides binding abutting. target sequences 
within yeast chromosomal DNA. This experiment was conducted at a pH of 
6.8, and all lanes were treated with piperidine. Lane 1: yeast chromosomal 
DNA incubated in the absence of oligonucleotide. Lane 2: yeast chromosomal 
DNA incubated with N-bromoacetyloligonucleotide Alk-19. Lane 3: yeast 
chromosomal DNA incubated with 2 11M N-bromoacetyloligonucleotide 
Alk-9. Lane 4: yeast chromosomal DNA incubated with 2 11M N-
bromoacetyloligonucleotide Alk-9 and oligonucleotide Coop-l0 (211M). Lane 
5: yeast chromosomal DNA incubated with 2 11M N-
bromo acetyl oligonucleotide Alk-9 and oligonucleotide Coop-l0 (10 11M). 
A. 
1 2 
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than 12 bases in length, in agreement with data obtained on plasmid DNA in 
solution. 
Cooperative binding to chromosomal DNA was investigated using two 
different concentrations of Coop-l0 at 2 ~M N-bromoacetyloligonucleotide 
Alk-9. In the presence of 2 ~M Coop-l0, a two-fold increase in cleavage 
efficiency is observed. Increasing the Coop-l0 concentration results in a 
decrease in cleavage efficiency, presumably due to competition of the two 
oligonucleotides for the same binding site. This indicates that two 
oligonucleotides can bind in a cooperative manner to a site found among 
almost 14 x 106 base pairs of DNA. 
Conclusions 
Efficient DNA alkylation can be accomplished using N-
bromoacetyloligonucleotides ~ 12 bases in length. Approximate dissociation 
constants for oligonucleotides 7, 9, 12, 14 and 19 bases in length have been 
determined. Degenerate N-bromoacetyloligonucleotides modify DNA with 
15-20% efficiencies on each strand, thus double strand modification 
efficiencies are low. This makes the identification of triplex/ alkylation sites 
using degenerate N-bromoacetyloligonucleotides difficult. 
Oligonucleotides binding to abutting sites on double helical DNA can 
interact in a cooperative manner which results in a ten-fold increase in 
binding affinity. A two-fold increase in binding affinity was observed for 
these oligonucleotides binding to yeast chromosomal DNA. This indicates 
that the cooperative binding of short oligonucleotides can be used to bind to 
sites on large DNA. 
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Part V 
Preliminary Studies on Use of 
N-Bromoacetyloligonuc1eotides to Effect 
Downstream Inhibition of Transcription 
Inhibition of Transcription by N-bromoacetyloligonuc1eotides downstream 
from the site of transcriptional initiation. 
Triple helix formation offers a method of targeting single sites within 
genomic size DNA, and the therapeutic potential of this motif has spawned 
great interest. Maher, Wold and Dervan have studied the effect of triple helix 
formation near the site of transcriptional initiation; however, preliminary 
data indicate that oligonucleotide-directed triple helices within the actual 
gene itself are not sufficiently stable to inhibit elongation of transcripts.106 
Cross-linking of the oligonucleotide to the duplex, or site specific 
modification of the duplex by N-bromoacetyloligonucleotides, may enable the 
use of N-bromoacetyloligonucleotides as inhibitors of DNA transcription 
downstream from promoter sequences. 
Plasmid pTPTR was constructed to determine the effect of 
oligonucleotide-directed triple helices on the transcriptional efficiencies of the 
bacterial RNA polymerases T3 and T7. Plasmid pTPTR was constructed by 
Jim Maher via ligation of oligonucleotides containing binding and alkylation 
sites (properly positioned guanine bases) into the plasmid pLJMl. The 
plasmid contains T3 and T7 promoter sites on opposite strands; therefore, it is 
possible to study the effect of triple helix formation and subsequent duplex 
modification both on the transcribed and non transcribed strands. 
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Fig. 4.40 Coarse resolution map of transcribed region of plasmid pTPTR. 
Plasmid pTPTR was constructed to allow the study of the effect of N-
bromoacetyloligonucleotide-directed modification of double helical DNA on 
transcriptional efficiency by the bacterial polymerases T7 and T3. The 
polymerases transcribe in the direction and along the strand indicated. Use of 
both polymerases allows determination of the effect of strand modification on 
either the transcribed or non-transcribed strand. To study transcription by T7, 
DNA cut with Sal I is used. Studies with T3 polymerase are conducted using 
DNA linearized with BamH I. In this way, full length transcripts from each 
promoter are approximately 400 bases in length. Inhibition at the triplex site 
should result in the production of prematurely terminated transcripts - 300 
(T7 transcript) and - 100 (T3 transcript) in length. Cleavage of the DNA using 
Hind III results in a transcript whose length is approximately equal to that of 
transcripts terminated at the triplex site. 
Transcription by the polymerases T3 and T7 was studied on fragments 
obtained by cleavage of the plasmid pTPTR by BamH I and Sal I respectively. 
Full length transcripts from each promoter are approximately 400 bases in 
length. The triplex site is located approximately 100 base pairs from the T3 
promoter and 300 base pairs from the T7 promoter. Transcription of a DNA 
template previously cut using Hind III results in the production of a fragment 
of the size expected if termination of transcription occurs at the triplex site. If 
transcriptional termination occurs at the alkylated guanines, the T3 and T7 
transcripts will be slightly longer than Hind III marker transcript, since the 
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modified guanines on each strand are slightly downstream of the Hind II site 
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Fig. 4.41. Nucleotide resolution map of the triplex site within the transcribed 
region of pTPTR. The target sequence constructed within plasmid pTPTR and 
the oligonucleotides synthesized for studies of transcriptional inhibition by 
unmodified and N-bromoacetyl-oligonucleotides downstream from 
promoter sites are indicated. Oligonucleotides are aligned above the bases 
they are designed to bind, with the exception of cross-over oligonucleotide 23. 
The N-bromoacetyloligonucleotide 23 binds and alkylates both strands of the 
duplex by crossing over in the major groove as described by Horne and 
Dervan.21 Guanine bases targeted for alkylation by oligonucleotide 23 are in 
bold. The guanine base targeted for alkylation by oligonucleotides TRSALK-9 
and TRSALK-19 is indicated by the arrow. These oligonucleotides bind and 
alkylate only the strand transcribed by the T3 polymerase. The central 
location of the Hind III site (S'-AAGCTI-3') is indicated. 
The plasmid pTPTR was digested with enzymes to produce DNA 
fragments truncated approximately 400 base pairs downstream from each 
promoter site. The DNA was incubated with both N-bromoacetyl and 
unmodified oligonucleotides. Transcription of the DNA results in the 
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Fig. 4.42. Transcriptional inhibition downstream of promoter sites by 
oligonucleotides and N-bromoacetyloligonucleotides. Double stranded 
template from plasmid pTPTR was cut with Sal I for studies with polymerase 
T7; with BamH I for studies with polymerase T3. Linearized DNA was 
incubated with 2 IlM oligonucleotide at 37 DC in 1 mM Co(NH3)6+3, 20 mM 
Hepes pH 7.2. After 24 hours, the reactions were precipitated and washed, 
than dissolved in Ix transcription buffer and polymerase and ATP, CTP, GTP, 
and a-32P-UTP added. After 1 hour at 37 DC, formamide was added, and the 
reactions loaded directly onto a 6% polyacrylamide denaturing gel. Lanes 1-9: 
DNA template linearized with Sal I. Lanes 10-18: DNA template linearized 
with BamH I. Lane 1 and 10: transcription of linearized DNA. Lanes 2 and 11: 
transcription of linearized DNA cut at the triplex site with Hind III. Lanes 3 
and 12: Incubation with oligonucleotide TRS9. Lanes 4 and 13: Incubation 
with N-bromoacetyloligonucleotide TRSALK-9. Lanes 5 and 14: Incubation 
with oligonucleotide TRSI9. Lanes 6 and 15: Incubation with N-
bromoacetyloligonucleotide TRSALK-19. Lanes 7 and 16: Incubation with 
oligonucleotide TRS9 and Coop-l0. Lanes 8 and 17: Incubation with N-
bromoacetyloligonucleotide TRSALK-9 and Coop-l0. Lanes 9 and 18: 
Incubation with N-bromoacetyl-cross-over oligonucleotide 23. 
Full Length ~ 
17 Runoff ~ 
T3 Runoff ~ . 
233 
~-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
17 T3 




production of 400 base full length transcripts. Inhibition of transcription at 
the triplex site results in the production of shorter truncated transcripts. 
DNA was incubated with a series of unmodified and N-
bromoacetyloligonucleotides under conditions where efficient alkylation 
occurs (1.0 mM Co(NH3)6+3, 20 mM Hepes pH 7.2). After incubation at 37°C 
for 24 hours, the DNA was precipitated and dissolved in transcription buffer 
(provided by the manufacturer) containing spermidine (2 mM), buffer (Tris, 
pH 7.8), and Mg+2 (6 mM). Transcription by both polymerases with each type 
of oligonucleotide was studied. Fig. 4.42 indicates that inhibition of 
transcription occurs only in cases where the DNA was incubated with N-
bromoacetyloligonucleotides. Unmodified oligonucleotides have no effect on 
the rate of transcription. Inhibition of transcription occurs only on the strand 
modified by the bromoacetyl group. For instance, T7 transcription is inhibited 
only by the cross-over oligonucleotide 23, since it is the only oligonucleotide 
which targets for modification a guanine within the T7 transcribed strand. 
Cross-over oligonucleotides inhibit transcription on both strands, since both 
strands are modified by this type of N-bromoacetyloligonucleotide. 
Termination of transcription at modified sites occurs close to the site of 
modification. Transcription of Hind III cleaved DNA results in a fragment 
slightly shorter than the transcript from DNA modified by N-
bromoacetyloligonucleotide 23. This oligonucleotide modifies the DNA 10 
bases downstream from the Hind III cleavage site (Fig. 4.41). The N-
bromoacetyloligonucleotide TRSALK-19 modifies the DNA an additional 11 
bases downstream. Although no sequencing analysis was conducted, 
comparison of the lengths of transcripts obtained from DNA templates 
alkylated at these two positions indicates that transcriptional termination 
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occurs approximately 10 and 20 bases from the Hind III site. This places the 
site of termination close to the site of DNA modification. The exact site of 
termination might be determined using a template extension assay. 
In the experiment described above, the triple helix may not be stable 
under the transcription conditions. To determine if triplexes formed during 
the transcription reaction inhibit transcription, oligonucleotides were 
incubated with target DNA in buffer compatible with triplex formation and 
transcription (2 mM spermine, 6 mM Mg+2, 20 mM Hepes pH 7.1). 
Transcription was initiated by direct addition of triphosphates and 
polymerase. Under these conditions, premature termination was observed in 
cases where the transcribed strand contained a guanine targeted for 
modification by a N-bromoacetyloligonucleotide (data not shown). No 
inhibition of transcription was observed upon incubation of the template 
DNA with unmodified oligonucleotides. These data indicate that 
transcriptional inhibition does not occur unless oligonucleotide-directed 
triple helix formation results in modification of the duplex on the strand 
being transcribed. 
The effect of buffer composition and the type of lesion at the triple 
helical complex was studied. In this experiment, the DNA was incubated 
with N -bromoacetyloligonucleotide Alk-19 under several different 
conditions. After incubation for 24 hours at 37°C, the DNA was treated in a 
manner which attempted to produce predominantly a single type of lesion 
(see subsequent discussion). The efficiency of transcription by T3, which 
transcribes the strand modified by TRSALK-19, was determined. The results 
are summarized in Fig. 4.43. 
Effect of buffer composition. Duplex DNA was incubated with the N-
bromoacetyloligonucleotide TRSALK-19 for 24 hours in a solution containing 
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one of the following salt compositions: no salts; Hepes (25 mM, pH 7.1) 
alone; Hepes with magnesium (6 mM); Hepes with spermine (2 mM); Hepes, 
spermine and magnesium; or Hepes and cobalt hexamine (1 mM). After 24 
hours, the reactions were precipitated and the DNA resuspended in 
transcription buffer. Transcription was than effected by addition of 
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Fig. 4.43. Inhibition of the polymerase T3 at the site of triple helix formation 
as a function of the type of legion and the reaction buffer. 
Fig. 4.43 indicates that limited transcriptional inhibition is observed in 
buffers containing no salt or little salt. This is presumably due to low 
modification yields due to the instability of the triplex. Addition of 
magnesium does not improve the efficiency of inhibition, despite the known 
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stabilizing effect magnesium ions have on triplexes (see Chapter 11).105,107 
Addition of spermine increases the amount of premature transcript 
termination. Incubation of the DNA with the N-bromoacetyloligonucleotide 
in a buffer containing Hepes, spermidine, and magnesium (transcription 
buffer) results in lower transcriptional inhibition. This suggests that 
magnesium ions inhibit modification of DNA by N-
bromoacetyloligonucleotides. Incubation of the DNA and N-
bromo acetyl oligonucleotides in Co(NH3)6+3 and Hepes, followed by 
transcription in transcription buffer, results in the highest yields of 
prematurely terminated transcripts . It was previously reported that lower 
yields of DNA modification by N-bromoacetyloligonucleotides are observed 
in buffers containing spermine. The increased yields of inhibition observed 
upon incubation of N-bromoacetyloligonucleotides with DNA in optimal 
alkylation buffers is most probably due to the increased yield of DNA 
modification in the absence of spermine. 
Effect of type of lesion. Binding of N -bromoacetyloligonucleotides to 
DNA can result in the formation of any of several types of complexes: (1) a 
noncovalent triple helical complex; (2) a complex containing a covalently 
attached oligonucleotide to the N-7 position of guanine; (3) a complex 
containing a depurinated guanine in which the oligonucleotide remains 
bound to the DNA with the depurinated guanine stacked and hydrogen 
bonded in the DNA duplex. To determine the ability of each of the complexes 
listed above to inhibit transcription, the DNA was treated in one of the 
following ways: (1) incubation of the N-bromoacetyloligonucleotide with the 
DNA in one of the solutions previously described; it is suggested that this 
results in the production of predominantly covalent oligonucleotide-double 
helical complexes; (2) incubation of the N-bromoacetyloligonucleotide with 
238 
the DNA, followed by heating to effect depurination. This produces 
predominantly the depurinated complex containing a guanine intercalated 
and hydrogen bonded in the duplex DNA; (3) incubation of the DNA with N-
bromoacetyloligonucleotide, followed by piperidine treatment to effect strand 
scission. 
It is expected that complete termination of transcription should occur at 
sites of strand scission. Strand scission effected by piperidine treated does not 
increase the extent of inhibition of transcription. This indicates that the 
covalent and depurinated complexes are as efficient at inhibiting 
transcription as a break in the phosphodiester backbone, and suggests that in 
vitro the bacterial polymerase T3 cannot read through these modifications, or 
that depurination and/or strand scission occurs spontaneously under the 
conditions of the reaction (37 °e, 24 hours). 
It should be noted that a variety of repair mechanisms exist in cells 
which rapidly identify and repair methylated bases and depurinated sites. It is 
unknown how quickly or with what efficiencies these enzymes could repair 
the lesions produced by N-bromoacetyloligonuc1eotides. These enzymes may 
be inhibited from the repair of lesions associated with N-
bromoacetyloligonucleotides by the presence of a triplex at the site of 
modifica tion. 
Conclusions 
Inhibition of transcription downstream from promoter sites via triple 
helix formation occurs only if modification of the transcribed strand occurs. 
The site of termination of the transcript is near the site of modification. Such 
modification is inhibited by the presence of Mg+2 and spermine. The 
efficiency of transcriptional termination is not increased by effecting strand 
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scission at the site of modification, indicating that DNA lesions caused by 
reaction of N-bromoacetyloligonucleotides with the DNA target are sufficient 
to result in 100% inhibition of transcription in vitro. 
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Part VI 
Initial Studies for the Determination of the Termini and End Products 
Obtained upon Alkylation of Double Helical DNA by 
N-Bromoacetyloligonucleotides 
Presented here are preliminary data concerning analysis of the nature of 
the mechanism of cleavage effected by N-bromoacetyloligonucleotides. This 
data represents part of a continuing project within the group to fully 
characterize the site of reaction of N -bromoacetyloligonuc1eotides with 
double helical DNA. As such, the data is not complete, and this part of the 
thesis merely represents a summary of work accomplished in this area. 
Analysis of DNA termini produced by DNA alkylation/cleavage mechanism 
The proposed mechanism of cleavage predicts the production of 3' and 5' 
phosphate ends identical with those observed with Maxam-Gilbert 
sequencing reactions (Fig. 4.2).62,63 N-Bromoacetyloligonuc1eotide 5 was 
incubated with 3' and 5' 32p labeled DNA fragments containing the triplex 
target site approximately 40 bp removed from the 32p label. The cleavage 
products were analyzed on a 15% polyacrylamide high resolution gel, and 
migrate with those obtained in a standard Maxam-Gilbert G reaction, known 
to be 3' and 5' phosphate (Fig. 4.44).62,63 Treatment of 3'-end-Iabeled DNA 
with calf alkaline phosphatase removes terminal 5' phosphates.?7 Treatment 
of N-bromoacetyloligonuc1eotide cleaved DNA with CAP results in a 
fragment with slightly slower mobility in a polyacrylamide gel (Fig. 4.44A, 
lane 3). Subsequent treatment of this fragment with kinase and ATP results 
in addition of a phosphate to the 5' hydroxyl.77 The product thus obtained 
241 
again co-migrates with the fragment obtained directly from the alkylation 
reaction before removal of the 5' phosphate (Fig. 4.44A, lane 4). 
5'-End-Iabeled DNA was cleaved using N-bromoacetyloligonucleotides. 
The product migrated with that produced by methylation/strand scission 
using dimethyl sulfate/piperidine as prescribed by Maxam and Gilbert,62,63 a 
procedure which produces 3' phosphate ends (Fig. 4.44B, lane 1 and 2). This 
DNA was subsequently treated with kinase under conditions known to result 
in removal of 3' phosphates108 A decrease in the migration rate of the band is 
observed (Fig. 4.44B, lane 3). These data indicate that alkylation of DNA by N-
bromoacetyloligonucleotides followed by piperidine treatment results in the 
production of 5' and 3' phosphate end products. 
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Fig. 4.44. Enzymatic analysis of the ends produced upon cleavage of DNA 
using the N-bromoacetyloligonucleotide alkylation/piperidine cleavage 
mechanism. 
A. Autoradiogram of a high resolution 15% denaturing polyacrylamide gel of 
cleavage products from the reaction of oligonucleotide 5 with 3' 32p end-
labeled fragment (Pst I/Eco0109 I) from plasmid pUCALK. Reaction 
conditions were 1 11M oligonucleotide 5, 20 mM Hepes, pH 7.4, 0.8 mM 
Co(NH3)+3, and 10,000 cpm end-labeled DNA in a total volume of 15 Ill. 
Reactions were incubated at 37 ec for 36 hours, precipitated with 
NaOAc/EtOH, washed with 70% EtOH, and treated with 1.0% aqueous 
piperidine (90 ec, 30 min). After lyophilization, the reactions were treated as 
follows. Lane 2: no additional treatment; Lane 3: treated with calf alkaline 
phosphatase under conditions recommended by the manufacturer to 
dephosphorylate 5' phosphates/7 Lane 4: treated as DNA in lane 3, followed 
by precipitation to purify the DNA, and treatment with kinase and ATP 
under conditions which phosphorylate 5' hydroxyl groups.77 Lane 1 is a 
standard OMS Maxam-Gilbert G reaction.62,63 
B. Autoradiogram of a high resolution 15% denaturing polyacrylamide gel of 
cleavage products from the reaction of oligonucleotide 5 with 5' 32p end-
labeled fragment (EcoR 1/ AIWN I) from plasmid pUCALK. Reactions were 
conducted as in (A), and were subsequently treated to produce a single type of 
lesion. Lane 2: no additional treatment; Lane 3: treated with kinase as 
described in Hertzberg, resulting in dephosphorylation of 3' phosphate 
groups.108 Lane 1 is a standard OMS Maxam-Gilbert G reaction.62,63 
A. 1 234 
DMS/piperidine + 
N-bromoacetyl 











B. 1 2 3 
DMS/piperidine + 







Preliminary attempts to identify the product produced during the 
alkylation/cleavage reaction 
The mechanism indica ted in Fig. 4.2 indicates that upon depurination, 
an guanine base remains covalen tl y attached to the oligonucleotide. 
Digestion of the oligonucleotides with phosphodiesterase and 
dephosphorylation with calf alkaline phosphatase should allow isolation of a 
thymidine-linker arm-N7-guanine adduct. 
PA- 3 : 
PA-4: 
5 '-GCTAGTAAAAGAAAAGGAAAGAAAAGTCG - 3 ' 
3 '-CGATCATTTTCTTTTCCTTTCT TTTCAGC -5' 
Fig. 4.45. Sequence of oligonucleotides used to identify product 




N-Bromoacetyloligonucleotide 5 was incubated with oligonucleotides 
PA-3 and PA-4 in 1 mM Co(NH3)6+3, 10 mM pH 7.0 Hepes, and 30% ethanol. 
The three oligonucleotides were heated to 55 °C and allowed to cool to room 
temperature, and than to 4 °C for several hours, after which the reaction was 
transferred to 37°C. The DNA was precipitated with ethanol, and incubated 
with 0.3 M NaOAc (pH 5.2) for 20 min. at 90°C. The DNA was precipitated a 
second time, washed, and incubated in phosphodiesterase buffer with 3 units 
of calf alkaline phosphatase and phosphodiesterase. After 45 min at 37 DC, the 
reaction was analyzed u sing reverse phase HPLC. Analysis was conducted 
using a reverse phase C-18 column (Brownlee Aquapore OD-300 C-18 column 
(200 mm x 4.6 mm) on a Hewlett-Packard HP 1090 with the following solvents 
and gradient: 
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Solvent A: 10 mM ammonium acetate, pH 5.2 










Flow Rate: 0.5 ml/minute 
Retention times under these conditions are as follows: 
amino-thymidine 
N-bromoacety 1 th ymidine 




A new product with a retention time of 25.4 minutes was observed. 
Independent synthesis and purification of a product with an equal 
retention time was accomplished (Fig. 4.46). The known nucleoside 2464 was 
incubated with ethylene diamine. Following removal of the solvent and 
drying of the compound, the aminonucleoside was derivatized using N-
hydroxysuccinimidyl bromoacetate in water. Reaction with 5'-O-DMT-2'-
deoxyguanosine in DMF, followed by purification of the product using prep 
reverse phase HPLC afforded compound 27. NMR is consistent with an 
adduct containing both guanine base and a thymidine with the linker arm. 
The UV of the product shows maxima at both 252 and 273 nm, with 
absorption tailing to > 310 nm. 
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Fig. 4.46. Scheme for the synthesis of expected product from alkylation-
depurination reaction. a) ethylene diamine, rt, 2 days; b) N-
hydroxysuccinimidyl bromoacetate, water; c) 5'-O-DMT-2'-deoxyguanosine, 
DMF, 2 days, 40°C. 
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Part VII 
Materials and Methods 
IH nuclear magnetic resonance (NMR) spectra were recorded on a Jeol 
]NM-GX400 FT 400 MHz spectrometer and are reported in parts per million 
(ppm) from tetramethylsilane. 31p NMR spectra were recorded on a Varian 
Associates EM-390 and are reported in parts per million from phosphoric acid. 
Ultraviolet-visible (UV-Vis) spectra were recorded on a Perkin-Elmer UV 
spectrophotometer. Mass spectra were obtained from the regional mass 
spectroscopy facility at the University of California, Riverside. Flash 
chromatography was carried out under positive air pressure using EM Science 
Kieselgel 60 (230-400 Mesh). Elemental analyses were performed by the 
analytical laboratory, California Institute of Technology. 
High pressure liquid chromatography (HPLC) was accomplished using a 
Hewlett-Packard 1090 liquid chromatograph with a diode array detector and a 
Hewlett-Packard 79994A analytical work station. Analytical reverse phase and 
oligonucleotide preparative HPLC was performed on a Brownlee Aquapore 
00-300 C-18 column (200 mm x 4.6 mm). Analytical and oligonucleotide 
preparative anion exchange HPLC was performed on a Vydac oligonucleotide 
anion exchange 4.6 x 200 mm column. 
Collidine, fluorenylmethyl chloroformate, 
p-ani s ylchlorodi ph en ylme thane, and 2-cyanoethyl-N, N-
diisopropylchlorophosphoramidite were purchased from Aldrich and used 
without further purification. Bromoacetic acid, iodoacetic acid, chloroacetic 
acid, bromoacetamide, and p-nitrophenol were purchased from Aldrich and 
used as received. N -hydroxysuccinimide, succinic anhydride, and 
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triethylamine were used as received from Fluka. CPG-amine solid support 
was purchased from Sigma, and was washed with DMF, methanol, and 
methylene chloride prior to use. Diisopropylethylamine (Aldrich) was 
distilled from CaH2 prior to use. Ethylene diamine, 1,3-diaminopropane, and 
1,4-diaminobutane (all from Aldrich) were distilled just prior to use. Dry 
solvents (DMF, methylene chloride, dioxane) were obtained from Fluka over 
molecular sieves when possible. Methylene chloride used for the synthesis of 
phosphoramidites was dried by passing over a column of basic alumina 
immediately before use. 
Restriction enzymes were obtained from New England BioLabs or 
Boehringer Mannheim, and used with the manufacturer's supplied buffers. 
Polynucleotide kinase and the Klenow fragment were obtained from 
Boehringer Mannheim. Terminal transferase was obtained from BRL with 5x 
reaction buffer. T3 and T7 RNA polymerases and RNase inhibitor were 
obtained from Stratagene. Radioactive nucleotides (32P-a-dATP, 32p-y-ATP, 
32P-a-UTP, 32P-a-ddATP, 32P-a-dCTP, 32P-a-TTP,and 32P-a-dGTP), were 
purchased from Amersham. Prep-a-Gene matrix was purchased from Bio-
Rad. Large scale plasmid purification was accomplished using Maxi-plasmid 
purification kits from Quiagen as suggested by the manufacturer. pUCLEU2 
was constructed by Scott Strobel for the subsequent construction of yeast 
strains containing desired sequences. 
Cobalt (III) hexamine trichloride was obtained from Kodak. 
Phosphoramidites for oligonucleotide synthesis were obtained from 
Cruachem. Plasmid pUC19 used for the construction of pUCALK was 
obtained from Bio-rad. XL-l competent cells were obtained from Stratagene. 
Dideoxy sequencing was accomplished using kits obtained from USB 
(Sequenase 2.0). Sep-Pak cartridges were from Waters. Sephadex was obtained 
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from Sigma and was equilibrated with water. Water was purified using a 
Milli-Q system, and filtered through a 0.45 11M filter. 
Synthesis of Nuc1eosides 
Nucleoside 2.65,66 The known aminonucleoside 164 (820 mg, 1.27 mmol 
lyophilized from dioxane) was dissolved dry dioxane (5 mL). Collidine (500 
ilL, 3.9 mmol, 3 equivalents) was added, and the solution chilled to 0 0c. 
Fluorenylmethyl chloroformate (670 mg, 2.6 mmol, 2 equivalents, dissolved 
in 5 mL dry dioxane) was added over a ten minute period, and the reaction 
warmed to room temperature. After 20 minutes, TLC (5% MeOH in MeCh) 
indicated formation of a single product. The solution was frozen and 
lyophilized. The product was purified by flash chromatography in 2% MeOH 
in MeC12 to afford 1.02 gm of pure product (92% yield). IH NMR (CDC13): 8 
7.72 (m, 2H), 7.55 (m, 3H). 7.13-7.39 (m, 14H), 6.80 (q, 4H), 6.35 (t, J = 7 Hz, 1H, 
Hd, 6.18 (bs, 1H), 5.52 (bs, 1H), 4.48 (m, 1H, H3'), 4.37 (d, 2H-Fmoc), 4.15 (t, 1H-
Fmoc), 4.04 (m, 1H, 1-4'),3.74 (s, 6H, OCH3), 3.38 (m, 2H, Hs'), 3.06-3.20 (m, 4H, 
NCH2), 2.37 (m, 2H, H2') 2.18 (m, 4H). IR (KBr) cm-I : 3367,3065,2933, 2836, 
2370, 1701, 1685, 1676, 1654, 1648, 1508, 1448, 1298, 1251, 1177, 1152, 1091, 1032, 
909, 829, 759, 714, 728. MS: (positive ion FAB) m/z 867 (0.7), 319 (2.2), 304 
(23.6), 303 (100), 179 (12.5), 178 (11), 155 (11), 152 (4), 138 (13), 137 (24). HRMS 
calculated for CSOHSIOlON4 (M+H+): 867.3607. Found 867.3580. 
Phosphoramidite 3. Nucleoside 2 (150 mg, 176 Ilmol) was dissolved in 
dry methylene chloride (3 mL). Diisopropylethylamine (350 ilL, 2 mmol) and 
2-cyanoeth y 1-N ,N -diisopropy lchlorophosphoramidite (100 ilL, 448 Ilmol) 
were added, and the reaction stirred for 3 hours. The reaction was quenched 
with the addition of ethanol (0.5 ml) and diluted with ethyl acetate. The 
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organic layer was washed with an aqueous solution of saturated NaHC03, 
water, and twice with an aqueous solution of saturated NaCl. After drying 
over N a2 S ° 4 and concen tra tion under reduced pressure, flash 
chromatography (500:15:5 methylene chloride:isopropanol:triethylamine) 
afforded 110 mg of product (60% yield) . IH NMR (COCl3): () 8.40 (bs, IH), 7.72 
(t, J= 7.3 Hz, 2H), 7.55 (m, 3H). 7.13-7.39 (m, 13H), 6.79 (m, 4H), 6.33 (m, IH, 
Hl'), 5.49 (m, IH), 4.59 (m, IH, H3o), 4.39 (d, 2H-Fmoc, J= 6.6 Hz), 4.15 (m, IH), 
4.09 (m, IH), 3.77 (s, 6H, OCH3), 3.54 (m, 2H, Hs'), 3.52-3.65 (m, 4H), 3.12-3.24 
(m,4H), 2.57 (t, J= 6.1 Hz, IH), 2.37 (t, J= 6.1 Hz, IH), 2.26 (m, 2H), 1.98-2.06 (m, 
4H), 1.00-1.14 (m, 12H). IR (KBr) cm-I : 3385, 3065, 2966, 2930, 2373, 1715, 1706, 
1701, 1685, 1648, 1508, 1458, 1449, 1251, 1180, 1154, 1081, 1032,978.6,830.1,759.6, 
742.5,700.2. 3Ip NMR (COCI3): () 149.081, 148.812. 
Nucleoside lla. 5-(2-carbomethoxyethyl)-5'-O-OMT-2'-deoxyuridine (767 
mg, 1.24 mmo!) was stirred in 1,3 diaminopropane (5 mL) overnight. The 
solvent was removed by rotary evaporation under vacuum, and the product 
dissolved in dioxane and lyophilized to dryness . The white solid was 
dissolved in dry pyridine (12 mL). Monomethoxytrityl chloride (1.07 gms, 3.5 
mmo!) was added over a period of 12 hours. The reaction was diluted with 
water, and extracted twice with diethyl ether. After concentration, flash 
chromatography afforded 745 mg of product (64.5 % yield). IH NMR (COCl3): () 
7.46 (s, IH), 7.14-7.42 (m, 21H), 6.77-6.84 (m, 6H), 6.32 (t, 1H), 5.67 (t, IH), 4.47 
(m, IH), 3.98 (m, IH), 3.75 (s, 9H), 3.36-3.41 (m, 2H), 3.18 (m, 2H), 2.19-2.24 (m, 
4H), 2.10 (m, 4H), 1.52 (m, 2H) . MS: (positive ion FAB) m/z 930 (1),461 (5),401 
(5),399 (4),355 (5), 325 (6),303 (67), 289 (6), 281 (13),274 (23),273 (100), 267 (6), 
221 (14),207 (17), 191 (7), 147 (45), 137 (10), 136 (19), 105 (7). HRMS calculated 
for Cs(,ffS809N4 (M+): 930.4206. Found 930.4204. 
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Nucleoside llb. Nucleoside lla (224 mg, 240 Ilmo!) was dissolved in dry 
methylene chloride (5 mL). Diisopropylethylamine (400 ilL, 2.3 mmol) and 2-
cyanoethyl-N,N-diisopropylchlorophosphoramidite (100 ilL, 450 Ilmol) were 
added, and the reaction stirred for 10 minutes. TLC (64:32:5 ethyl 
acetate:hexane:methanol) indicated that the reaction was complete. The 
reaction was quenched with ethanol (5 mL) and diluted with ethyl acetate (40 
mL). The organic layer was washed three times with an aqueous saturated 
solution of NaHC03, and once with an aqueous saturated sodium chloride 
solution. After drying (Na2S04) and concentration under reduced pressure, 
flash chromatography (97:2:1 methylene chloride:isopropanol:triethylamine) 
afforded 185 mgs (70% yield) of nucleoside llb. The compound was used 
directly in the machine synthesis of oligonucleotide 13. 
Nucleoside 12a. 5-(2-carbomethoxyethyl)-2'-deoxyuridine (417 mg, 620 
Ilmo!) was stirred in freshly distilled 1,4-diaminobutane (5 mL) for two days, 
with the round bottom flask held just above a heat block, set on "low" to 
prevent crystallization of the solvent. The diaminobutane was removed by 
distillation under vacuum. The product was dissolved in dioxane and 
lyophilized. After lyophilization, the nucleoside was dissolved in dry 
pyridine (6 mL), and monomethoxytrityl chloride (550 mg, 1.78 mmol) was 
added over a period of three hours. The reaction was diluted with water and 
extracted twice with diethyl ether. After concentration, flash chromatography 
in 4% MeOH/MeCl2 yielded 273 mgs of product (52% overall yield) . IH NMR 
(CDCl3): 07.13-7.47 (m, 21H), 6.78-6.91 (m, 6H), 6.32 (t, IH), 5.27 (m, IH), 4.48 
(m, IH), 3.98 (m, IH), 3.76 (d, 9H), 3.43-3.46 (m, IH), 3.32-3.36 (m, IH), 3.02 (m, 
2H), 2.06-2.37 (m, 8H), 1.37 (m, 4H). MS: (positive ion FAB) m/z 944 «I), 304 
(16),303 (50), 281 (5),289 (5), 274 (24), 273 (100),207 (7), 154 (7), 147 (16), 136 (14). 
HRMS calculated for CS7HS909N4 (M-H+): 944.4363. Found 943.4274. 
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Nucleoside 12b. Nucleoside 12a (53 mgs, 56 Ilmol) was dissolved in dry 
methylene chloride (3 mL). Diisopropylethylamine (150 ilL, 0.9 mmol) and 2-
cyanoethyl-N,N-diisopropylchlorophosphoramidite (24 ilL, 100 Ilmol) were 
added, and the reaction stirred for 10 minutes. TLC (64:32:5 ethyl 
acetate:hexane:methanol) indicated that the reaction was complete. The 
reaction was quenched with ethanol (1 mL) and diluted with ethyl acetate (20 
mL). The organic layer was washed three times with an aqueous saturated 
solution of NaHC03, and once with an aqueous saturated sodium chloride 
solution. After drying (Na2S04) and concentration under reduced pressure, 
flash chromatography (230:2:2 methylene chloride:methanol:triethylamine) 
afforded 48 mgs (75 % yield) of nucleoside 12b. The compound was used 
directly in the machine synthesis of oligonucleotide 14. 
N -hydroxysuccinimidyl bromoacetate. N -hydroxysuccinimidyl 
bromoacetate was synthesized as described previously. 68-70 
N-hydroxysuccinimide (2.75 gm, 27.2 mmol) and bromoacetic acid (3.25 gms, 
23.4 mmol) were dissolved in dioxane (30 mL). Dicyclohexylcarbodiimide 
(6.09 gms, 295 mmol) was added, and the reaction stirred for 80 minutes. 
After removal of the urea by filtration, petroleum ether was added and the 
. product crystallized. IH NMR (CDCl3) : 04.64 (s, 1H), 2.82 (s, 2H). N-
hydroxysuccinimidyl iodo- and chloro- acetates were synthesized analogously 
using iodo- and chloroacetic acids. 
Synthesis of CPG-Alk-2. Synthesis of 3'-O-DMT-nucleosides linked to 
CPG solid support via the 5' hydroxyl have been described. l1O This general 
procedure was used to link the amino-thymidine derivative to CPG for the 
synthesis of cross-over molecules of the type described by Horne and 
Dervan.21 
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Nucleoside 16.111,112 5-(2-carbomethoxyethyl)-2'-deoxyuridine64 (15) (430 
mgs, 1.37 mmo!) and imidazole (252 mg, 3.7 mmo!) were dissolved in OMF 
(10 mL) and chilled to 0 dc. tert-Butyl-dimethylsilylchloride (236 mg, 1.57 
mmo!) was added in one portion, and the reaction stirred for 11 hours at 4 dc. 
The reaction was partitioned between diethyl ether and water. The aqueous 
layer was extracted with diethyl ether, the combined organic layers were 
concentrated under reduced pressure, and pure product obtained after flash 
chromatography in 5% MeOH/methylene chloride to afford 472 mgs (80% 
yield) of product. IH NMR (COCl3): 88.26 (5, IH), 7.52 (5, IH, H6), 6.32 (t, J = 6 
Hz, IH, HI'), 4.47 (m, IH, H3'), 4.00 (m, IH), 3.86 (d, J = 3.4 Hz, 2H, HS'), 3.66 (s, 
3H), 2.60 (m, 4H), 2.36 (m, 1H), 2.14 (m, 1H), 0.91 (s, 9H), 0.11 (m,6H). 
Nucleoside 17 .113 5-(2-carbomethoxyethyl)-5'-O-tert-butyldimethylsilyl-
2'-deoxyuridine (16,472 mgs, 1.10 mmo!), dimethoxytrityl chloride (453 mgs, 
1.34 mmol) and pyridine (350 ilL, 4.33 mmol) were refluxed in methylene 
chloride for three hours. The reaction was diluted with methylene chloride 
and washed with water. After separation, the organic layer was extracted 
twice with methylene chloride, and the organic layers combined and 
concentrated under reduced pressure. Flash chromatography (1 % 
MeOH/methylene chloride) yielded 646 mg of product (80% yield) . IH NMR 
(COCI3): 88.35 (s, IH), 7.59 (5, 3H), 7.31-7.39 (m, 7H), 6.92 (d, 4H), 6.45 (m, IH, 
Hl')' 4.34 (d, 1H, H3'), 4.11 (5, 1H, H4'), 3.88 (5, 6H), 3.71 (5, 3H), 3.71-3.74 (m, 1H, 
Hs'), 3.39 (bd, IH, Hs'), 2.62 (m, 4H), 1.66-1.81 (m, 2H, H2'), 0.89 (s, 9H), 0.09 (s, 
3H), 0.04 (5, 3H). 
Nucleoside 18.111 ,112 Nucleoside 17 (860 mg, 1.17 mmo!) was dissolved in 
THF (10 mL). Tetrabutylammonium fluoride (1.0 M, 4 mL.) was added and 
the reaction stirred at room temperature for three hours. The reaction was 
diluted with methylene chloride, washed with an aqueous solution of 
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saturated NaHC03, an aqueous solution of saturated NaCl, dried (Na2S04), 
and concentrated under reduced pressure. Flash chromatography in 1% 
MeOH/MeC12 afforded complete separation from a yellow impurity which 
was otherwise difficult to remove. Yield: 483 mgs, 67%. 1 H NMR (CDCl3): 0 
8.27 (s, IH), 7.57 (s, IH), 7.45 (d, 2H), 7.20-7.35 (m, 7H), 6.83 (d, 4H), 6.27 (t, J = 6 
Hz, IH, HI '), 4.39 (d, J = 6 Hz, IH), 3 .90 (m, IH), 3.80 (s, 6H), 3.62-3.67 (m, IH), 
3.61 (s, 3H), 3.29 (m, IH), 2.99 (t, IH), 2.51-2.62 (m, 4H), 1.80-1.88 (m, 2H, H2')' 
HRMS calculated for C34H3709N2 (M+H+): 617.2500. Found 617.2462. 
Nucleoside 19. Nucleoside 18 (320 mg, 494 ~mol) was stirred in ethylene 
diamine (5 mL) at room temperature. After 36 hours, TLC (3% MeOH/MeC12) 
indicated complete loss of starting material. The reaction was concentrated 
under reduced pressure, dissolved in dioxane, and lyophilized. The resulting 
white powder was dissolved in dry dioxane (8 mL). Pyridine (300 ~L, 3.71 
mmol) was added and the reaction chilled to 0 0c. Fluorenylmethyl 
chloroformate (159 mg, 0.615 ~mol) was added, and the reaction allowed to 
warm to room temperature. After 30 minutes, additional fluorenylmethyl 
chloroformate 050 mg) was added (580 ~mol, 1.19 mmol total). The reaction 
was frozen and lyophilized. Flash chromatography (3% MeOH/MeC12) 
yielded product in high yield 000%), indicatirig the possible presence of an 
impurity. 1H NMR (CDC13): 8 7.64-7.75 (m, 4H), 7.56 (d, 2H), 7.20-45 (m, 14H), 
6.81 (t, 4H), 6.52 (bm, IH), 6.33 (m, IH, H1», 5.32 (bm, IH), 4.39 (d, 2H, Fmoc), 
4.21 (t, IH, Fmoc), 3.85 (m, IH), 3.76 (s, 6H), 3.56-3.64 (m, 3H), 3.24 (m, 4H), 2.52-
2.61 (m, 2H), 2.36-44 (m, 2H), 1.82 (m, 2H, H2'). MS: (positive ion FAB) m/z 
867 «I), 304 (24), 303 (100), 273 (3),227 (5), 213 (3), 210 (5), 179 (16), 178 (13), 154 
(0), 136 (9), 107 (3) . HRMS calculated for CSOHS101ON4 (M+H+): 867.3607. 
Found 867.3619. 
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Nucleoside 20. Nucleoside 19 (368 mgs, 424 Ilmo!), 
dimethylaminopyridine (13 mgs, 106 ~mol), pyridine (400 ~L, 5.0 mmol), and 
succinic anhydride (74.3 mgs, 742 Ilmol) were refluxed in dry methylene 
chloride (15 mL). After 12 hours, TLC (9:1 CHCl3:MeOH) indicated complete 
conversion to a single product. The reaction was diluted with methylene 
chloride, washed twice with ice cold 10% citric acid, once with an aqueous 
solution of saturated NaCt dried (Na2S04), and concentrated under reduced 
pressure. Flash chromatography (5% MeOH/MeCl2) yielded 244 mg of 
product (60% yield) . The low yield reflects the presence of an impurity in the 
starting material. MS: (positive ion FA B) m/z 966 (2), 665 (4), 304 (22t 303 
(100), 243 (10), 213 (9), 179 (15), 178 (14), 149 (25), 137 (34), 136 (47). HRMS 
calculated for CS4HsS013N4 (M+H+): 967.3767. Found 967.3715 .. 
Control Pore Glass-3'-Tamine (21). Nucleoside 20 (220 mg, 227 Ilmol) and 
p-nitro-phenol (81.4 mg, 585 Ilmol) were dissolved in THF (5 mL). 
Dicyclohexylcarbodiimide (84 mgs, 408 ~mol) was added, and the reaction 
stirred for six hours. Additional p-nitrophenol (30 mg 215 ~mol) and 
dicyclohexylcarbodiimide (30 mg, 145 ~mol) were added, and the reaction 
stirred for an additional four hours. The reaction was diluted with diethyl 
ether, washed with an aqueous solution of saturated NaHC03, water, an 
aqueous solution of saturated NaCt and concentrated under reduced 
pressure. Flash chromatography in 80:20 ethyl acetate:methylene chloride 
afforded 222 mgs of product (90% yield), which was used directly to derivatize 
the CPG solid support. 
Controlled pore glass was treated with 1 M triethylamine in DMF. The 
support was filtered over medium porosity glass filter, washed extensively 
with DMF, and dried under vacuum. The para-nitro ester of Alk-2 (60 mg, 55 
~mol) was stirred with approximately 500 mgs of support and 5 ~L of 
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triethylamine in DMF (10 mL) . Use of excess triethylamine results in 
cleavage of the Fmoc protecting group. After 24 hours, the support was 
filtered (medium glass pore) and washed extensively with DMF, methylene 
chloride and methanol. Loading was determined by treatment with 60% 
perchloric acid and measurement by UV of the dimethoxytrityl cation 
released.67 A yield of 20 ~mol/ gm support was achieved. Acetylation of the 
support was achieved using acetic anhydride according to standard 
procedure.67 
Synthesis of oligonucleotides. Oligonucleotides were synthesized on an 
Applied Biosystems 380B automated DNA synthesizer, and deprotected with 
concentrated NH40H at 55 °c for 20 hours . After lyophilization, 
oligonucleotides were purified by electrophoresis through 20% denaturing 
polyacrylamide gels. The probe was eluted from the excised band by 
incubation in 200 mM NaCl, 1 mM EDTA for 24 hours at 37 0c. 
Oligonucleotides were dialyzed against Millipore Ultra-pure water, and their 
concentrations determined based on their UV absorbance (extinction 
coefficients were determined by summing the values for the individual 
nucleosides, using values of e260 = 8800 for T and plk, e260 = 5700 for MeSC, 
~80 = 6400 for T and e280= 8300 for MeSC). 
Derivatization of oligonucleotides. Ten nanomoles of the amino-
oligonucleotide were dissolved in 10 ilL of 200 mM borate buffer, pH 8.9. An 
equal volume of 250 mM N-hydroxysuccinimidyl bromoacetate in DMF was 
added. After five minutes, the solution was injected directly onto a Hewlett-
Packard 1090 HPLC. 
Purification was accomplished using either reverse phase or anion 
exchange chromatography . Reverse phase chromatography was 
,-
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accomplished with a Brownlee Aquapore 00-300 C-18 column (200 mm x 4.6 
mm) using a gradient of 10 - 15% acetonitrile in 100 mM ammonium acetate, 
pH 4.6, over 25 minutes. Retention times for oligonucleotides 4 and 5 under 
these conditions are 15.2 and 16.2 minutes. 
Anion exchange chromatography was accomplished with a Vyadac 
oligonucleotide anion exchange 4.6 x 200 mm column using 20 mM Na2HP04 
(solvent A) and 20 mM Na2HP04, 1 M NaCl (solvent B). The oligonucleotide 
5 was eluted using a gradient of 40-80% B over 60 minutes. Elution times 
were 15.4 minutes for the underivatized oligonucleotide 4, and 18.2 minutes 
for the N-bromoacetyloligonucleotide 5. The product peak was collected and 
extracted with butanol to remove the acetonitrile. Salts were removed using 
a 3 ml Sephadex G-50-80 spin column, and the eluent precipitated with three 
volumes of NaOAc/ethanol and washed with 70% ethanol. The probe was 
diluted in water to determine its concentration via UV analysis, lyophilized, 
and stored at -20°C until needed. 
Oerivatization of Alk-14, Alk-12, Alk-9 and Alk-7 oligonucleotides was 
accomplished as described above. The oligonucleotides were not purified by 
polyacrylamide gel electrophoresis, but were simply deprotected, lyophilized, 
derivatized, and purified using HPLC. Purification of the oligonucleotides 
using anion exchange HPLC was accomplished using the solvents described 
above, with the following gradients: 




20 - 60 % B over 40 minutes 
25 - 65 % B over 40 minutes 
30 - 70 % B over 40 minutes. 
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Separation of the amino-nucleoside, the derivatized nucleoside, and the N-1 
length unmodified oligonucleotide was possible for oligonucleotides of 
length :s; 14 bases. Retention times under these conditions were: 
amino-oligonucleotide N-bromoacetyloligonucleotide 










The dinuc1eosideT-TE (8) was synthesized by coupling of 
phosphoramidite 3 to T-support (Cruachem) using automated synthesis. The 
dinucleoside was deprotected by treatment with concentrated ammonia (55 
ec, 24 hrs), and lyophilized to dryness. Derivatization to the N-
bromoacetyldinucleoside 9 was accomplished using N-hydroxysuccinimidyl 
bromoacetate. HPLC Purification was accomplished using reverse-phase 
chromatography in 100 mM ammonium acetate (pH 4.7), with a gradient of 0 
- 8% acetonitrile from 0 to 24 minutes, followed by 8 - 20% acetonitrile from 
24-50 minutes. Synthesis of the expected hydrolyzed product was 
accomplished by derivatization of 8 with the N-hydroxysuccinimidyl ester of 
glycolic acid. Retention times were: 





Construction of plasmids. 
pUCALK. The plasmid pUCALK was constructed by ligation of 
oligonucleotides of sequence 5'-
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GATCTAAGGGGAAAAGAAAAGGAAAGAAAAAGCTTTCTTCTTCCCTA-
3' and the complementary oligonucleotide 5' -
TCGAT AGGGAAGAAGAAAGCTTTTTCTTTCCTTTTCTTTTCCCTTA-3' 
into pUC19114 linearized with BamH I and Sal I. Linearized plasmid (0.5 Ilgm, 
0.28 pmol) was mixed with ligase buffer, ATP (1 mM final concentration), and 
hybridized oligonucleotides in various ratios, and reacted with ligase for 24 
hours at 6 0c. Competent E. Coli cells were transformed with ligated plasmid 
by mixing 15 III of the ligation reaction with 100 III of cells and 1.7 III of is-
mercaptoethanol. The reactions were placed on ice for 30 minutes, heat 
shocked at 42 °C for 45 seconds, and chilled on ice for 2 minutes. L-B77 media 
(900 Ill) was added and the cells incubated at 37 °C for 1 hour with shaking. 
The cells were plated and selected on an ampicillin media using an a-
complementation assay .77 Colonies were picked, and mini-preps of 
transformants sequenced to insure that the appropriate sequence was present. 
Large scale plasmid preparation was accomplished by growing transformed 
cells overnight in 500 mL of ampicillin containing culture. A Quiagen 
plasmid Maxi purification kit was used according to the manufacturer's 
instructions to obtain purified DNA. Yields were excellent (1.5 mgs/500 ml of 
culture) . . DNA contained a small amount of material which ran as distinct 
bands with slower mobility in agarose gels. 
pUCLEU2C. The plasmid pUCLEU2C was constructed by Scott Strobel by 
ligation of oligonucleotides of sequence 5'-
TCGACTTTTCTTTCCTTTTCTTTT ACTAGT AAAAGAAAAGGAAAGAAA 
AG-3' into the unique Xho I site of plasmid pUCLEU2,31 destroying the Xho I 
site. Competent E. Coli cells were transformed with plasmid Xho I digested 
plasmid pUCLEU2C, and selected on an ampicillin media using an a-
complementation assay. Transformants were sequenced to insure that an 
260 
appropriate sequence was present. Plasmids were purified from 500 mL of 
culture using a Quiagen plasmid Maxi purification kit according to the 
manufacturer's instructions as described above. 
pUCLEU2D. Plasmid pUCLEU2D was constructed by Scott Strobel using 
oligonucleotides containing the sequence 5'-
TCGACTAGTAAAGAAAAAGCTTTCTTCTTACTAG-3' with the procedure 
described above. Large scale preparation followed the procedure previously 
described. 
pTPTR. Plasmid pTPTR was constructed by Jim Maher by ligation of 
oligonucleotides conta i ning the sequence 5'-
GTGACGGAAGAAAGAAGAAAAGAAAAAGCTTTCTTCTTA into the site 
of the plasmid pLJMl. Plasmids were purified as indicated above. 
pUCSfi. The plasmid pUCSfi was constructed by Scott Strobel via 
insertion of an oligonucleotide containing the sequence 5'-
GATCGGCCTCTAGGGCCCTGCA-3' into the polylinker region of the BamH I 
and Pst I linearized parent plasmid, pUC19.31 Because the insertion does not 
contain a frame shift in the lacZ gene, and the two amino acid substitutions 
are conservative, the resulting plasmid continues to yield blue colonies in a-
complementation assays and contains a unique Sfi I site. Subsequent 
insertion of DNA fragments into the Sfi I site can thus be screened via 
blue/white a-complementation assay. 
Production of alternate yeast strain. Yeast strain SEY6210 leu2- was 
grown in a 200 ml liquid culture to an 00600 of 0.7, harvested by 
centrifugation at 5,000 rpm for five minutes at 5° C, washed in sterile H20, 
centrifuged, resuspended in 40 mL 0.1 M LiOAc, 10 mM Tris-HCl pH 8.0, 1 
mM EDTA and incubated at 30 °C for 1 hour . Cells were again harvested by 
centrifugation, resuspended in 2 mL of LiOAc solution and 50 mL of 
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competent cells aliquoted into sterile micro centrifuge tubes. Five Ilg of Pst! 
digested pUCLEU2C was added to the yeast solution and incubated at 30°C for 
one hour. The cells were heat shocked for five minutes at 37 °C and 
harvested by brief (3 sec.) centrifugation. The supernatant was removed, the 
cells resuspended in 125 ml of sterile H20 and plated on yeast minimal media 
plates lacking leucine. Recombinants were detected after two days at 30°C, 
selected colonies restreaked on a second minimal media plate, grown an 
additional two days at 30°C, and screened for proper insertion of the 
oligonucleotide target sites adjacent to the LEU2 gene by PCR amplification 
(using a LEU2 specific primer and a copy of the inserted oligonucleotide as 
primers for amplification) and DNA hybridization. 
PCR amplification was performed using two 20 base oligonucleotides 
which hybridize approximately 250 bp on either side of the oligonucleotide 
insertion site. Chromosomal DNA was prepared from 0.5 mL of yeast liquid 
culture by glass bead lysis followed by PCR amplification with Taq polymerase 
(Perkin Elmer Cetus) according to manufacturer's protocol. The 500 bp 
amplified products were digested with either Xho I or Hind III. Proper 
insertion of the oligonucleotide target sites yields a PCR product cut only with 
Hind III, whereas an improperly modified strain is cut by Xho I. Intact 
chromosomal DNA from Hind III cut transformants was prepared in an 
agarose matrix, separated on a pulsed-field gel and screened for unique 
insertion of the LEU2 gene within chromosome III by Southern blotting with 
the random primer labeled EcoR I/Kpn I fragment from pUCLEU2C. A yeast 
strain meeting these criteria was then used in alkylation reactions with N-
bromoacetyloligon\.!.cleotides. 
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Analysis of alkylation/cleavage reactions to nucleotide resolution. 
Radio-labeling. Plasmid pUCALK was linearized with Pst I, 3'-end-
labeled using terminal transferase and 32p-ddATpl15 in the buffer provided by 
BRL.1l5 After incubation at 37 °C for 45 minutes, unincorporated nucleotides 
were removed by phenol extraction (2x), precipitation with NaOAc (2x), and 
washing with 70% ethanol. Digestion with Ssp I produced bands 659 and 
2064 bp in length. The 659 bp restriction fragment was isolated after 
electrophoresis through 5% polyacrylamide (non-denaturing) by elution of 
the product band at 37 °C using a solution of 200 mM NaCl, 1 mM EDTA. The 
gel pieces were removed by filtration through a 0.45 11M (Centrex) filter, and 
the DNA purified by butanol extraction and a series of ethanol precipitations. 
DNA for end-product analysis was obtained by digestion with Pst I (3' 
end-label) or EcoR I (5' end-label) . After digestion and precipitation of the 
DNA, 3' end-labeling was accomplished using terminal transferase,115 using 
the buffer provided (BRL) and 32P-2',3'-dideoxy-ATP.1l5 After digestion with 
Eco0109, a 783 bp fragment was isolated after 5% polyacrylamide gel 
electrophoresis as described above. Labeling of the 5' end was accomplished 
by linearization with EcoR I in 100 ilL, phenol extraction to remove the 
restriction endonuclease, addition of 100 ilL of Ix CAP buffer and removal of 
the terminal 5'-phosphate with CAP (2 units). After phenol extraction 
(twice), washing with diethyl ether (three times), and NaOAc/ethanol 
precipitation, radio-labeling was accomplished using 32p_y-ATP and 
polynucleotide kinase (37°C, 1 hr.) . Unincorporated nucleotides were 
removed by phenol extraction (twice), precipitation with NaOAc (twice), and 
washing with 70% ethanol. After digestion with AIWNI, the 863 bp 
fragment was isolated after 5% polyacrylamide gel electrophoresis as described 
previously. 
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The plasmids pUCLEU2D and pUCLEU2C were radio-labeled by first 
digesting with Nar I, resulting in the production of linear pieces of DNA 5597 
and 1134 base pairs in length. The DNA was labeled at the 5' end using 
polynucleotide kinase and y_32p ATP, and at the 3' end using the Klenow 
fragment to incorporate a-32P-dCTP and a-32P-dGTP. After labeling, 
unincorporated nucleotides were removed using a 1 ml Sephadex G-50-BO 
spin column. The DNA was digested with EcoR I, producing bands 4.5, 1.1, 
0.9, and 0.2 kilobase pairs in size. The 0.9 kbp band, containing the target 
sequence, was isolated from a 5% polyacrylamide gel and eluted at 37°C by 
incubation of the ground gel slice in a solution of 200 mM NaCl, 1 mM EDTA. 
The ground gel was removed by filtration through a 0.45 !J.M (Centrex) filter, 
and the DNA purified by butanol extraction and a series of ethanol 
precipitations. 
Cleavage reactions. Approximately 10,000 cpm of DNA was incubated in 
20 !J.L containing O.B mM Co(NH3)6+3, 10 mM Hepes pH 7.4 and 100 nM N-
bromoacetyloligonucleotide. After 24 - 36 hours, the reactions were 
precipitated with the addition of NaOAc and EtOH, washed, and treated with 
1.0% piperidine at 90° C for 30 minutes The samples were lyophilized, 
resuspended in formamide loading buffer, and loaded onto an 8% (studies on 
pUCALK plasmid DNA) or 6% (studies on pUCLEU2C and pUCLEU2D 
plasmid DNA) denaturing polyacrylamide gel for analysis . Cleavage 
efficiencies were determined by phosphorimaging (vide infra). 
Rate constants for the reaction of N-bromoacetyloligonucleotide 5 with 
the modified strand in pUCALK and with each strand in pUCLEU2C were 
determined by running several parallel reactions. A reaction mixture 
containing O.B mM Co(NH3)6+3, 20 mM Hepes, pH 7.4, and 1 !J.M N-
bromoacetyloligonucleotide in a final volume of 150 !J.L was divided into 10 
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reactions (15 ilL per reaction). The tubes were incubated at 37°C, and 
individual tubes were quenched at appropriate time intervals by addition of 
0.1 volume of 3 M NaOAc and 3 volumes of ethanol, and storage at -78 °C. 
The reactions were precipitated, washed, and treated with piperidine (1.0% 
aqueous piperidine, 90 °C, 30 minutes). Phosphorimaging of the 6 % gel used 
to separate the cleavage products was used to determine the fraction of intact 
and cleaved DNA. Plotting In(fraction of intact DNA) vs. time yielded 
pseudo first-order kinetics from which rate constants were derived. 
Phosphorimaging. Phosphorimaging analysis was accomplished using a 
Molecular Dynamics PhosphorImager 4005 and IQ software. Typically, a gel 
was exposed to a phosphor-storage screen overnight. The intensity of bands 
corresponding to alkylation/cleavage and uncut DNA was determined for 
both lanes containing DNA incubated with and without N-
bromoacetyloligonucleotides. Band intensity was determined using boxes of 
equal size for each band, with a zero value obtained using a box of equal size 
in a non-exposed part of the gel. 
Double strand modification and cleavage of plasmid DNA. 
Double strand cleavage in solution. Plasmid pUCLEU2C was linearized 
with Hind III, resulting in a linear piece of DNA approximately 6.7 kilobase 
pairs in length. Approximately 1 Ilg of DNA was incubated in 0.8 mM 
Co(NH3)6+3, 10 mM Hepes pH 7.4, and 100 nM N-bromoacetyloligonucleotide 
(final volume 20 ilL) for 24 hours at 37 °C. The DNA was precipitated with 
NaOAc/ ethanol, washed in 70% ethanol, dried, and treated with 100 ilL of 
0.1 % piperidine, 100 mM NaCl, 10 mM Tris pH 8.0, 10 mM EDTA at 55°C for 
12 hours. The DNA was loaded onto a 0.8% ethidium containing agarose gel 
and electrophoresed for 5 hours at 100 V. Size standards were obtained by 
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digesting circular pUCLEU2C with Dra I (yielding fragments 0.2, 0.7, La, and 
4.8 kbp in size) and Ssp I (yielding fragments 0.1, 0.5, 1.2, 1.5, and 3.4 kbp in 
size). 
Cleavage efficiencies were determined from experiments using radio-
labeled DNA and phosphorimaging. Hind III linearized DNA was labeled at 
both ends using Klenow and a-32P-dATP. Unincorporated radioactive 
nucleotides were removed using a 1 ml Sephadex G-50-80 spin column. The 
labeled DNA was incubated with N-bromoacetyloligonucleotide 5 (0.8 mM 
Co(NH3)6+3, 10 mM Hepes pH 7.4, and 100 nM N-bromoacetyloligonucleotide 
5), treated with 0.1 % piperidine (100 mM NaCl, 10 mM EDTA, 10 mM Tris, 
pH 8.0, 55 ec, 12 hrs.), and separation of the cleaved fragments achieved using 
1 % agarose gel electrophoresis. Labeled DNA was also digested with EcoR I, 
Nar I, and Sal I to produce labeled markers approximately 4.8, 3.4, 3.1, 2.6, 2.0, 
and 1.1 kbp in size. After electrophoresis, the gel was dried and exposed. 
Quantitation was accomplished using phosphorimaging as above. 
Cleavage of plasmid DNA in agarose plugs. Cleavage of double helical 
DNA within agarose plugs was effected by mixing Hind III linearized 
pUCLEU2C DNA doubly 32p end-labeled at the 3' end in 1.6 mM Co(NH3)6+3, 
20 mM Hepes pH 7.0 to a final volume of 15 ilL. An equal volume of 2.0% 
agarose solution (50 °C) in water was added, the solution vortexed and chilled 
immediately on ice. The resulting plug was incubated in approximately 100 
ilL of 0.8 mM Co(NH3)6+3 , 10 mM Hepes pH 7.0 and N-
bromoacetyloligonuc1eotide 5 added to a concentration of 500 nM. The plug 
was incubated at 37 ec for 36 hours, washed 3x with 900 ilL of 0.1 % 
piperidine, 100 mM NaCl, 10 mM Tris pH 7.4, 10 mM EDTA. To effect strand 
scission, the plug was soaked in 100 ilL of piperidine solution and heated to 60 
ec (12 hrs) . The DNA plug was melted, loading buffer added to the solution, 
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and the solution was loaded directly. After separation of the products by 
electrophoresis (100 V, 4 hrs .), cleavage efficiencies were determined by 
phosphorimaging. 
Agarose may contain nucleophilic sites capable of reaction with 
bromoacetyl moieties. To protect these sites, DNA was incubated in agarose 
pre-treated by incubation bromoacetamide. Agarose (1.0%) was poured into 
6 x 6 x 100 mm molds to afford a high surface:volume ratio. The resulting 
plugs were incubated with 10 mM bromoacetamide at 37°C for 36 hours, after 
which they were washed extensively with water. After washing, the plugs 
were melted, and plasmid DNA imbedded within them as described above. 
The final agarose concentration in these studies was 0.8%. Reactions with 
these plugs were run as described above. 
Ligation of double strand cleavage products with Sfi I cut ends. 
The plasmid pUCSfi was derived by insertion of the oligonucleotide 
sequence 5'-GATCGGCCTCTAGGGCCCTGCA-3' into the polylinker region of 
the BamH I and Pst! linearized parent plasmid, pUC19. Because the insertion 
does not contain a frame shift in the lacZ gene and the two amino acid 
substitutions are conservative, the resulting plasmid continues to yield blue 
colonies in a-complementation assays and contains a unique Sfi I site. 
Subsequent insertion of DNA fragments into the Sfi I site can thus be 
screened via blue/white a-complementation assay. 
Production of ligatable ends. pUCLEU2C DNA was digested with EcoR I 
to completion and cleaved in high yield using N-bromoacetyloligonucleotide 
5. The resulting 450 and 600 bp fragments were gel purified and cleaned with 
Prep-a-Gene matrix (Bio-Rad) according to manufacture's protocol. Five Ilg of 
pUCSfiI DNA was cut with Sfi I and EcoR I, gel purified and desalted as above. 
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Ten ng of pUCSfiI DNA in ten mL T4 DNA ligase buffer was added to two 
molar equivalents of either of the oligonuc1eotide/EcoR I fragments from 
pUCLEU2C, heated to 55 °C for 5 minutes to denature all sticky ends, cooled to 
16°C, and allowed to react with 10 units T4 DNA ligase for four hours. The 
ligation mixture was used to transform competent E. Coli (XLI-Blue, 
Stratagene) according to manufacturer's protocol. Transformed cells were 
spread on TYE plates containing the antibiotic ampicillin (50 mg/ml) and X-
gal and IPTG for a-complementation. Growth overnight at 37°C produced 
white colonies which were miniprepped by SDS/NaOH lysis and sequenced 
by dideoxynuc1eotide chain termination using the USB Sequenase 2.0 kit. 
Yeast experiments. 
Isolation of yeast genomic DNA and incorporation into agarose. Yeast 
strains containing modified chromosome III were cultured overnight in 100 
ml of media. The yeast cells were spun in 50 ml tubes at 5000 rpm, 4°C, for 
five minutes. The pellet was resuspended in 0.9 M sorbitol, 50 mM EDTA, 20 
mM Tris, pH 7.5, and spun again as above. The pellet was resuspended in 16 
mL of the sorbitol solution and 1/100 volume of 2 mgs/ml zymolyase in 20 
mM phosphate pH 7.0 buffer was added. The solution was incubated at 37°C 
for one hour, and the cells pelle ted as above. After removal of the 
supernatant, the pellet was resuspended in 6 mL of sorbitol solution and 
warmed to 37°C. A solution of 1.8% low melt agarose, 0.9 M sorbitol, 20 mM 
Tris pH 7.5, 50 mM EDTA was prepared and cooled to approximately 45°C. 
Equal volumes of the agarose solution and yeast suspension were mixed and 
rapidly poured into 6 x 6 mm plastic molds, which were chilled immediately 
on ice. After the agarose plugs had solidified, they were removed from the 
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molds and placed in 50 ml sterile polypropylene tubes. Approximately 25 mL 
of a solution containing 0.5 M EDTA, 20 mM Tris, pH 8.0, 1 % lauryl sarcosyl, 
and 1 mg/ml Proteinase K was added to each tube, and the tubes incubated at 
50°C with gentle agitation overnight. The plugs were incubated with a 
second aliquot of Proteinase K solution at a concentration of 0.5 mg/ml for 
approximately two hours at 50°C. The plugs were dialyzed extensively, first 
with a solution of 0.5 M EDTA, and then with a solution of 10 mM EDTA, in 
which they were stored at 4 0C. 
Alkylation of yeast genomic DNA. A typical procedure for 
alkylation/cleavage of yeast chromosomal DNA is described. Changes were 
made to study effect of pH, oligonucleotide concentration, and number of 
cycles on cleavage efficiency. Agarose plugs were cut to approximately 1 mm 
thickness (volume approximately 40 1-lL) and placed in 2 ml Eppendorf tubes . 
The plugs were washed four times with 900 I-lL of 1 mM Co(NH3)6+3, 20 mM 
Hepes pH 7.2, and 5 mM EDTA (triplex/alkylation buffer). After removal of 
the last wash, the plugs were incubated with 120 I-lL of triplex/ alkylation 
buffer, and N-bromoacetyloligonucleotide 5 was added to a concentration of 1 
I-lM. After 20 hours at 37°C, the plugs were washed 4x in 900 I-lL of 10 mM 
Tris, pH 9.5, 10 mM EDTA for 30 minutes each, allowing the N-
bromoacetyloligonucleotide to fully diffuse from the DNA and out of the 
agarose. The plugs were washed 4 times for 15 minutes each with 900 I-lL of 
triplex/alkylation buffer, and incubated with 120 I-lL triplex/alkylation buffer 
and N-bromoacetyloligonucleotide as before. After this second 20 hour 
incubation, the plugs were washed three times (15 minutes) in 900 I-lL of 0.1 % 
piperidine, 100 mM NaCl, 10 mM Tris, pH 8.0, 10 mM EDTA. After removal 
of the final wash, the plugs were heated in 900 I-lL of the above piperidine 
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solution at 55°C for 12 hours. The plugs were washed twice with O.5x TBE 
buffer before casting into a 1.0% agarose gel and electrophoresis using a 
BioRad Chef-DRTM II Electrophoresis control station and cell. 
Electrophoresis was effected at 200 V for 24 hours, with switch times ramped 
from 10 to 40 seconds over the first 18 hours, and from 60 to 90 seconds over 
the last six hours. The gel was stained with ethidium bromide and 
photographed. 
Hybridization with radio-labeled probes. Due to the large size of the 
DNA, efficient transfer to membranes requires fragmentation of the DNA, 
accomplished by exposure of each side of the gel to 254 nm UV 
transilluminator light for 40 seconds. The gel was soaked in 1.0 M NaCl, 0.5 
M NaOH for 30 minutes to denature the DNA, and equilibrated in 1.5 M 
NaCl, 0.5 M Tris, pH 7.4 to neutralize the gel. The DNA was transferred to a 
Schleicher and Schuell Nytran membrane using a Stratagene Pressure 
Control Station (1 hour, 75 psi) . Cross-linking of the membrane was 
accomplished using a Stratagene Stratolinker UV apparatus. The HIS4 probe 
was obtained from Scott Strobel, and was originally obtained from clones 
containing the HIS4 gene. 26,116 The probe was labeled using random probe 
hybridization with degenerate 6mers and a-32P-dCTP.77 Briefly, 3 fJ.L of 
degenerate 6mer (90 OD units/m!), 29 fJ.L of water, and 1 fJ.L of DNA template 
were mixed, heated to 98°C for two minutes, chilled on ice (two minutes), 
and incubated at 37 °C for 20 minutes. OLB buffer (10 fJ.L) (containing dGTP, 
dATP, and dTTP), 5 fJ.L of 32P-a-dCTP, and 1 fJ.L (2 units) of Klenow fragment 
were added and the solution incubated for ~ four hours. 77 Enzyme and 
unincorporated a-32P-dCTP were removed by phenol extraction and a 1 ml 
Sephadex G-50-80 column. Typical yields were 60 x 106 cpm. 
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The membrane was pre-hybridized with 5 mL of a solution containing 
6x SSPE, lax Denhardt's, 1 % SDS, and 50 Ilg/ml Salmon sperm DNA at 42°C 
for 2-4 hours. After removal of this solution, the membrane was washed 
with 2 mL of 6x SSPE, 50% formamide, and 1 % SDS, 50 Ilg/ml salmon sperm 
DNA solution at 42 °C for 30-60 minutes The 32P-Iabeled probe was 
denatured by incubation at 37 °C for 5 minutes with 1/10 volume of 0.1 M 
NaOH, and incubated with the membrane in 2 mL of 6x SSPE, 50% 
formamide, 1 % SDS, 50 Ilg/ml salmon sperm DNA solution at 42°C 
overnight. The blot was washed four times in 25 mL of Ix SSPE buffer, 1 % 
SDS at 42 °C, exposed to film, and cleavage efficiencies quantitated using 
phosphor imaging. 
Determination of oligonucleotide length requirements, cooperativity 
experiments, and cleavage by degenerate oligonucleotides. 
The Nar I/EcoR I 32p 3'-end-Iabeled fragment from pUCLEU2C (10,000 
cpm) was incubated in 1.0 mM Co(NH3)6+3, 20 mM Hepes pH 7.0 with 
oligonucleotides Alk-7 - Alk-19 (length studies) or Alk-9 with/without Coop-
10 (cooperativity studies) at desired concentrations for - 36 hours at 37°C. 
Exact reaction times and conditions are listed in the figure legend associated 
with the individual autoradiogram. The DNA was precipitated, washed, and 
strand scission effected using 1.0% piperidine (90 °C, 30 min.). After 
lyophilization and resuspension in formamide loading buffer, DNA products 
were separated by electrophoresis using a 6% polyacrylamide gel. Cleavage 
efficiencies were determined by phosphorimaging. 
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Determination of rate of reaction between bromoacetamide and DNA. 
The Nar I/EcoR I 32p 3'-end-Iabeled fragment from pUCLEU2C (10,000 
cpm) was incubated in 50 mM NaCl, 40 mM Hepes pH 7.4. An equal volume 
of 2-bromoacetic acid in water was added. The DNA and bromoacetic acid 
were mixed to afford a final volume of 110 ilL, which was aliquoted into 5 
tubes containing 20 ilL each. One tube was immediately quenched by addition 
of three volumes of 0.1 M NaOAc/EtOH, and stored at -78°C. The remainder 
were incubated at 37 °C and, at appropriate time intervals, individual 
reactions were removed from the incubator and quenched as above. After all 
the reactions were quenched, the DNA reactions were precipitated, washed 
(70% ethanol), and treated with piperidine (1 % aqueous piperidine, 90°C, 30 
min.). After lyophilization, the DNA was resuspended in formamide buffer 
and loaded onto a 6% polyacrylamide gel for electrophoresis and analysis by 
phosphorimaging. 
Transcriptional Studies. 
The plasmid pTPTR was constructed by Jim Maher via ligation of 
oligonucleotides containing the sequence 5'-
GTAAGAAAGAAGAAAAGAAAAAGCTTTCTTCTTAG-3' into the plasmid 
pLJMl. This plasmid contains promoters for the T3 and T7 polymerases on 
opposite strands, allowing the study of either T3 or T7 RNA polymerases. 
The cloned site contains binding sites for the 19 base oligonucleotide Alk-19 
and the cross-over N-bromoacetyloligonucleotide 23. 
Plasmid pTPTR was digested with Sal I or BamH I for studies with T7 
polymerases or T3 polymerases respectively. Transcription with T7 or T3 
polymerases to the end of the DNA fragment (run off transcription) results in 
the production of transcripts approximately 400 base pairs in length. The 
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triplex site is located approximately 300 base pairs from the T7 promoter, and 
100 base pairs from the T3 promoter. Thus, premature termination of 
transcription at the triple helix site results in the production of 300 and 100 
base transcripts by the polymerases T7 and T3 respectively. 
Linearized plasmid pTPTR (200 ngms) was incubated in a volume of 20 
ilL with N-bromoacetyloligonucleotide (2 IlM), Co(NH3)6+3 (1 mM), Hepes pH 
7.2 (20 mM) at 37°C for 24 hours. The reactions were precipitated and 
washed, and the DNA dissolved in 10 ilL of a solution containing polymerase 
buffer (final concentrations: 25 mM Tris pH 8.0, 70 mM NaCl, 20 mM MgCl2, 
and 0.4 mM spermidine), CTP (400 IlM), GTP (400 IlM), ATP (400 IlM), DTT 
(10 mM), 3.2 units of RNase inhibitor, two units of polymerase, and 0.04 ilL of 
a-32P-UTP per reaction. Reactions were incubated at 37°C for one hour, 
whereupon 15 ilL of formamide containing 0.05% xylene cyanol and 
bromophenol blue was added directly to the reaction. Approximately 2 ilL 
were loaded onto a 6% polyacrylamide gel for electrophoretic analysis. The 
gel was run for one hour at 1500 V, not allowing unincorporated nucleotides 
to run into the buffer. After transfer to a 3mm Whatman filter paper, the 
bottom of the gel was discarded. Analysis was accomplished using 
phosphorimaging. For analysis of T3 polymerase inhibition, the strength of 
the signal for the truncated transcriptional sequences is multiplied by 4, since 
this fragment is only 0.25 the length of the full length transcript, thus 
containing only 1/4 as many radio-labeled residues. 
In a second set of experiments, N-bromoacetyloligonucleotide TRSALK-
19 was incubated with BamH I cut target DNA in three sets of six reactions. In 
each set, the six reactions contained: (i) no salts; (ii) 20 mM Hepes, pH 7.1; (iii) 
20 mM Hepes and 6 mM Mg+2; (iv) 20 mM Hepes and 2 mM spermine; (v) 20 
mM Hepes, 6 mM Mg+2 and 2 mM spermine; (vi) 1 mM Co(NH3)6+3 and 20 
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mM Hepes pH 7.1. After 24 hours at 37 ec, the reactions were precipitated. 
The first set of reactions were transcribed directly. The second set was first 
treated with 0.3 M NaOAc at 90 ec for 30 minutes to effect depurination, and 
precipitated. The third set was treated with aqueous 1 % piperidine, 90 ec, 30 
minutes, to effect strand scission, followed by precipitation. The reactions 
were transcribed by dissolution of the DNA in transcription buffer (2 mM 
spermine, 6 mM Mg+2, 20 mM Tris pH 8.0) and addition of triphosphates, 
RNase inhibitor, and T3 polymerase as described above. 
Studies for the analysis of site of alkylation reaction. 
Analysis of DNA Termini. Radio-labeled restriction fragments from the 
plasmid pUCALK were obtained by digestion with Pst I for the 3' end-label or 
EcoR I followed by treatment with calk alkaline phosphatase for the 5' end-
label. Radio-labeling with 32P was accomplished using terminal 
transferase115 (3' end-label) or polynucleotide kinase (5' end label), followed 
by digestion with a second restriction endonuclease to produce 3' end-labeled 
(Pst I/EcoOl09) or 5' end-labeled (EcoR II AIWNI) restriction fragments. 
Fragments were purified and isolated using 5% polyacrylamide gels as 
described previously. 
5' end-group analysis was conducted by incubating N-
bromoacetyloligonucleotide 5 with three aliquots of 3' end-labeled DNA in 
the presence of 1 mM Co(NH3)6+3 and 20 mM Hepes, pH 7.2. After 72 hours, 
the DNA was precipitated, strand scission effected using piperidine (1 % 
piperidine, 90 ec, 30 min.), and the solution lyophilized. Two aliquots of 
DNA were dissolved in dephosphorylation buffer, and one unit of calf 
alkaline phosphatase added to each reaction. After 30 minutes at 37 ec, two 
additional units of CAP were added , and the solution incubated for an 
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additional 30 minutes. After phenol extraction to remove enzyme, the DNA 
was precipitated and washed. One aliquot of the DNA was treated with 
kinase in the presence of A TP (37°C, 25 minutes), effecting addition of a 
terminal 5' phosphate. 
3' end-group analysis was conducted by incubating N-
bromoacetyloligonucleotide 5 with two aliquots of 5' end-labeled DNA in the 
presence of 1 mM Co(NH3)6+3 and 20 mM Hepes, pH 7.2. After 72 hours, the 
DNA was precipitated, strand scission effected using piperidine (1 % 
piperidine, 90°C, 30 min.), and the solution lyophilized. One aliquot was 
dissolved in buffer containing 10 mM Tris, pH 6.6, 10 mM Mg+2 and 10 mM 
2-mercaptoethanol, and incubated with 10 units of polynucleotide kinase (37 
°C, 30 minutes) After 30 minutes, an additional 10 units of kinase were added 
(37°C, 30 minutes). The DNA was then precipitated. 
Precipitated DNA from each of the above reactions was dissolved in 
formamide buffer and loaded onto a 15% polyacrylamide denaturing gel. 
Analysis of product produced in alkylation reaction. Equimolar 
mixtures of oligonucleotides PA-3 and PA-4 (2 nmol) were mixed with N-
bromoacetyloligonucleotide 5 (2 nmol) in 1 mM Co(NH3)6+3, 10 mM Hepes 
pH 7.0, 30% ethanol. The solution was heated to 55 °C and allowed to cool to 
room temperature, then incubated at 4 °C for several hours . The reaction was 
transferred to a 37°C incubator. After 36 hours, the reaction was precipitated 
with ethanol, and depurination was effected by incubating the DNA in a 
solution of 0.3 M NaOAc, pH 5.2, at 90 °C for 20 minutes. The DNA was again 
precipitated, washed, and digested with mononucleosides using 
phosphodiesterase and calf alkaline phosphatase. The DNA was suspended 
in a buffer of 100 mM MgCl2, 50 mM Tris, pH 8.1. Digestion with 
phosphodiesterase and calf alkaline phosphatase was accomplished for 2 
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hours at 37°C, after which the reaction was lyophilized, suspended in 10 III of 
water, and injected for anlaysis on HPLC. Analysis was conducted on a 
reverse phase C-18 column (Brownlee Aquapore OD-300 C-18 column (200 
mm x 4.6 mm) on a Hewlett-Packard HP 1090 using the following solvents 
and gradient: 
Solvent A: 10 mM ammonium acetate, pH 5.2 









Retention times under these conditions are as follows: 
amino-th ymidine 
N-bromoacetylthymidine 




Synthesis of expected product from DNA alkylation reaction. 
Nucleoside 25. Nucleoside 2464 was stirred in freshly distilled ethylene 
diamine for 2 days. The ethylene diamine was removed under reduced 
pressure and the product was dried under vacuum. 
Nucleoside 26. Nucleoside 25 (90 mg, 263 Ilmo!) was dissolved in 2 ml of 
water, and N-hydroxysuccinimidyl bromoacetate (90 mg, 342 Ilmol) was 
added. After 10 min., analysis by analytical HPLC (gradient as above) 
indicated that the reaction had proceeded to approximately 50%. After 
addition of an additional 90 mg of N-hydroxysuccinimidyl bromoacetate, the 
reaction was complete. The solution was extracted twice with ethyl acetate, 
the the aqueous layer frozen and lyophilized to a slightly brown solid. 
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Nucleoside 27. Nucleoside 26 (product from above reaction, - 263 Ilmol) 
was dissolved in OMF. S'-0-OMT-2'-deoxyguanosine (300 mg, 500 Ilmol) was 
added, and the reaction stirred at 40 °C for 2 days. The solvent was removed 
under reduced pressure, and the reaction mixture was dissolved in water. 
Non-soluble product and S'-0-OMT-2'-deoxyguanosine was removed by 
filtration, and the product purified on a preparative HPLC (Hewlett-Packard 
Series 1050), using a Vydac Protein and Peptide 218TP210 column. The 
solvents used to effect separation were: 
A: 10 mM ammonium acetate, pH 5.2. 
B: 10 mM ammonium acetate, pH 5.2; 80 % methanol. 







The column was washed with 100% acetonitrile at 4 ml/min following 
each preparative run, to insure removal of S'-0-OMT-2'-deoxyguanosine. 
Retention times observed were: 
N-bromoacetylthymidine 26.1 
Isolated product 21 .9 
A major impurity formed during the reaction with a retention time of 
25.0 was also observed, but was not isolated. The product was lyophilized. 
NMR is consistent with the formation of a guanine-thymidine adduct. 
IHNMR (020, referenced to HDO): d 7.90 (s, IH), 7.53 (s, IH), 6.18 (t, J = 7.0 Hz, 
IH), 4.93 (s, 2H), 4.81 (s, IH), 4.36 (m, IH), 3.93 (m, IH), 3.65-3.75 (m, 2H), 3.13-
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